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Background: The Medical Research Council published the second edition of its framework in 2006
on developing and evaluating complex interventions. Since then, there have been considerable
developments in the field of complex intervention research. The objective of this project was to
update the framework in the light of these developments. The framework aims to help research
teams prioritise research questions and design, and conduct research with an appropriate choice of
methods, rather than to provide detailed guidance on the use of specific methods.
Methods: There were four stages to the update: (1) gap analysis to identify developments in the methods
and practice since the previous framework was published; (2) an expert workshop of 36 participants to
discuss the topics identified in the gap analysis; (3) an open consultation process to seek comments on
a first draft of the new framework; and (4) findings from the previous stages were used to redraft the
framework, and final expert review was obtained. The process was overseen by a Scientific Advisory
Group representing the range of relevant National Institute for Health Research and Medical Research
Council research investments.
Results: Key changes to the previous framework include (1) an updated definition of complex
interventions, highlighting the dynamic relationship between the intervention and its context; (2) an
emphasis on the use of diverse research perspectives: efficacy, effectiveness, theory-based and systems
perspectives; (3) a focus on the usefulness of evidence as the basis for determining research perspective
and questions; (4) an increased focus on interventions developed outside research teams, for example
changes in policy or health services delivery; and (5) the identification of six ‘core elements’ that should
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guide all phases of complex intervention research: consider context; develop, refine and test
programme theory; engage stakeholders; identify key uncertainties; refine the intervention; and
economic considerations. We divide the research process into four phases: development, feasibility,
evaluation and implementation. For each phase we provide a concise summary of recent developments,
key points to address and signposts to further reading. We also present case studies to illustrate the
points being made throughout.
Limitations: The framework aims to help research teams prioritise research questions and design and
conduct research with an appropriate choice of methods, rather than to provide detailed guidance
on the use of specific methods. In many of the areas of innovation that we highlight, such as the use
of systems approaches, there are still only a few practical examples. We refer to more specific and
detailed guidance where available and note where promising approaches require further development.
Conclusions: This new framework incorporates developments in complex intervention research
published since the previous edition was written in 2006. As well as taking account of established
practice and recent refinements, we draw attention to new approaches and place greater emphasis
on economic considerations in complex intervention research. We have introduced a new emphasis
on the importance of context and the value of understanding interventions as ‘events in systems’ that
produce effects through interactions with features of the contexts in which they are implemented.
The framework adopts a pluralist approach, encouraging researchers and research funders to adopt
diverse research perspectives and to select research questions and methods pragmatically, with the
aim of providing evidence that is useful to decision-makers.
Future work: We call for further work to develop relevant methods and provide examples in practice.
The use of this framework should be monitored and the move should be made to a more fluid resource
in the future, for example a web-based format that can be frequently updated to incorporate new
material and links to emerging resources.
Funding: This project was jointly funded by the Medical Research Council (MRC) and the National
Institute for Health Research (Department of Health and Social Care 73514).
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Adaptation Where an existing intervention is modified or tailored to adapt it to a new population,
setting or context (note that this is distinct from ‘adaptation’ as a property of complex adaptive
systems: a change of system behaviour in response to an intervention).
Agent ‘An agent is any entity whose behaviour is autonomous yet complying with implicit or explicit
behavioural rules’ (Signal LN, Walton MD, Ni Mhurchu C, Maddison R, Bowers SG, Carter KN, et al.
Tackling ‘wicked’ health promotion problems: a New Zealand case study. Health Promot Int
2012;28:84–94).
Complex intervention An intervention is conceived to be complex either (1) because of the
characteristics of the intervention itself, for example multiple components or mechanisms of change,
and/or (2) because how the intervention generates outcomes is dependent on exogenous factors,
including the characteristics of recipients, and/or the context or system within which it is implemented.
Complexity-informed research Research that attends to complexity rather than focusing on
controlling for it. This involves being aware of system properties and how they may play a role in how
the intervention affects change.
Context ‘Any feature of the circumstances in which an intervention is conceived, developed,
implemented and evaluated’, for example social, political, economic and geographical context {Craig P,
Di Ruggiero E, Frolich KL, Mykhalovskiy E, White M, on behalf of the Canadian Institutes of Health
Research (CIHR)–National Institute for Health Research (NIHR) Context Guidance Authors Group.
Taking Account of Context in Population Health Intervention Research: Guidance for Producers, Users and
Funders of Research. Southampton: National Institute for Health Research; 2018 [contains information
licensed under the Non-Commercial Government Licence v2.0]}.
Cost–benefit analysis A form of economic evaluation that expresses all gains and costs in monetary terms,
allowing a judgement to be made about whether or not or to what extent an objective should be pursued.
Cost–consequences analysis A form of economic evaluation in which the whole array of outputs is
presented alongside the costs, without any attempt to aggregate the outputs.
Cost-effectiveness analysis A form of economic evaluation that compares the relative costs and
outcomes (effects) of different courses of action. Outcomes are measured in natural units.
Cost–utility analysis A form of cost-effectiveness analysis in which benefits are measured in terms of
a utility measure, such as the quality-adjusted life-year.
Critical realism A philosophy of science associated with realist methods of evaluation. Critical
realism asserts that causes can be understood in terms of mechanisms, rather than just inferred from
sequences of events [Archer M, Decoteau C, Gorski P, Little D, Porpora D, Rutzou T, et al. What is
critical realism? Perspectives: American Sociological Association Theory 2016;38:4–9. URL: www.asatheory.
org/uploads/4/3/3/7/43371669/perspectives_38_2__fall_2016_final.pdf (accessed 1 March 2021);
Bhaskar R. A Realist Theory of Science. New York, NY: Routledge; 2013].
Decision-makers The people who use our research evidence to make decisions on what and how
interventions are implemented in practice. The term ‘research end-user’ is sometimes used in other
documents to mean the same thing. Examples of decision-makers that are relevant here include
policy-makers (local and national), health-care professionals and service managers.
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Difference-in-differences A statistical technique using observational data to mimic an experimental
research design, by studying the differential effect of a treatment on a ‘treatment group’ versus a
‘control group’.
Disability-adjusted life-year An outcome measure that adjusts the change in life expectancy produced
by an intervention according to changes in the level of disability (see also Quality-adjusted life-year).
Economic evaluation Research to determine whether or not an intervention is an efficient use of
resources; ‘the comparative analysis of alternative courses of action in terms of both their costs and
consequences’ (Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the
Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press; 2005).
Effectiveness The degree to which the intervention produces the intended effects in routine practice
rather than in tightly controlled, experimental circumstances.
Efficacy Efficacy studies focus on whether or not an intervention can produce an intended outcome in
an idealised experimental setting.
Efficiency Maximising the benefit to any resource expenditure or minimising the cost of any
achieved benefit.
Equality Equal distribution of resources or benefits among different individuals or groups.
Equity Fair distribution of resources or benefits among different individuals or groups. Fairness is
closely related to whether or not departures from equality are avoidable and how the groups
are defined.
Evaluability assessment A systematic approach to planning evaluation projects.
Evaluation A study carried out to enable judgements to be made about the value of an intervention.
Evaluation studies usually seek to determine whether or not an intervention ‘works’ in the sense of
achieving its intended outcome. Other aims include identifying unanticipated or adverse impacts,
theorising how the intervention works, exploring how it interacts with the context in which it is
implemented, exploring how it contributes to system change and exploring how evaluation evidence
can be used to support real-world decision-making.
Evidence synthesis Comprehensive, systematic and transparent interpretation of a combination of
multiple sources of evidence.
External validity The extent to which the results of a study can be applied to a wider population of
interest or to some other context.
Feasibility study Research carried out before a main study to answer the question ‘Can this study be
done?’ (Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010
statement: extension to randomised pilot and feasibility trials. BMJ 2016;355:i5239).
Fidelity The degree to which an intervention or programme is delivered as intended.
Health economics The study of how scarce resources are allocated among alternative uses for the
care of sickness and the promotion, maintenance and improvement of health, including the study of
how health-care and health-related services, their costs and benefits, and health itself are distributed
among individuals and groups in society.
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Implementation Delivery of an intervention as part of routine practice. Implementation research refers
to ‘deliberate efforts to increase the impact of successfully tested health innovations so as to benefit
more people and to foster policy and programme development on a lasting basis’ [Reproduced from
World Health Organization (WHO). Nine Steps for Developing a Scaling-up Strategy. Geneva: WHO; 2010].
Incremental cost-effectiveness ratio A relative measure of cost-effectiveness. This is obtained by
dividing the difference between the costs of the two interventions by the difference in the outcomes
(i.e. the extra cost per extra unit of effect).
Internal validity The degree to which a study provides unbiased estimates of the causal relationships
under investigation.
Intervention An ‘action or programme that aims to bring about identifiable outcomes’ (Rychetnik L,
Hawe P, Waters E, Barratt A, Frommer M. A glossary for evidence based public health. J Epidemiol
Comm Health 2004;58:538–45). This term is used for everything from medical treatment to changes in
policy; it could be something developed and implemented by the research team, for example a surgical
procedure, or something beyond the researchers’ control, for example a change in welfare policy, such
as the implementation of universal credit. In some interventions, the main aim is not necessarily to
bring about health outcomes, but the intervention may indirectly lead to changes in health.
Interventions can be thought of as interruptions in or changes to a system.
Intervention development The term ‘development’ is used here for the whole process of designing
and planning an intervention from initial conception through to feasibility, pilot or evaluation study.
Key uncertainties Identifying the key uncertainties that exist given what is already known and what
the programme theory, research team and stakeholders identify as being the most important to find
out. These judgements inform the framing of research questions, which in turn govern the choice of
research perspective.
Logic model A method of representing some elements of the programme theory, typically presented
in a linear pathway. Simple logic models may include only observable inputs, outputs and intended
outcomes; more detailed logic (causal) models will include other components of the programme theory
including mechanisms by which an intervention is thought to generate outcomes, and the contextual
dependencies and other preconditions on which that is based.
Mechanism A causal link between an exposure (e.g. to some feature of an intervention) and an outcome.
Mixed-methods evaluation The use and integration of quantitative and qualitative approaches to
collect, analyse and interpret data to answer evaluation questions.
Natural experiment ‘Events, interventions or policies which are not under the control of researchers, but
which are amenable to research which uses the variation in exposure that they generate to analyse their
impact’ (Craig P, Cooper C, Gunnell D, Haw S, Lawson K, Macintyre S, et al. Using Natural Experiments to
Evaluate Population Health Interventions: Guidance for Producers and Users of Evidence. London: Medical
Research Council; 2012) (reproduced with permission). A natural experimental study is the methodological
approach to evaluating the impact of a natural experiment on health or other outcomes.
Process evaluation ‘A study which aims to understand the functioning of an intervention, by examining
implementation, mechanisms of impact, and contextual factors. Process evaluation is complementary
to, but not a substitute for, high quality outcome evaluation’ (Moore G, Audrey S, Barker M, Bond L,
Bonell C, Hardeman W, et al. Process Evaluation of Complex Interventions. Medical Research Council
Guidance. London: Medical Research Council Population Health Science Research Network; 2014)
(reproduced with permission).
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Programme theory Describes how an intervention is expected to lead to its effects and under what
conditions. It articulates (1) the key components of the intervention and how they interact; (2) the
mechanisms of the intervention; (3) the features of the context that are expected to influence those
mechanisms; and (4) how those mechanisms may influence the context (Funnell SC, Rogers PJ.
Purposeful Program Theory. Effective Use of Theories of Change and Logic Models. San Francisco, CA:
Jossey-Bass; 2011). In the economic literature, conceptual modelling is often used to refer to the
process of developing programme theory.
Quality-adjusted life-years An outcome incorporating both quality of life and life expectancy.
Calculated by adjusting the estimated number of years of life an individual is expected to gain from an
intervention for the expected quality of life in those years. The quality-of-life score will range between
0 for death and 1 for perfect health, with negative scores being allowed for states considered worse
than death.
Realist evaluation An approach to evaluation in which researchers develop mid-range theories to take
account of how context and mechanisms of interventions interact to produce outcomes, that is causal
mechanisms of an intervention are context specific. Realist evaluation sets out to answer the question:
‘what works in which circumstances and for whom?’ (Pawson R, Tilley N. Realistic Evaluation. London:
SAGE Publications Ltd; 1997).
Refinement The process of ‘fine tuning’ or making changes to the intervention once a preliminary
version (prototype) has been developed (O’Cathain A, Croot L, Sworn K, Duncan E, Rousseau N,
Turner K, et al. Taxonomy of approaches to developing interventions to improve health: a systematic
methods overview. Pilot Feasibility Stud 2019;5:41).
Resources Things that are used up in the production of output. Money gives a command over
resources but is not a resource per se.
Sensitivity analysis A process through which the robustness of an economic or statistical model is
assessed by examining the changes in results of the analysis when key variables are varied over a specified
range. Sensitivity analysis is used to determine how far conclusions rely on particular assumptions.
Soft system methodologies A set of methods used to engage stakeholders and create conceptual
models about issues or problems to consider ‘real-world’ solutions.
Stakeholders Those who are targeted by the intervention or policy, those who are involved in its
development or delivery or, more broadly, those whose personal or professional interests are affected
(i.e. who have a stake in the topic). This includes patients and members of the public as well as those
linked in a professional capacity.
System A set of things that are interconnected in such a way that they produce their own pattern of
behaviour over time (Meadows DH. Thinking in Systems: A Primer. White River Junction, VT: Chelsea
Green Publishing; 2008).
System boundary A boundary used to define the set of elements that comprise a system of interest to
make research on that system tractable. It is not always feasible, necessary or desirable to consider the
whole system in evaluative research. Nonetheless, it is important to be aware of the wider system and
to justify the choice of boundaries. Boundaries are dependent on the problem and research question,
and can be set in different ways, for example based on geography or concept.
System map A conceptual visual representation of the components within a system. Creating a system
map should involve discussion between a multidisciplinary team to identify the components in the
system and how they interact.
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Systems thinking A holistic way of thinking about complex systems, focusing on the interactions
between entities that comprise a system and between those entities and their environment, rather
than assuming that a system can be understood by breaking it down into its individual entities and
studying each part separately.
Theory Beliefs or assumptions underlying action and explanations of the phenomena of interest. A
distinction can be drawn between grand (high-level generalisations that can be applied across domains),
mid-range (limited to a specific area) and programme theory (specific to an individual intervention).
Theory of the problem Clarification of the problem with stakeholders using the existing research
evidence. Once the problem is defined it should be established how the problem is socially and
spatially distributed, including who is most/least likely to benefit from an intervention. In addition, to
understand the immediate and underlying influences that give rise to the specified problem (Wight D,
Wimbush E, Jepson R, Doi L. Six steps in quality intervention development (6SQuID). J Epidemiol Comm
Health 2016;70:520–5). This is relevant not only in intervention development, but in evaluation of
natural experiments, for which it is important to understand the problem that the policy change/
intervention was attempting to alter.
Utility A measure of the ‘satisfaction’ (benefit) obtained from consuming goods and services.
Value-of-information analysis A quantitative analysis that puts a monetary value on further research
based on the expected gain from reducing uncertainty surrounding the current cost-effectiveness
decision through additional research activities.
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CEEBIT Continuous Evaluation of Evolving
Behavioural Intervention
Technologies
COMET Core Outcome Measures in
Effectiveness Trials
CONSORT Consolidated Standards of
Reporting Trials
CUA cost–utility analysis
DELTA2 Difference ELicitation in TriAls
FFIT Football Fans in Training
GP general practitioner
HIV human immunodeficiency virus
ICAMO intervention–context–
actor–mechanism–outcome
MCDA multi-criteria decision analysis
MRC Medical Research Council
MRP Methodology Research Programme
NICE National Institute for Health and
Care Excellence
NIHR National Institute for Health
Research




PHSG Population Health Sciences Group




QCA qualitative comparative analysis
RCT randomised controlled trial
SAG Scientific Advisory Group
SDIL Soft Drinks Industry Levy
SMART Sequential Multiple Assignment
Randomised Trial
VOI value of information
WHO World Health Organization
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Interventions are actions taken to make a change, for example heart surgery, an exercise programmeor a smoking ban in public. Interventions are described as complex if they comprise several stages or
parts or if the context in which they are delivered is complex.
A framework on how to develop and evaluate complex interventions was last published by the
Medical Research Council in 2006 (Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M.
Developing and Evaluating Complex Interventions. London: Medical Research Council; 2006). This document
describes how the framework has been updated to include advances in research methods and thinking
and presents the new framework document.
The updating process had four stages: (1) review of the literature to identify areas requiring update;
(2) workshop of experts to discuss topics to update; (3) open consultation on a draft of the framework;
and (4) writing the framework.
The updated framework divides the research process into four phases: development, feasibility,
evaluation and implementation. Key updates include:
1. the definition of a complex intervention was changed to include both the content of the
intervention and the context in which it is conducted
2. addition of systems thinking methods: an approach that considers the broader system an
intervention sits within
3. more emphasis on interventions that are not developed by researchers (e.g. policy changes and
health services delivery)
4. emphasis on the usefulness of evidence as the key goal of complex intervention research
5. identification of six elements to be addressed throughout the research process: context; theory
refinement and testing; stakeholder involvement; identification of key uncertainties; intervention
refinement; and economic considerations.
The updated framework is intended to help those involved in funding and designing research to
consider a range of approaches, questions and methods and to choose the most appropriate. It also
aims to help researchers conduct and report research that is as useful as possible to users of research.
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In 2006, the Medical Research Council published guidance for developing and evaluating complex
interventions (Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and
Evaluating Complex Interventions. London: Medical Research Council; 2006), building on a framework
that was published in 2000 (Medical Research Council. A Framework for Development and Evaluation of
RCTs for Complex Interventions to Improve Health. London: Medical Research Council; 2000). The aim was
to help researchers and research funders recognise and adopt appropriate methods to improve the
quality of research to develop and evaluate complex interventions and, thereby, maximise its impact.
Since the 2006 edition of the guidance was published, there have been considerable developments
in the field of complex intervention research. In some areas, the accumulation of experience and
knowledge in the application of approaches and methods has led to the publication of detailed, focused
guidance on the conduct and/or reporting of research. In other areas, new challenges in complex
intervention research have been identified and the reliance on traditional approaches and methods
promoted in previous guidance has been challenged.
There was, therefore, a need to update the 2006 guidance and, given the greater amount of detailed
guidance now available and the need for inclusion of a wider range of approaches, the aim was to
provide a less prescriptive and more flexible guide. The new framework aims to improve the design
and conduct of complex intervention research to increase its utility, efficiency and impact. Consistent
with the principles of increasing the value of research and minimising research waste, the framework
(1) emphasises the use of diverse research perspectives and the inclusion of research users, clinicians,
patients and the public in research teams, and (2) aims to help research teams prioritise research
questions and choose and implement appropriate methods.
Methods
The framework was developed in four stages.
Stage 1
The ‘gap analysis’ aimed to identify and summarise aspects of the previous guidance that required
updating. An initial list of topics to explore further was developed by the project team and the
Scientific Advisory Group. A brief scoping review of existing literature was undertaken for each topic.
This was then used to develop questions to explore in more detail with experts in stage 2. This initial
stage set the agenda for the update.
Stage 2
The expert workshop was facilitated to obtain views and record discussions on topics that should be
newly covered or updated. Participants were identified by the project team and Scientific Advisory
Group, and we aimed to have at least two experts for each of the topics identified in the gap analysis.
These topics were then the starting point for the facilitated breakout discussions. Thirty-six experts
from many disciplines relevant to complex intervention development and evaluation, such as public
health, health services research, clinical research and health economics, participated in the workshop.
Discussions were audio-recorded and these recordings were reviewed and thematically organised and
used to make decisions on the content of the first draft of the updated framework.
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Stage 3
The open consultation (April 2019) aimed to collect views on the first full draft of the framework
document. Consultees were targeted via e-mail, but also through public social media channels.
Consultation responses (n = 52) were organised thematically and the project team, along with the
Scientific Advisory Group, decided how to revise the framework.
Stage 4
The project team, in discussion with the Scientific Advisory Group and with the support of all authors,
drafted the final document.We then sought further review from the Medical Research Council and National
Institute for Health Research (NIHR) Methodology Research Programme Advisory Group and Population
Health Sciences Group, plus another eight experts in May/June 2020, and made final edits accordingly.
Results
The findings from each stage of the process described above supported decisions taken on the content
of the new framework.
Key changes from the previous guidance:
1. We have extended the definition of a complex intervention to include complexity that arises from
the interaction between an intervention and the context in which it is implemented, as well as
complexity arising from the structure of the intervention.
2. We draw on recent developments in thinking and methods to suggest ways in which researchers
can take account of complexity, and we encourage consideration and use of diverse research
perspectives and the pragmatic and pluralist choice of research questions and methods. We define
four overlapping research perspectives that can be drawn on to answer different types of
research questions:
i. Efficacy perspective – to what extent does the intervention produce the intended outcome(s) in
experimental or ideal settings?
ii. Effectiveness perspective – to what extent does the intervention produce the intended outcome(s)
in real-world settings?
iii. Theory-based perspective – what works in which circumstances and how?
iv. Systems perspective – how do the system and intervention adapt to one another?
We encourage consideration of the different research perspectives, particularly how they could be
used to conceptualise and evaluate the intervention, the intervention’s place in the wider systems in
which it is implemented and the interdependence between the two over time. The aim of this is to
encourage appropriate consideration of the potential sources of complexity.
3. We identify six core elements that should be addressed throughout the research process:
i. Context – we have introduced a new emphasis on the importance of context and the value of
understanding interventions as ‘events in systems’ that produce effects through interactions with
features of the contexts in which they are implemented.
ii. Refinement and testing of programme theory – programme theory describes how an intervention is
expected to lead to its effects and under what conditions. The programme theory should be tested
and refined at all stages and used to guide the identification of uncertainties, research questions and
evaluation outcomes. The development of programme theory is a collaborative and iterative process.
iii. Stakeholders – genuine engagement of appropriate stakeholders throughout the research
process and working with them as partners to jointly develop, identify or prioritise interventions
for research and agree programme theories, research perspectives, key uncertainties and
research questions.
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iv. Uncertainties – identifying the key uncertainties that exist given what is already known and what
the programme theory, research team and stakeholders identify as being the most important.
These judgements inform the framing and prioritisation of research questions and should yield
more useful evidence for decision-making.
v. Intervention refinement – the process of ‘fine tuning’ or making changes to the intervention once
a preliminary version (prototype) has been developed. We suggest that ongoing refinement of an
intervention, consistent with the programme theory, can improve the potential implementability
of the intervention.
vi. Economic considerations – the comparative resource and outcome consequences of the interventions
for those people and organisations affected. More emphasis is placed on these than in the previous
guidance because we see them as a key element at all phases of a research project, rather than
simply a set of methods for assessing cost-effectiveness.
We divide the research process into four phases: development, feasibility, evaluation and implementation.
For each, we provide a concise summary of recent developments, key points to address and signposts to
further reading.
1. Development
i. Developing an intervention: we draw heavily on the comprehensive guidance provided by
the INDEX study (O’Cathain A, Croot L, Duncan E, Rousseau N, Sworn K, Turner KM, et al.
Guidance on how to develop complex interventions to improve health and healthcare. BMJ Open
2019;9:e029954). The steps are adequate planning; involving stakeholders; bringing together
an intervention development team with relevant expertise; review related existing literature
and theories; develop, test and refine programme theory; draw on primary data; take efforts
to understand the context of the intervention; consider future implementation; refine the
intervention as appropriate; and end the development phase, including writing up the process. In
addition to these steps, we have added four sets of issues that may be useful in the development
of an intervention: adaptation of interventions to new contexts, consideration of wider system
factors, modelling or simulation of the intervention and consideration of economic factors.
ii. Identifying an intervention: researchers are not always involved in the design phase of
intervention development, for example where interventions are designed and driven in policy
settings. This presents slightly different challenges for this phase of research. For example,
it may not be entirely clear what the theoretical basis for the intervention is, or there may not
be explicit programme theory. At this phase of research, the key step is to develop programme
theory, which will be an important basis for considerations around the evaluation design.
2. Feasibility
This phase is designed to explore the uncertainties that have been identified at the development
phase. ‘Progression criteria’, ideally developed with input from multiple relevant stakeholders,
should be used to guide the decision on whether or not to proceed to the next stage of evaluation,
conduct more feasibility work, return to intervention development or terminate the research.
Criteria for progression could relate to the evaluation design, for which key aspects are feasibility
of recruitment and retention of participants; capacity to achieve appropriate sample size; feasibility
of the outcomes of the evaluation (e.g. data collection tools and follow-up duration); the capacity
and time to collect and analyse the data; and consideration of the unintended outcomes. Criteria
for progression could also relate to uncertainties around the intervention itself, for example optimal
and acceptable intervention content and delivery; adherence to the intervention; likelihood of
cost-effectiveness; and capacity of those providing the intervention to deliver as planned. This is
important even if the intervention has been shown to be efficacious, particularly where contextual
or implementation factors may influence the intervention’s effectiveness. A key point here is that
further work may be required to refine the intervention before embarking on full-scale evaluation,
and the programme theory itself should be refined in an ongoing manner. Economic modelling can
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be used to assess whether or not expected benefits from an intervention justify its costs and, thus,
is useful for decisions on whether or not it is worth proceeding to full-scale evaluation. Evaluability
assessment is a complementary approach to a feasibility study. This is a collaborative approach to
support the development and evaluation of interventions, aiming to determine whether or not an
intervention can usefully be evaluated, and the most appropriate methods for doing so.
3. Evaluation
At this phase it is important to consider how to maximise the ‘usefulness’ of information for
decision-making. To do this, there needs to be an understanding of the key uncertainties
surrounding the intervention, and research questions should be developed that are relevant to
resolving these uncertainties. As noted above, there are a range of research perspectives that
should be considered, rather than necessarily focusing on effectiveness alone. There are numerous
study designs and the decision on which to use should be made based on the research questions
posed, which should be defined based on the uncertainties that have been identified. There is no
‘best’ study design: the approach needs to be tailored. A crucial aspect is the choice of outcome
measures or evidence of change. Again, these should be chosen based on which outcomes or change
are important for stakeholders and on a good theoretical understanding of the intervention.
Outcome measures do not need to be reserved to capturing changes in individuals, but can also
assess changes in the system, for example changes to policy or to social norms, or by exploring how
changing the dynamics in one part of the system alters behaviour in other parts, for example the
displacement of smoking into the home after a public smoking ban.
4. Implementation
This phase is about taking deliberate effort to increase the impact of interventions. Even where
interventions are shown to be effective, they are seldom implemented successfully. Implementation
science is a developing research field, with one focus being on maximising the effective implementation
of interventions that have already demonstrated effectiveness in a study. In implementation studies,
the main outcomes of interest are measures of the effectiveness of implementation, for example reach,
policy impact and uptake of a service. Implementation should be considered in all phases of complex
intervention research. Early consideration of implementation increases the potential of developing
interventions that can be adopted and maintained in real-world settings.
We present case studies, which are referred to in relevant parts of the text, to illustrate a variety of
approaches and demonstrate particular points.
Throughout the phases of complex intervention research, we encourage a regular return to ‘check in’
with the core elements mentioned above. We provide a checklist to support and document use of
this framework, in particular the attention to the core elements and the key considerations for each
research phase, in the preparation of funding applications and journal articles.
Complex intervention research is an interdisciplinary, rapidly developing field in which key terms
are used in varying ways. The glossary sets out our working definitions of these terms. The framework
document provides brief guidance on how complexity should be approached in evidence synthesis.
Conclusions
The framework adopts a pluralist approach and encourages consideration and use of diverse research
perspectives. We acknowledge that to generate the most useful evidence for decision-making will
often require a trade-off between precise, unbiased answers to narrowly defined questions and more
uncertain answers to broader, more complex questions. Earlier editions of this framework were
underpinned by an assumption that unbiased estimates of effectiveness are the cardinal goal of
evaluation. We have emphasised that improving theories and understanding how and in what
circumstances interventions contribute to change are also an important goal for complex
intervention research.
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For many complex intervention research problems an efficacy or effectiveness perspective will be
the optimal approach, for which a randomised controlled trial will probably provide the best design
to achieve an unbiased estimate. For other problems, this will not be the case and alternative
perspectives and designs will be more likely to generate useful new knowledge to help reduce
decision-maker uncertainty. What is important for the future is that the scope of intervention
research commissioned by funders and undertaken by researchers is not constrained to a limited
set of perspectives and approaches that may be less risky to commission and more likely to produce a
clear and unbiased answer to a specific question. In many cases, what is needed is a bolder approach,
including some methods and perspectives for which experience is still quite limited, but for which there
is an urgent need to make progress by mainstreaming new methods that are not yet widely used, as
well as undertaking methodological innovation.
It is recommended that future updates of this framework continue to adopt a broad, pluralist
perspective, which means that given the widening scope of the framework and the rich, diverse and
constantly evolving body of detailed methods guidance that is now available on specific methods and
topics, it will most usefully be in the form of a high-level framework with signposting, published in a
fluid, web-based format, which will ideally be frequently updated to incorporate new material, through
both updating of text and the addition of new links to updated and emerging key resources.
Funding
This project was jointly funded by the Medical Research Council (MRC) and NIHR (Department of
Health and Social Care 73514).
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Chapter 1 Development of the framework
Introduction
In 2006, the Medical Research Council (MRC) published guidance for developing and evaluating
complex interventions,1 building on a framework that was published in 2000.2 The aim was to help
researchers and research funders recognise and adopt appropriate methods to improve the quality
of research to develop and evaluate complex interventions and, thereby, maximise its impact.
The guidance documents have been highly influential, and the accompanying papers published in the
British Medical Journal are widely cited.3,4
Since the 2006 edition of the guidance was published, there have been considerable developments
in the field of complex intervention research. In some areas, the accumulation of experience and
knowledge in the application of approaches and methods that were novel or undeveloped at the
time of writing the previous guidance has led to the publication of detailed, focused guidance on the
conduct and/or reporting of research, including the MRC guidance on ‘process evaluation’.5 In other
areas, new challenges in complex intervention research have been identified and the reliance on
traditional approaches and methods promoted in previous guidance has been challenged.6–8 The
guidance has also been complemented by MRC guidance on ‘natural experiments’,9 an important
area of development in methods and practice. Given that complex intervention research is a broader
and more active field, this new framework provides a less prescriptive and more flexible guide. The
framework aims to improve the design and conduct of complex intervention research to increase its
utility, efficiency and impact. Consistent with the principles of increasing the value of research and
minimising research waste, the framework (1) emphasises the use of diverse research perspectives
and the inclusion of research users, clinicians, patients and the public in research teams; and (2) aims
to help research teams prioritise research questions and choose and implement appropriate methods.
This aims to provide pragmatic recommendations aimed at an audience from multiple disciplines, and
we have taken a pluralist approach.
Updating the framework was a pragmatic, staged process, in which the findings from one stage fed
into the next. The next section, therefore, provides the methods followed by the results for each stage
(gap analysis, expert workshop, open consultation and writing the new framework). We then provide
concluding remarks and suggestions for moving forward. The resulting framework is presented
in Chapter 2.
This project was overseen by a Scientific Advisory Group (SAG) that comprised representatives of
each of the National Institute for Health Research (NIHR) programmes, the MRC–NIHR Methodology
Research Panel, key MRC population health research investments and authors of the 2006 guidance
(see Appendix 1). A prospectively agreed protocol, outlining the work plan, was agreed with the
MRC and NIHR and signed off by the SAG (see Appendix 2). At various points throughout the
writing process, we consulted with other researchers, evidence users, journal editors and funders
(see Appendix 3).
As terminology can often be ambiguous, and there are often terms used interchangeably, we have
provided a Glossary of key terms.
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Methods and results
The framework was updated using multiple methods over several stages:
l stage 1 – a gap analysis of the evidence base for complex interventions
l stage 2 – a workshop that collated insight from current experts in the field
l stage 3 – an open consultation
l stage 4 – drafting the updated framework and a final feedback exercise.
Various stakeholders, for example researchers, research users (patients, public, policy-influencers
and NHS), funders and journal editors, were engaged at different stages of the drafting process.
The methods and findings from each of the stages are described in the following sections.
Stage 1: gap analysis
Methods for stage 1: gap analysis
The aim of the gap analysis was to identify and summarise aspects of the previous guidance that
required updating. We used these gaps as a starting point for discussion within the project team,
SAG (for a list of members, see Appendix 3) and identified experts. It was, therefore, a method of
agenda setting and, thus, did not aim to be comprehensive. The intention was that issues could be
added as the work progressed.
Our first step was a brief horizon scanning review that focused on new approaches/progress since
the previous guidance, criticisms of existing guidance and other gaps. Based on initial reading of the
literature and the experience of the project team, the SAG were provided with a list of topics for
update. This was discussed at the initial SAG meeting (24 November 2017) and the list of topics was
updated for more in-depth exploration of the literature.
Separate literature searches were conducted for each of the identified topics using keywords (the topic
of interest plus variations of ‘complex intervention’) in Web of Science, restricted to English language
with the date limited to those published since 2008. Where there were existing guidance documents
relevant to the development, implementation or evaluation of complex interventions, we used these
as our starting point and limited our literature review to documents published after these existing
guidance documents. For example, guidance existed for natural experiments,9 process evaluation5
and context,10 which we drew heavily on. We also discussed this new framework with those involved
in developing other guidance at the time, for example for intervention development,11 exploratory
studies12 and systems thinking.13,14 We excluded guidance that did not provide substantive information
on methodological issues. Criteria for including other publications were broadly that they provided
relevant thinking that could be used to progress the work. A summary of the findings from each topic
search was created and used to identify focal points for the expert workshop.
Findings from stage 1: gap analysis
Several limitations of the 2006 guidance were highlighted. These mainly related to (1) the focus on
effectiveness; (2) considering randomised controlled trials (RCTs) as the gold standard research design;
(3) the lack of detail on economic evaluation; (4) the lack of attention to mechanisms that deliver
change; (5) the lack of acknowledgement of complex organisational systems or complexity theory; and
(6) omission of the importance of policy context, including the impossibility of standardising context.
In addition to these issues, there were several areas that had progressed since 2006, which were
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considered to be important to explore in more detail. Here we provide a brief summary of the gaps that
were identified in 2017 and what we initially proposed to be discussed with experts at the workshop:
l Complex intervention definition –
¢ Key issue for the update – definition is too narrow.
¢ There are different dimensions of complexity. How can we improve the definition of complex
intervention to better acknowledge contextual complexity and the system-level properties that
add to this complexity?
¢ Does the term ‘complex intervention’ make sense when complexity arises from the intervention
context and the interplay between intervention and context as well as the intervention itself?
l Intervention development –
¢ Key issue for update – little practical guidance on this phase and subsequent literature provides
more detail on certain aspects, for example using a theory-driven approach;15,16 identifying
and delivering the mechanism of change;17 co-production and prototyping of public health
interventions;18 and optimisation of the intervention.19
¢ There is guidance under way on intervention development (INDEX study11) that is about
identifying and assessing different approaches to developing complex interventions. Given that
this is current and there are clear overlaps, are there any issues that are not covered in the
INDEX guidelines that we should consider adding in this document?
l Pre-evaluation phase: appraisal of evaluation options or exploratory work –
¢ Key issue for update – previous complex intervention guidance highlighted the importance of
preparatory work, with the focus being on conducting a pilot study; however, detail on feasibility
issues and how to develop the feasibility stage is required.
¢ Similar to the development phase, there is work in progress to create guidance for Exploratory
Studies of Complex Public Health Interventions (GuESt study12), which includes a lot of relevant
information. Should the current update include anything further and how can we make it
relevant beyond public health?
l Context –
¢ Key issue to update – although the previous complex intervention guidance states the
importance of taking account of context, this is mostly about how context affects outcomes at
the evaluation phase and how interventions may require adaptation for implementation in
different contexts. There is little attention to the consideration of context throughout the
research phases or guidance on how to take it into account.
¢ How do ‘context’ and ‘system’ differ/overlap?
¢ Context is a critical construct; how do we ensure that we refer to it throughout the research process?
¢ Do we want to go further than the recently published guidance on taking account of context in
population health intervention research?10 What are the key points for considering context in
complex intervention research more broadly?
l Ideas from complex systems science –
¢ Key issue to update – this is an area that has received increasing attention in the last decade,
and for this reason the previous complex intervention guidance did not draw on it.
¢ Examples of using complex systems thinking in public health research have been limited to
describing and modelling systems; this has not yet been taken further and been used to develop
and evaluate interventions.7
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¢ When is it critical to embrace a complexity perspective (and when it is not necessary: simple and
complicated questions and approaches have their merits) and how can such a perspective be
implemented methodologically?
¢ How can a complex systems approach guide each phase of complex intervention research?
l Programme theory –
¢ Key issue to update – the previous complex intervention guidance provided brief information on
causal mechanisms and on developing a theoretical understanding of the process of change;
however, this lacks the required level of information to guide researchers in developing
programme theory from the outset.
¢ Further detail is needed to illustrate the steps required to undertake a robust planning phase,
including (1) identifying appropriate theories of change, (2) considering potential mechanisms of
change, (3) anticipating important contextual factors that could influence the change mechanism
and outcomes and (4) mapping appropriate methods to operationalise the chosen theory
into practice.
l Implementation research –
¢ Key issue to update – the previous complex intervention guidance has limited information on the
practical implementation process and needs to understand and account for dynamic contextual factors.
¢ Successful implementation is critical to the scaling up of interventions and the new framework
should reflect this by emphasising implementation throughout the research process.
¢ When do you stop doing effectiveness studies and start doing implementation studies?
¢ How can we include the wider aspects of implementation that may enable or constrain desired
change? For example, how much guidance do we provide on addressing intervention context and
addressing future implementation on a greater scale?
¢ How do we make the information palatable for decision-makers?
l Economic evaluation and priority setting –
¢ Key issue to update – the previous complex intervention guidance did not go into any detail
on how standard economic evaluation methods need to be adapted to deal with particularly
complex interventions.
¢ Issues around timeline – outcomes are likely to extend beyond the lifetime of an evaluation –
can economists work with proxies to system change?
¢ How do we best guide on issues for existing economic evaluation methods where interventions
aim to change the properties of complex systems? That is, it is not appropriate to evaluate
health outcomes only at the individual level if a component of the intervention is to effect
change to the system; outcomes are broader than individual health and costs (is a societal rather
than a health-care perspective required?).
¢ (How) should we include equity issues and economic evaluation analytical approaches, which are
growing and complicated methodological areas?
¢ How can we guide on economic evaluation for priority setting? That is, what is the most efficient
use of resources (to determine whether or not the additional cost of a research project or
particular study design is justified)? Are decision-modelling and value-of-information analysis
(VOI) practical propositions?
l Systematic reviews of complex interventions –
¢ Key issue to update – the previous complex intervention guidance did not address issues related
to the inclusion of complex intervention studies in systematic reviews, much beyond acknowledging
that they can be problematic. Should we add more?
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¢ Systematic review methods may differ from standard methods and extra consideration is
necessary where the systematic review includes complex interventions (if the review is about
complexity), for example in defining the research questions, developing the protocol, the use
of theory, searching for relevant evidence, and assessing complexity and quality of evidence
(how to identify key components of complex interventions; how to assess study quality).
¢ What should be the end point of a systemic review of complex interventions? For example,
effect size, decision model, improved theory or supporting policy decisions?
l Patient and public involvement (PPI) and co-production –
¢ Key issue to update – previous complex intervention guidance mentioned that stakeholders
should be consulted at various points, but did not emphasise the need to engage relevant
stakeholders throughout the research process or provide any guidance on how to do this.
¢ How do we guide on effective engagement of stakeholders throughout?
l Evaluation –
¢ Key issue to update – the previous complex intervention guidance focused on designing
evaluations to minimise bias (i.e. with high internal validity) and, in doing so, did not consider
how to maximise the usefulness of evidence for decision-making. These are not mutually
exclusive concerns: could both be considered?
¢ Should we take an approach that promotes ‘usefulness of evidence’ rather than hierarchy of
evaluation study design?
¢ Should we present evaluation options that go beyond individual-level primary health outcomes?
For example, taking account of system change.
¢ Evaluation study designs – what should be added to reflect development in this area? For
example, n-of-1, adaptive trials. How much information should we present on individual
study design?
These topic areas and questions were intended to be a foundation for discussion and further
consideration, rather than an exhaustive or definitive list.
Stage 2: expert workshop
Methods for stage 2: expert workshop
A 1-day expert workshop was convened in London in May 2018. A list of those who attended the
workshop is given in Appendix 3. The aim of the workshop was to obtain views and record discussions
on topics that should be newly covered or updated. Participants were identified by the project team
and SAG. We aimed to have at least two experts for each of the identified topics and include a range
of people from across the UK, plus international representation as far as budget allowed.
In advance of the workshop, the participants were asked to provide two key points, each with one
sentence of explanation, that they felt should be taken into account in the update. These key points,
alongside findings from the stage 1 gap analysis and discussion with the SAG, were used to inform the
agenda and develop content for an interactive, multidisciplinary expert workshop.
After an introductory presentation by the project team, participants were split into five groups (of seven
or eight) for the morning session round-table discussion.
The topics covered for all groups (presented in a different order) were:
l the definition of complexity
l the overall framing and scope
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l potential impact of the new framework
l the main diagram of the framework (key elements of the development and evaluation process)
l complex systems thinking.
For each of the two afternoon sessions, participants were split into five ‘expert groups’ aligned with
their topic areas of expertise. Topics covered in these smaller specialised groups included:
l options for study design
l the previous guidance’s emphasis on ‘effectiveness’
l choice of outcomes
l considerations for economic evaluation
l pre-evaluation and development phases
l considerations for implementation
l key focus areas to improve applications for funding
l evidence synthesis of complex interventions
l considerations for digital health
l programme theory.
Each session was facilitated by a member of the project team and was supported by a colleague from the
MRC/Chief Scientist Office Social and Public Health Sciences Unit, University of Glasgow. Colleagues
assisted the facilitators by taking notes of key points during each discussion, clarifying main points with
attendees and producing a written summary of each discussion after the workshop. SAG members were
also present in each discussion. Round-table discussions were audio-recorded. Throughout the day,
participants were asked to provide their thoughts on key points, case study examples and key references
on Post-it® notes (3M, Saint Paul, MN, USA) on dedicated noticeboards.
Data from each of the 15 workshop discussions and post-it points were thematically coded, and
summaries drawing on all of the data were created for each theme. These workshop summaries were
sent to workshop participants by e-mail as a follow-up consultation to ensure that the thematic
summaries that we created from the workshops were accurate overviews of the discussions in
which they were involved. Final summaries were discussed in detail with the SAG to support the
decision-making on the content of the document.
Findings from stage 2: expert workshop
Seventy experts were invited to the workshop (with the aim of facilitating a workshop of around
40 participants). In total, 37 experts confirmed their attendance; one who accepted the invitation
did not attend (owing to sickness), three people did not respond to our invitation and 30 people
could not attend for various reasons, some of whom recommended others who did attend. In total,
36 participants attended the workshop. Key issues that were identified are summarised in Table 1.
Decisions taken following the expert workshop
There was considerable agreement across the workshop discussions; however, as seen in Table 1, there
were some issues for which consensus was not reached or for which competing points were made
in different break-out discussions. The main example of controversy was the purpose of evaluation
(theory as an end point, the need for primary outcome). In addition, some of the points that were made
were very specialised, for example related to particular methods or specialties. Along with the SAG, the
project team determined which focus areas to incorporate in the document, keeping them high level
rather than getting into specific detail. With respect to the issues for which views diverged (primarily
related to effectiveness and the purpose of evaluation), we consider the document as a ‘thinking tool’
to provide recommendations to arrive at the most appropriate approach for each piece of complex
intervention research (with no ‘one size fits all’ approach, instead determined by the problem that is
being addressed and taking a ‘usefulness of evidence’ approach).
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l Requires clarity regarding the use of the terms simple and complex, and the use of the
term intervention
l Needs to include context, systems thinking, feedback loops and the fundamental aspects
of complexity
l Thinking about complex interventions in terms of how ‘simple’ or ‘complicated’ they are is
not very helpful, as there are many aspects that make an intervention complex
Framing and scope l Reaching a new audience is important: as well as researchers, the framework needs to
reach ‘practitioner researchers’, Health Technology Assessment and policy-makers. A
common language is needed and it is, therefore, important to include different stakeholders
in this process. Provide clarification of terminology
l A more iterative and fluid research process needs to be emphasised. More options should
be given to avoid saying there’s ‘one way of doing this’
Intervention
development
l More emphasis on determining the problem and establishing the research questions
l Acknowledge that there are different starting points to the research process, for example the
process does not necessarily start with development, researchers may not be involved in the
intervention’s development (e.g. a national policy) and researchers could join/start at any phase
Study design l Agreement regarding the need to choose a design that is best suited to answer the
research question in a given context (i.e. there is no novel design that caters for
‘complex interventions’)
l It is important to emphasise that there are more (and often more suitable) options than RCTs
l Guide people to think about the function of the intervention in choosing the study design. Give
examples of what researchers have undertaken in different contexts and include case studies
l Usefulness of evidence is a good approach, rather than the previous hierarchy of evidence
approach. This requires thinking of the right research questions for the intended use of
the research
l Acknowledge that rapidly changing fields require faster routes of evaluation before the
overall context changes (e.g. in digital health)
Systems thinking l General agreement regarding including systems thinking and encouraging researchers to
think with a ‘systems lens’
l However, there was also agreement that this field is developing and there are limitations to
how much guidance we can currently give
l Introduce three levels of systems thinking: (1) conceptualisation of the system (what does
it currently look like), (2) what parts of the system can be influenced (and what are the
boundaries) and (3) what is happening outside the boundary (providing richer context)




l Clarity is required on ongoing modification at the implementation phase
l Clarity on terminology required (delivery of intervention/implementation)
l Implementation should be emphasised throughout (e.g. from development stages)
Programme theory l Clarity on terminology is required (e.g. people are typically unclear on what theory is; there
do not seem to be consistent definitions of terms, such as ‘logic model’ and ‘programme
theory’; and other terms, such as mechanism of action, etc., need to be defined)
l Include information on theory (e.g. thinking about what the problem is at the start and what
should be changed; articulating what theory is and is not; considering how theory may be
influenced by context; and encouraging adaptive and iterative theory development)
l Researchers need to be encouraged to articulate their theory in full, not solely in a visual
model that will miss some of the important detail
Economic evaluation l There was general agreement that new methods were not needed, but that standard
methods could be adapted to more effectively explore complex interventions
l Signpost recent developments since the previous guidance and link them to the
existing guidance
l Emphasise the need to measure aspects of programme theory and resource use, rather than
just effectiveness of outcomes
l Mention cost–consequence analysis to help highlight links between processes and outcomes
l Emphasise the need for a broader range of outcomes
l End point: it should be about revealing the resource cost/outcome trade-offs and causal
connection, as much as it is about producing a ratio or a number. We need the trade-offs for
each resource use
continued
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Some examples of the decisions taken are as follows:
l Clarity in terminology – include a comprehensive glossary.
l Include a series of case studies as an appendix, highlighting particular aspects of each phase and
core elements of the research process.
l Highlight the distinctive methods of evidence generation, emphasising that the research can begin
at any stage of the intervention and that there may be different approaches for researchers not
involved in intervention development.
l Not to be prescriptive but rather provide options for approaching the research, which should be
chosen by taking the problem as the starting point and working out what is most useful in terms of
decision-making for policy and practice going forward.
l Update the diagram included in the 2006 guidance that showed ‘Key elements of the development
and evaluation process’,1 particularly to include context.
l Include a greater focus on programme theory, but one that encourages its consideration and
refining throughout.
TABLE 1 Summary of the key points from the expert workshop in 2018 (continued )
Topic Key points
Effectiveness l There were diverse views on whether or not traditional effectiveness is an appropriate end
point for an evaluation, for example some were keen to abolish effect sizes altogether, look
at other things and answer different questions (e.g. what happened?). This would include
having theory as an end point in itself. Others disagreed that theory should be an end point
and felt strongly that evaluations have to answer the ‘does it work?’ question; however,
there was general agreement that this (does it work?) in itself is not enough
l In relation to this, there was debate about whether or not evaluations should have primary
(health) outcomes, with some of the opinion that there needs to be a prespecified outcome
for the intervention that is being tested, and without a primary outcome there is the risk
of ‘cherry picking’ the most improved outcome to make the intervention appear effective.
Others disagreed and felt that evaluation should explore the impact on multiple effects,
including system change (not individual effect sizes), with the goal of theory development
Stakeholders l There was more emphasis required than in the previous guidance
l Place higher priority on co-production and non-researcher-led interventions
l Articulation of the problem needs to come from shared space; genuine co-creation of
interventions from this starting point
Evidence synthesis l Acknowledge that methods still need to be developed
l Context:
¢ The value of an evidence synthesis does not lie only in obtaining the most unbiased estimate
(in terms of effect size) or in meta-analysis; there needs to be a focus on exploring
heterogeneity across contexts and identifying the mechanisms that drive variation
¢ There will never be a complete suite of studies of complex interventions in all of the
relevant contexts, so there needs to be a way of extrapolating from what we have
¢ Provide pointers to things that would help decision-makers know if they could use the
evidence and make judgements about transferability, how their context differs and what
might be the things that facilitate change
¢ Decision-makers could be encouraged to think about socially significant differences
in context
l One challenge is that, with some exceptions, evidence synthesis organisations focus on
trials. The new framework should seek to widen the range of evidence included in syntheses
used for decision-making and ensure the inclusion of mixed-methods research. It should
also clarify what we mean by ‘evidence’ and acknowledge that this includes theory as well
as information about outcomes
l General agreement that an improvement in primary studies that follows from the
recommendations will have a positive impact on evidence synthesis in time (there will be
more appropriate studies to synthesise)
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l Systems thinking – not to provide detailed guidance on systems thinking and methods because this
is beyond the scope; rather it will be a starting point for encouraging people to consider how a
systems perspective could help develop and evaluate complex interventions, with methodological
development to follow.
l Evidence synthesis – following the expert workshop, information that others were developing
guidance in this area and discussion with the SAG we took the decision to focus on primary studies;
therefore, we did not include a section in the main document on evidence synthesis. It is hoped that
an improvement in primary studies, brought about by this new framework, would in time have a
positive impact on evidence synthesis. We added an appendix to highlight some of the main
considerations for evidence synthesis (see Appendix 5).
Further decisions were taken regarding the need to obtain further expertise in drafting the document.
We approached three health economists for a follow-up meeting to discuss further issues related to
economic considerations for complex intervention research; following this, they agreed to take on the
responsibility of drafting sections that related to economic considerations and became co-authors. We
also approached experts in systems thinking to discuss some of the emerging ideas on taking a systems
perspective to complex intervention research. We convened a meeting in December 2018 in London
with a group of researchers with such expertise (individually acknowledged in this monograph).
Similarly, we convened a meeting in January 2019 with researchers who were creating guidelines on
intervention development (individually acknowledged in this monograph) to discuss the overlap and the
use of the INDEX guidance within the current document.
Stage 3: open consultation
Methods for stage 3: open consultation
The first draft of the updated document was made available for open consultation from Friday 22 March
to Friday 5 April 2019.
Potential respondents were targeted, as follows:
l those invited to the expert workshop
l other experts identified from the suggestions of workshop participants, with greater focus on
international experts





We e-mailed potential respondents with advance notice of the consultation dates and a link to
register their interest in participating, and sent a further message when the consultation opened.
Two reminder e-mails were also sent. As well as targeted promotion, we used social media to publicise
the consultation and encouraged others to pass on the link.
Consultees were informed that they were responding about an early draft of the revised framework
and that their involvement was an important part of the process for its final development. We asked
them to relate topics in the draft to a project that they had recently worked on and to provide
feedback on its usability.
The online consultation was guided by a questionnaire that was developed by the project team
(the questions that all consultees were asked to complete are presented in Appendix 4). Responses
were anonymous.
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Findings from stage 3: open consultation
We received 52 individual responses, plus some follow-up e-mail comments. This amounted to 25,000 words
of response. The majority of responses were from researchers, but some identified as funders (n= 3), journal
editors (n= 7), NHS (n= 7), policy-influencers (n= 3) and service users (patient or public, n= 5). Most of the
respondents said that their main field of expertise was public health (n= 21) or health services research
(n= 20), with others stating clinical medicine (n= 6), implementing policy (n= 3), systems-based research
(n= 4), patient or public involvement (n= 4) and other (n= 7: statistics, sociology, health economics and
triallist) as their main field of expertise. A summary of the consultation suggestions is provided below;
however, it is important to note that there were conflicting views on some aspects, which we have noted.
Overall
l Overall layout: extra sections are required – an executive summary and a preface chapter that
details how this is related to previous guidance and that this document is a standalone framework
that does not require reference back to the 2006 version. Consider placing more emphasis on
development in the earlier sections of the document rather than delve straight into evaluation.
l Definition of complexity: the distinction made between complicated and complex interventions was
said to be unclear. Respondents stressed that a clear definition of complex intervention and a more
accessible account of how complexity affects the research process are required.
l Key elements for developing and evaluating complex interventions (Figure 1): respondents felt that the
‘overarching considerations’ should all be highlighted as central to the research process and that some
text detail should be added to each phase box to provide more information on what each means.
l Evaluation perspectives (shown in the x-axis of Figure 2): many respondents felt that the
perspectives that we presented were shown to be mutually exclusive and hierarchical (which was
not the intention). There was significant pushback on using the term ‘realist’ as an evaluation
perspective. Respondents questioned whether or not we were advocating for evaluations that
do not measure effectiveness, with some conflicting views on whether or not this was a positive
change. It was felt that there was not enough focus on how the perspectives relate to intervention
development or to the development of research questions.
l Framework for addressing complexity within an evaluation (see Figure 2): although some liked this
framework, on balance respondents did not feel that this figure complemented the text or was very clear.
Complexity does not increase in a linear fashion based on intervention components and perspective
taken. Context and system were missing from the diagram despite being a large focus of the text.
Research phases (shown Figure 1, plus a section of text was also dedicated to each phase)
l Developing and identifying complex interventions: suggestions included that we consider minimising
detail in this section and signpost to the MRC-funded INDEX guidance;11 clarify the different
circumstances in which development versus identification of interventions is appropriate; and
consider including something specific on digital interventions.
l Feasibility: make sure that the definition of feasibility is clear, for example in line with other
standard definitions. There was a call for additional detail on the role of context in determining
uncertainties for feasibility testing.
l Evaluation: as in the expert workshop, there was conflicting feedback from respondents on how to
provide guidance on evaluation. Suggestions included highlighting that evaluations must focus on
effectiveness, with additions (not replacements) relating to theory and systems perspectives, but
also to include better examples of evaluations focusing on systemic questions. Many respondents
felt that there was too much focus on realist evaluation and little mention of theory-based
evaluation approaches. The section on study design needs to be clearer, particularly on why some
designs are included but others are not.
l Implementation: suggestions were made to differentiate between clinical and implementation
interventions; add EPOC (Effective Practice and Organisation of Care) criteria20 and diagnostic
approaches to implementation; and clarify the time and stage of modification in relation
to implementation.
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Overarching considerations (see Figure 1)
l Programme theory: it was suggested that we provide greater detail on theory-led research, with a
balance of signposting to appropriate resources; address how theory-based content is written and
presented for readers who come from non-theory-based disciplines, to avoid alienating people;
and clarify the terminology relating to ‘mechanism’, ‘programme theory’ and ‘logic models’.
l ‘Modification’ (changed to refinement in the final version): there were conflicting opinions on the use
of terminology, particularly with the (MRC-/NIHR-funded) adaptation guidance (in preparation21).
Respondents called for guidance on where/when to perform modifications and how to agree acceptable
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FIGURE 1 Key elements for developing and evaluating complex interventions (consultation version).
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l Stakeholders: respondents encouraged a greater focus on PPI, more consideration of the challenges
of ‘stakeholder engagement’, as well as practical examples of how to engage stakeholders.
l Economic considerations: respondents suggested that we make sure that sensitivity analysis is
discussed in relation to statistical models as well as economic models; that we give mention to
the tensions between equity and efficiency in evaluating complex interventions; and that we
provide more detail on generalisability and context dependency of cost-effectiveness as well as
effectiveness, and the possibility of using programme theory to achieve this.
The majority of respondents were positive about the document overall, albeit with constructive
criticism that required the project team to reconsider various aspects. Examples of changes that were
made following consultation (note that this is not an exhaustive list of changes) were:
l Figures –
¢ the framework for addressing complexity in evaluation was removed (see Figure 2)
¢ Figure 1 was updated to place ‘context’ in the centre with the other ‘overarching considerations’
(re-termed ‘core elements’) and short descriptors added to each of the phases.
l Evaluation perspectives (see Figure 2) – a rewrite of this section was required (now termed ‘research
perspectives’). We changed ‘realist perspective’ to ‘theory-based perspective’ to take account of other
approaches to evaluation that aim to explore how and why interventions bring about change.
l Terminology –
¢ the definition of ‘complex intervention’ was updated
¢ ‘modification’ was changed to ‘refinement’
¢ programme theory/logic model – a decision was taken to use ‘logic model’ for the visualisation of
the ‘programme theory’, with programme theory detailed with text.
l Programme theory: we have clarified terminology in the text and Glossary.
l Modification/refinement: we changed the term from ‘intervention modification’ to ‘intervention
refinement’, and differentiated from ‘adaptation’. We have added detail to this section on when you
would expect interventions to be refined and why, including a separate section on rapid refinement
of digital interventions.
l Stakeholders: we separated the section on stakeholders into PPI and professional stakeholders, and
added text to highlight the challenges in engaging stakeholders.
l Economic considerations: we have edited and moved some of this section to other parts of the
document to avoid repetition. We add detail on the potential trade-off between equity and efficiency.
l Developing and identifying interventions: we removed text and used the INDEX guidance as the
basis for this section, adding three more points that were not highlighted in that guidance but were
felt to be important throughout the process of developing this document.
l Feasibility: we further clarify what we mean by ‘feasibility’. We have re-ordered this section to
improve readability. We have added a section on ‘efficacy signals’ to further show the potential of
feasibility studies.
l Evaluation: we have added detail on how the research perspectives are related to evaluation, as
well as more case studies to illustrate the main points. We have emphasised the need for qualitative
study in an evaluation and have added detail on process evaluation. We have added detail on the
strengths and limitations of each type of economic evaluation.
l Implementation: we have considered separately in this section (1) implementation science research,
which focuses specifically on the development and evaluation of interventions to maximise effective
implementation; and (2) the need to emphasise implementation considerations in earlier phases,
including hybrid effectiveness/implementation designs. In the earlier phases and in the core elements,
we have highlighted context, stakeholder input and the need for a broader programme theory, all of
which contribute to increased consideration of implementation factors.
DEVELOPMENT OF THE FRAMEWORK
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Stage 4: writing the updated framework
Methods for stage 4: writing the updated framework
The writing of the framework was led by the project team and was supported by co-authors in the
writing group and the SAG. Feedback was received at various stages throughout the writing process
from members of the MRC’s Population Health Sciences Group (PHSG) and the MRC–NIHR
Methodology Research Programme (MRP) Advisory Group.
Given that the document had changed substantially from the open consultation draft, we asked a
further set of external individuals to provide comments on the near-final draft. We received feedback
from eight people in May/June 2020. The final draft was then sent to all co-authors for approval.
Findings from stage 4: final approval and sign-off
The final draft was approved by the MRC’s PHSG in March 2020.
Patient and public involvement
This project was methodological; views of patients and the public were included at the open
consultation stage of the update. The open consultation, involving access to an initial draft, was
promoted to our networks via e-mail and via digital channels, such as our unit Twitter account (Twitter,
Inc., San Francisco, CA, USA; www.twitter.com). We received five responses from people who identified
as ‘service users’ (rather than researchers or professionals in a relevant capacity). Their input included
helpful feedback on the main complexity diagram, the different research perspectives, the challenge
of moving interventions between different contexts and overall readability and accessibility of the
document. Several respondents also highlighted useful signposts to include for readers.
In relation to broader PPI, the resulting updated framework (see Chapter 2) highlights the need to
include PPI at every phase of developing and evaluating complex interventions. We have drawn on and
referred to numerous sources that provide further detail or guidance in how to do so.
Limitations
There was a huge amount to cover in developing this document. We have not provided detailed
methodological guidance where that is covered elsewhere because we have tried to focus on the main
areas of change and novelty. In many of these areas of novelty, methods and experience are in some
parts quite limited. In addition, we have foregrounded the very important concept of ‘uncertainties’
and, although there are methods of doing this through, for example, decision-modelling and more
qualitative soft system methodologies, this area is limited and specific guidance on how to determine
uncertainties in a formal way may seem unclear. We recommend that due consideration is given to this
concept and call for further work to develop methods and provide examples in practice. Invariably we
may have missed something in our writing and, furthermore, the fields will inevitably move on at pace
following publication of this document.
Conclusion
Parts of this text have been reproduced with permission from Skivington et al.26 This is an Open Access
article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0)
license, which permits others to distribute, remix, adapt and build upon this work, for commercial use,
provided the original work is properly cited. See: https://creativecommons.org/licenses/by/4.0/. The text
below includes minor additions and formatting changes to the original text.
In this document, we have incorporated developments in complex intervention research that were
published since the previous edition was written in 2006. We have retained the basic structure of the
research process as comprising four phases – development, feasibility, evaluation and implementation –
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but we emphasise that a programme of research may begin at any of these points, depending on what
is already known. We have emphasised that complex intervention research will not always involve the
development of new researcher-led interventions, but will often involve the evaluation of interventions
that are not in the control of the researcher, but instead led by policy-makers or service managers,
or are the adaptation of interventions from another context. We have highlighted the importance of
engaging stakeholders throughout the research process, including patients, the public, practitioners
and decision-makers. We emphasise the value of working with them as partners in research teams to
jointly identify or prioritise research questions; develop, identify or prioritise interventions; and agree
programme theories, research perspectives, key uncertainties and research questions.
As with earlier editions, we stress the importance of thorough development and feasibility testing
prior to large-scale evaluation studies. As well as taking account of established practice and recent
refinements in the methodology of intervention development, feasibility and pilot studies, we draw
attention to new approaches, such as evaluability assessment, that can be used to engage stakeholders
in collaborative ways of planning and conducting research. We place greater emphasis than in the
previous edition on economic considerations in complex intervention research. We see these as a vital
to all phases of a research project, rather than simply a set of methods for assessing cost-effectiveness.
We have introduced a new emphasis on the importance of context and the value of understanding
interventions as ‘events in systems’ that produce effects through interactions with features of the
contexts in which they are implemented. We adopt a pluralist approach and encourage consideration
and use of diverse research perspectives, namely efficacy, effectiveness, theory-based and systems
perspectives, and the pragmatic choice of research questions and methods that are selected to
optimally address the key uncertainties that remain. We acknowledge that to generate the most useful
evidence for decision-making will often require a trade-off between precise, unbiased answers to
narrowly defined questions and less certain answers to broader, more complex questions.
Although we have not explicitly discussed epistemology, we have challenged the position established
in earlier editions that unbiased estimates of effectiveness are the cardinal goal of evaluation, and
we have emphasised that improving theories and understanding of how and in what circumstances
interventions contribute to change is also an important goal for complex intervention research.
For many complex intervention research problems, an efficacy or effectiveness perspective will be
the optimal approach, for which a RCT will probably provide the best design to achieve an unbiased
estimate. For other problems this will not be the case, and alternative perspectives and designs will be
more likely to generate useful new knowledge to help reduce decision-maker uncertainty. What is
important for the future is that the scope of intervention research commissioned by funders and
undertaken by researchers is not constrained to a limited set of perspectives and approaches that
may be less risky to commission and more likely to produce a clear and unbiased answer to a specific
question. What is needed is a bolder approach, including some methods and perspectives for which
experience is still quite limited, where we (supported by our workshop participants and respondents
to our consultations) believe that there is an urgent need to make progress by mainstreaming new
methods that are not yet widely used, as well as undertaking methodological innovation.
We have emphasised the importance of continued deliberation by the research team of what the key
uncertainties are that are relevant to that stage of research, and then defining research questions and
selecting research perspectives and methods that will reduce that uncertainty. We reiterate that our
recommendation is not to undervalue research principally designed to minimise bias in the estimation
of effects; rather, we encourage the use of a wider range of perspectives and methods, augmenting the
available toolbox and, thus, increasing the scope of complex intervention research and maximising its
utility for decision-makers. This more deliberative, flexible approach is intended to reduce research
waste and increase the efficiency with which complex intervention research generates knowledge that
contributes to health improvement.
DEVELOPMENT OF THE FRAMEWORK
NIHR Journals Library www.journalslibrary.nihr.ac.uk
14
We acknowledge that some readers may prefer more detailed guidance on the design and conduct of
any specific complex intervention research project. The approach taken is to help researchers identify
the key issues that ideally need to be considered at each stage of the research process, to help
research teams choose research perspectives and prioritise research questions, and to design and
conduct research with an appropriate choice of methods. We have not provided detailed methodological
guidance, primarily because that is well covered elsewhere. We have been fortunate to be able to draw on
and refer to many other guidance documents that address specific and vitally important aspects of the
complex intervention research process and specific aspects of research design, conduct and reporting.
We encourage researchers to consult these sources, which provide more detail than we were able to
here. We have provided more emphasis and detail in areas of change and novelty introduced in this
edition. However, in many of these areas there is an urgent need for further methods development and
guidance for their application and reporting in complex health intervention research. These include
more formal methods to quantify or consider uncertainty, for example decision-modelling approaches,
Bayesian approaches, uncertainty quantification or more qualitative soft systems methodologies, and
methods suited to a systems perspective including simulation approaches and qualitative comparative
analysis methods.
Recommendations
The recommendations of this work are given in Chapter 2. At the end of each research phase section
(see Chapter 2, Phases of research) we include a table of elements that we recommend should be
considered at that phase. The overall recommendation, therefore, is that people use the tables at the
end of each phase when developing research questions and use the checklist in Appendix 6 as a tool to
record where/how the recommendations have been followed.
Monitoring the use of this framework and evaluating its acceptability and impact is warranted: this
has been lacking in the past. We encourage research funders and journal editors to support the
diversity of research perspectives and methods that are advocated and to seek evidence that the
key considerations are attended to in research design and conduct. The use of the checklist that we
provide to support the preparation of funding applications, research protocols and journal publications
(see Appendix 6) offers one way to monitor impact of the framework on researchers, funders and
journal editors. Further refinement of the checklist is likely to be helpful.
We recommend that future updates of this framework continue to adopt a broad, pluralist perspective.
Given the widening scope and the rich, diverse and constantly evolving body of detailed methods
guidance that is now available on specific methods and topics, the framework will most usefully be in
the form of a high-level framework with signposting, published in a fluid, web-based format, which will
ideally be frequently updated to incorporate new material, both through updates to the text and case
studies and through the addition of new links to updated and emerging key resources.
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Chapter 2 The new framework
Introduction
Aims of the framework
The framework aims to improve the design and conduct of complex intervention research to increase
its utility, efficiency and impact. Consistent with the principles of increasing the value of research and
minimising research waste,22 the framework (1) emphasises the use of diverse research perspectives
and the inclusion of research users, clinicians, patients and the public in research teams, and (2) aims to
help research teams prioritise research questions and choose and implement appropriate methods.
Structure of the framework
The framework is presented as follows:
l In What is a ‘complex intervention’?, we provide an updated definition of ‘complex intervention’
informed by a broader understanding of complexity, and introduce how different research
perspectives can be employed in complex intervention research.
l In Framework for the main phases and core elements of complex intervention research, we set out the
revised framework for developing and evaluating complex interventions and provide an overview
of the key core elements that we recommend are considered repeatedly throughout the phases of
complex intervention research.
l In Phases of research, we go into further detail about each of the key phases in complex
intervention research.
l In Case studies, we present illustrative case studies to help exemplify aspects of the framework using
a variety of study designs, from a range of disciplines, undertaken in a range of settings.
How to use the framework
In the 20002 and 20061 versions of this document, there was a key explanatory diagram in which complex
intervention research was divided into a number of key phases. In this edition, we have developed a revised
explanatory diagram (see Figure 3). This does not offer a linear or even cyclical pathway through the phases
of development and evaluation of interventions, but emphasises that at any phase key core elements should
be considered to guide decisions as to whether or not the research should proceed to the next phase,
return to a previous phase, repeat a phase or be aborted. The framework encourages teams to consider the
research perspective(s) most suited to the research challenge that they are aiming to address and to use the
six core elements to guide the choices that they make at each research phase. A programme of intervention
research may begin at any one of the four phases, depending on the key uncertainties that are associated
with the intervention and taking into account existing evidence and/or experience. Users can, therefore,
choose which sections of the recommendations are most appropriate to their own research plans. To aid
navigation through the document, we provide extensive hyperlinks to cross-references between sections.
Throughout the document, we refer to existing detailed guidance and provide key points and signposts to
further reading. At the end of the sections on each phase of research (see Tables 4–8) we include a table
that lists the core considerations relevant to that phase, which we recommend to be used as a tool in
research planning.
Given that this is a pragmatic framework aimed at an audience from multiple disciplines, we have taken
a pluralist approach. Terminology that is related to the study of complex interventions is not used
consistently across disciplines; our use of terms is detailed in the Glossary. Note that we focus on
evaluation rather than ex ante appraisal,23 and specifically on evaluations that contribute to the scientific
evidence base, rather than those that are conducted primarily for monitoring and accountability purposes.
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Previous guidance has focused on statistical and qualitative considerations; we refer to this as well as
highlight the importance of statistical and qualitative considerations throughout the research process.
Economic issues in the context of developing and evaluating complex interventions have been given
less attention; however, their consideration is also important from the early phases of research in
relation to intervention development, evaluation and future implementation. We, therefore, provide
more detail in this section of the framework.
We focus on primary research but note that other types of research, in particular evidence synthesis,
must consider how to approach complex interventions as well. In Appendix 5, we provide some brief
points and signposts to further reading on approaching complexity for producers and users of evidence
syntheses. In Appendix 6, we provide a checklist to support and document the use of this framework in
the preparation of funding applications and journal articles.
What is a ‘complex intervention’?
Few interventions are truly simple. Complexity arises from the properties of the intervention itself,
the context in which an intervention is delivered and the interaction between the two.8,24,25
Sources of complexity
Complexity owing to characteristics of the intervention
Parts of this text have been reproduced with permission from Skivington et al.26 This is an Open Access
article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license,
which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided
the original work is properly cited. See: https://creativecommons.org/licenses/by/4.0/. The text below
includes minor additions and formatting changes to the original text.
Interventions become more complex in line with increasing the:1
l number of intervention components and the interactions between them
l range of behaviours, expertise and skills (e.g. particular techniques and communication) required by
those delivering or receiving the intervention
l number of groups, organisational levels or settings that are targeted by the intervention
l level of flexibility or tailoring of the intervention or its components that is permitted (i.e. how
dynamic or adaptive the intervention is).
For example, the Links Worker Programme27 was an intervention in primary care in Glasgow, Scotland, that
aimed to link people with community resources that could help them to ‘live well’ in their communities. It
targeted individual, primary care [general practitioner (GP) surgery] and community levels; the intervention
was flexible in that it could differ between primary care GP surgeries. In addition, there was no single health
or well-being issue that the Link Workers specifically supported: bereavement, substance use, employment
and learning difficulties were all things that could be included.27 The inherent complexity of this intervention
had implications for many aspects of its evaluation, such as the choice of appropriate outcomes.
Complexity arising from context
Context: . . . any feature of the circumstances in which an intervention is conceived, developed,
implemented and evaluated.
Reproduced with permission from Craig et al.10 Contains information
licensed under the Non-Commercial Government Licence v2.0
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Examples of features include social, political, economic and geographical contexts. Whether or not and
how an intervention generates outcomes can be dependent on a wide range of contextual factors.
These contextual factors will be intervention specific and may be difficult to anticipate. An example of
an intervention that may seem simple, until context is considered, is the ‘Lucky Iron Fish’ (Box 1).10
It is important to consider what features of context may be important in determining how an
intervention achieves outcomes and under what circumstances an intervention may be more or less
effective. This is important for all phases, that is for developing a new intervention, adapting or
translating an existing intervention to a new context, evaluation and implementation.
Interventions as ‘events in systems’
System: a set of things that are interconnected in such a way that they produce their own pattern of
behaviour over time.
Meadows and Wright31
Systems thinking can help us to understand the interaction between an intervention and the context in
which the intervention is implemented in a more dynamic way. Systems can be thought of as complex
and adaptive,32 in that they are defined by system-level properties, such as feedback, emergence,
adaptation and self-organisation (Table 2). We can theorise interventions as ‘events in systems’24 and
can conceive an intervention’s outcomes as being generated through the interdependence of the
intervention and a dynamic system context.
Change in complex systems may be unpredictable. In a social system, people interact with each
other and other parts of the system in non-linear and interconnected ways so that the actions of one
person alter the context for others.35 For example, removing hospital car-parking charges has clear
beneficiaries. However, by encouraging people to drive, the policy may reduce demand for public
transport, leading to a reduction or withdrawal of services. The net effect may be to reduce
accessibility to those without a car. Demand for car parking will increase, possibly beyond capacity,
and alternative options will have diminished. What might appear at first sight to be a positive
intervention may have adverse effects on health and serve to widen inequalities.
BOX 1 Considering context: ‘Lucky Iron Fish’ example
A small fish-shaped iron ingot placed in a pot while cooking or boiling drinking water. The ingots have been
shown to be an effective way of reducing iron deficiency anaemia in women in some communities in rural
Cambodia.28 The intervention was carefully developed to be effective and sustainable in this setting and
population. The ingots could be produced locally, at lower cost than conventional nutritional supplements,
and making them fish-shaped encouraged uptake because fish are considered to be lucky by Cambodian
villagers. Even so, an earlier trial found that short-term improvements in iron status were not sustained,
because seasonal changes in water supply reduced the dietary availability of iron from the cooking water.29
A subsequent trial in a different region of Cambodia also found little benefit, because anaemia in this
region was primarily due to inherited problems with haemoglobin production, rather than dietary
iron deficiency.30
Example taken from Taking Account of Context in Population Health Intervention Research: Guidance for Producers,
Users and Funders of Research.10 Reproduced with permission from Craig et al.10 Contains information licensed
under the Non-Commercial Government Licence v2.0.
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TABLE 2 Properties of complex adaptive systems, with examples
Properties of complex adaptive systems Example
Emergence
Complex systems have emergent properties
that are a feature of the system as a whole.
Emergent properties are often unanticipated,
arising without intention
Group-based interventions that target at-risk young people may be
undermined by the emergence of new social relationships among
the group that increase exposure to and reinforce risk behaviours,
while reducing their contact with mainstream youth culture where
risk-taking is less tolerated33
Enhanced recovery pathways are introduced to optimise early
discharge and improve patient outcomes. They involve changes across
pre-operative care where patient expectations are managed; changes
in theatre by minimising the length of surgical incisions and the use of
surgical drains; and changes in postoperative care on surgical wards
(e.g. the use of physiotherapy). As enhanced recovery pathways are
introduced for specific patients it influences management of other
patients; thus, the whole culture of surgical practice within a hospital
changes towards ‘enhanced recovery’
Feedback
Where one change reinforces, promotes,
balances or diminishes another
A smoking ban in public places reduces the visibility and convenience
of smoking. Fewer young people start smoking because of its reduced
appeal, thus further reducing its visibility and so on in a reinforcing loop7
Adaptation
A change of system behaviour in response to
an intervention
Retailers adapted to the ban on multibuy discounts for alcohol by placing
discounts on individual alcohol products, offering them at the same price
individually as they would have been if part of a multibuy offer34
Self-organisation
Organisation and order achieved as the
product of spontaneous local interaction
rather than of a preconceived plan or
external control
Individually focused treatment for people who misuse alcohol did
not address some social aspects of alcohol dependency; as a result,
recovery groups were self-organised in a collective effort and
Alcoholics Anonymous (New York, NY, USA) was formed
Reproduced with permission from Skivington et al.26 This is an Open Access article distributed in accordance with the
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and
build upon this work, for commercial use, provided the original work is properly cited. See: https://creativecommons.
org/licenses/by/4.0/. The table includes minor additions and formatting changes to the original table.
SIGNPOSTS TO FURTHER READING 1 Systems thinking in health research
l For a more detailed accessible introduction to applying systems thinking to public health evaluation,
see Egan et al.13,14
l The Health Foundation’s overarching description and evidence scan.32
l Understanding complexity in health systems: international perspectives. A series of academic papers on
the topic.8
l The Magenta Book36 is from the UK Government and provides guidance on the evaluation of
government interventions, with recommendations for the planning, conduct and management of the
evaluation. It provides relevant guidance on complex systems-informed evaluation and a supplementary
guide that specifically focuses on handling complexity in policy evaluation. This highlights the challenges
of complexity to policy evaluation and the importance of its consideration in commissioning and
managing interventions, including guidance on the approaches available to support such projects.36
l A report published by the Centre for Complexity Across the Nexus and commissioned by the
Department for Environment, Food and Rural Affairs provides a framework for evaluation, specifically to
support evaluations of government policy to consider the implications of complexity theory.37
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Complexity and the research perspective
We aim to encourage wider awareness, understanding and use of ‘complexity-informed’ research,8 by
which we mean research that gives sufficient and appropriate consideration to all of the sources of
complexity outlined in the previous section. There are several overlapping perspectives that can be
employed in complex intervention research (Box 2), each associated with different types of research
questions. Examples of complex intervention studies taking different research perspectives are given at
the end of this subsection (see Box 4).
Efficacy perspective
Research taking an efficacy or effectiveness perspective is principally concerned with obtaining unbiased
estimates of the average effect of interventions on predetermined outcomes. Studies from an efficacy
perspective aim to test hypotheses about the mechanisms of action of interventions.38 Such research aims
for high internal validity, taking an explanatory approach to test causal hypotheses about the outcome(s)
generated by the intervention. This contrasts with effectiveness studies, which take a more pragmatic
approach. The PRagmatic Explanatory Continuum Indicator Summary (PRECIS)-2 tool39 identifies nine
domains on which study design decisions may vary according to the perspective or approach. Few studies
exhibit all of the characteristics of a purely efficacy or a purely effectiveness perspective; there is not
necessarily a dichotomy between efficacy and effectiveness studies, rather a continuum.
Studies from an efficacy perspective will typically evaluate interventions in idealised, controlled
conditions among a homogeneous group of highly selected participants using a proximal outcome,
such as disease activity, with the intervention delivered in a standardised manner with high fidelity to a
protocol or manual, by highly trained practitioners, without the flexibility and variability that is likely to
occur in real-world practice. Evidence from an efficacy study indicates whether or not an intervention
can work in idealised conditions. Typically, efficacy studies control for contextual variation, so do
not usually help to illuminate context dependence. An efficacy perspective could be taken to the
development, feasibility and evaluation phases of intervention research. However, if found efficacious,
this would not provide sufficient evidence for implementation. For example, testing whether or not a
vaccine is efficacious in preventing infection under optimal conditions would be undertaken prior to
developing a delivery programme, which would then need to be tested for effectiveness in practice.
Another example is testing a psychosocial intervention for efficacy in optimal conditions, using
experienced practitioners and carefully selected patients, a precursor to a further research cycle to
refine and test the intervention for effectiveness in real-world settings.
BOX 2 Continuum of research perspectives
Research perspectives that are used in the development and evaluation of interventions are best not thought
of as mutually exclusive. The types of questions that these perspectives can be used to answer include:
l Efficacy perspective: to what extent does the intervention produce the intended outcome(s) in
experimental or ideal settings?
l Effectiveness perspective: to what extent does the intervention produce the intended outcome(s) in
real-world settings?
l Theory-based perspectives: what works in which circumstances and how?
l Systems perspective: how do the system and intervention adapt to one another?
Adapted with permission from Skivington et al.26 This is an Open Access article distributed in accordance
with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute,
remix, adapt and build upon this work, for commercial use, provided the original work is properly cited.
See: https://creativecommons.org/licenses/by/4.0/. The box includes minor additions and formatting changes
to the original box.
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Effectiveness perspective
Research from an effectiveness perspective seeks to answer pragmatic questions about the effects that
are produced by interventions in routine practice to directly inform the choice between intervention
options.38 Effectiveness studies aim to test an intervention in samples and settings representative of
those in which the intervention would be implemented in everyday practice, usually with a health or
health service outcome. Flexibility in intervention delivery and adherence may be permitted to allow
for variation in how, where and by whom interventions are delivered and received. Standardisation of
interventions may relate more to the underlying process and functions of the intervention than on the
specific form of components delivered.40 For example, the INCLUSIVE trial41 assessed the effectiveness
of the Learning Together programme of restorative justice to reduce bullying and aggression in
schools. Although key intervention inputs were provided to all intervention schools with the aim
that key functions were delivered to trigger the theorised mechanisms of change, each school was
encouraged to ensure that the form of local implementation was appropriate for their students and
context, with scope for locally decided actions.41
Theory-based perspective
The primary aim of adopting a theory-based perspective is to provide evidence on the processes
through which interventions lead to change in outcomes and what prerequisites may be required
for this change to take place, thus exploring how and why they bring about change. This differs from
developing or evaluating interventions using an effectiveness perspective, which focuses on identifying
whether or not they ‘work’ based primarily on average estimates of effect. It also differs from an
efficacy perspective, as theory-based perspectives explore interventions in practice, taking account of
context, and often explore more than one single theoretical account of how the intervention may work.
Such approaches to evaluation aim to broaden the scope of the evaluation to understand how an
intervention works and how this may vary across different contexts or for different individuals.42
In research taking a theory-based perspective, interventions are developed and evaluated through
a continuous process of developing, testing and updating programme theory. Research from this
perspective can generate an understanding of how mechanisms and context interact, providing
evidence that can be applied in other contexts. For example, there are numerous mechanisms by which
group-based weight loss interventions may bring about behaviour change. Change may be motivated
by participants’ relationship with the facilitator or by interaction and sharing of experiences among
members of the group, as well as by the specific content of the intervention. Whether or not and how
such mechanisms generate outcomes will depend on the context in which the intervention is being
applied.43 Thus, the impacts of interventions cannot confidently be determined in the absence of
knowledge of the context in which they have been implemented.44
There are several approaches that take a theory-based perspective (Box 3 shows a selection of
examples). They are ‘methods neutral’ in the sense that they draw on both quantitative and qualitative
study designs to test and refine programme theories.
Systems perspective
A systems perspective suggests that interventions can be better understood with an examination of
the system(s) in which they are embedded or the systems that they set out to change. A systems
perspective treats interventions as events within, or disruptions to, systems.24 The properties of a
system cannot be fully explained by understanding only each of the system’s individual parts.49
This perspective is concerned with an awareness and understanding of the whole system:
The essential point is that the theory driving the intervention is about the dynamics of the context or
system, not the psyche or attributes of the individuals within it.
Hawe et al.24
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Key to a systems perspective is considering the relationships between intervention and context, engaging
with multiple perspectives, and identifying and reflecting on system boundaries.50 A systems perspective
encourages researchers to consider how the intervention may be influenced by and impact on many
elements of the system, and over an extended period of time. Rather than focusing on a narrow and
predetermined set of individuals and outcomes within a fixed time period, a systems perspective will aim to
consider multiple ways by which an intervention may contribute to system change. These may occur through
multiple, often indirect, routes over an extended time period and through spillover and diffusion processes,
some of which may be unintended. It is not usually possible to take account of a whole, often open, system;
therefore, to make an evaluation tractable it will be necessary to limit its scope by determining a system
boundary and restricting the range of potential mechanisms or explanations that are investigated.
Summary
Interventions rarely achieve effects evenly across individuals, populations and contexts. For complex
intervention research to be useful to decision-makers it needs to take into account the complexity that
arises both from the intervention’s components and from the intervention’s interaction with context.
Intervention effects can be dependent on, can influence or change contexts, and this interdependence
can vary over time. Complex intervention research should be conducted with an awareness of these
multiple potential sources of complexity, with the design of any specific research study adopting the
research perspective that is most suited to the research question that it aims to address (see Box 4
for examples). The preponderance of complex health intervention research to date has taken an
efficacy or effectiveness perspective, and there will continue to be many situations in which research
questions for which these perspectives are most suited will continue to be prioritised. However,
for many interventions, the most critical research questions and the needs of decision-makers who use
research evidence are not met by research that is restricted to questions of efficacy and effectiveness;
BOX 3 Different approaches to taking a theory-based perspective
Fourth Generation Evaluation45
This approach to evaluation was developed in the 1980s; it aims to move beyond ‘just getting the facts—to
include the myriad human, political, social, cultural and contextual elements that are involved’.45 To do this,
the involvement of stakeholders and their ‘claims, concerns and issues’45 are essential.
Theory of change approach46,47
‘A systematic and cumulative study of the links between activities, outcomes, and contexts of the
initiative’.46 This involves developing ‘plausible, doable, and testable’46 programme theories in collaboration
with stakeholders to determine the intended outcomes of the intervention, the activities required to
achieve those outcomes and the potential influence of contextual factors. The programme theory
determines which outcome and interim measures should be collected in evaluation and which contextual
factors should be considered. If activities, context and outcomes occur as expected in the prespecified
theory of change, then the outcomes can be attributed to the intervention.
Realist Evaluation48
Realist evaluation sets out to answer ‘what works in which circumstances and for whom?’.48 The important
aspect of realist evaluation is that the intervention’s explanatory components – context(s), mechanisms
and outcomes – are identified, articulated, tested and refined. The development of context–mechanism–
outcome configurations provides plausible explanations for the observed patterns of outcomes, and a key
purpose is to test and refine programme theory based on the evaluation findings.
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BOX 4 Examples of complex intervention studies in smoking prevention research taking different research perspectives
Efficacy perspective
Initial trials of NRT for smoking cessation focused on establishing the efficacy of different forms of NRT.
One example is for nasal nicotine spray, for which the efficacy study included a highly selected group of
participants (in that they were patients attending a smokers’ clinic). It suggested that the intervention was
efficacious but that it would require further testing for generalisability to other smokers and settings, and
to compare it with other forms of NRT.51
Effectiveness perspective
Two school smoking education programmes were evaluated and found to be efficacious in terms
of delaying the onset and reducing the uptake of smoking in young people, and were subsequently
evaluated for effectiveness under normal classroom conditions using a cluster RCT.52 The research
found no significant differences in uptake of smoking between intervention and control groups. The
authors suggest that the experimental conditions in which the interventions were originally tested may
be associated with success, in contrast to this study where the programmes were taught under typical
classroom conditions, by usual classroom teachers. It was recommended that further work be carried out
to develop interventions that are effective in practice and that it is important to formally ‘field test’ under
usual conditions before widespread dissemination.
Theory-based perspective
Although there has been promising evidence about smoking cessation programmes, they do not necessarily
work for everyone in every context. Further investigation using a theory-based approach is, therefore,
appropriate to provide a better understanding of how such interventions work, for whom and why.53 An
example is research that explores the perspectives of smoking and non-smoking pregnant women with
regard to smoking in pregnancy, and relating this to anti-smoking interventions, identifying why standard
cessation efforts may not be successful for some women. For example, rather than pregnant smokers being
ignorant of the facts of smoking in pregnancy (the key issue that mass-media interventions target), they
may be aware of the facts but do not place credibility in them in the same way as non-smoking pregnant
women do, instead favouring information from family and friends.54
Systems perspective
The strategy to evaluate the legislation to ban smoking in enclosed public places in Scotland took a
comprehensive approach that involved seven linked studies.55 The primary aim of the legislation was
to reduce the negative health impact of exposure to environmental tobacco smoke, which has been
evaluated.56–58 In addition, included in the evaluation strategy was research to determine whether or
not the legislation had an impact on smoking quit attempts and successful quitting;59 those at particular
risk, such as bar workers;60 and the performance of the hospitality sector (that has potential impacts for
unemployment in certain areas and a plausible impact on health).61 Studies were also commissioned to
explore the potential effect of the legislation on the context, for example smoking culture and social
norms about smoking, and the potential harmful effects, including the risk of increased exposure to
environmental tobacco smoke in the home among children.57 Although not explicitly theorised as taking
a systems perspective, the evaluation was informed by a programme theory that hypothesised multiple
effects across a range of outcomes, settings and population groups. In retrospect, a systems perspective
can be used to understand how and why these effects occurred in an even broader context, by theorising
smoke-free legislation as an event that occurred at a critical time in the history of the system and activated
further system change including, for example, the growing adoption of smoke-free homes and the greater
advocacy and public support for further tobacco control.62
NRT, nicotine replacement therapy.
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therefore, a wider range of research perspectives and methods needs to be considered and used by
researchers, and supported by funders. This may particularly be the case in health service delivery
and public health research, in which organisational-level and population-level interventions and
outcomes are research priorities that are not well served by traditional methods.6,7 Key questions for
evaluation include identifying generalisable determinants of beneficial outcomes and assessing how an
intervention contributes to reshaping a system in favourable ways, rather than the dominant focus on
the binary question of effectiveness in terms of individual-level outcomes. In the next section, we set
out the revised framework that aims to help research teams consider the research perspective(s) most
suited to the research challenge that they are aiming to address, to prioritise research questions, and
choose and implement appropriate methods.
KEY POINTS 1 Intervention complexity and research perspectives
l Complexity arises from properties of the intervention, from the context in which it is delivered and from
the interaction between the two.
l Consider different research perspectives and how they could be used to conceptualise and evaluate the
intervention, its place in the wider system in which it is implemented and the interdependence between
the two over time.
l The key to choosing a research perspective is to consider the available approaches and use those that
are most helpful, given your research questions.
l Complexity-informed research with an awareness of system(s) can encourage (1) researchers to develop
research questions that take into account the wider contextual factors that influence and/or are
influenced by an intervention over time, and (2) researchers, funders, practitioners and policy-makers to
develop, evaluate and implement interventions using the most appropriate tools and methods.
Framework for the main phases and core elements of complex
intervention research
Overview
This section presents an overview of the main phases and core elements of complex intervention research.
Figure 3 shows the four main phases of intervention research: development or identification, feasibility,
evaluation and implementation. Each phase is connected to a set of core elements considering context,
developing and refining programme theory, engaging stakeholders, identifying key uncertainties,
refining the intervention and economic considerations. We recommend that these elements are
revisited continually throughout the research process and especially before moving between phases
(e.g. between feasibility assessment and evaluation). It is vital that stakeholder input, contextual
considerations and economic considerations are included early and continually throughout the research
process, given that there is little point in going through the other phases if ultimately the intervention
is unlikely to ever be implementable in real-world practice. Case study 1 provides an example of a
complex intervention throughout its journey from development to implementation and its adaptation
to different contexts.
A complex intervention research programme may begin at any phase, depending on what the key
uncertainties are about the intervention in question. The research may involve numerous iterative
stages. Repeating of phases is preferable to automatic progression if uncertainties remain unresolved.
As with drug development research, for which only a tiny minority of promising drug discoveries make
it through to implementation,63 it is likely that many new intervention ideas will prove not to be
worthwhile. If the feasibility phase shows that the initial intervention idea is not deliverable or
acceptable, a decision is needed on whether to stop the research altogether or to do further
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FIGURE 3 Main phases and core elements of complex intervention research. The diagram illustrates the non-linear,
iterative pathway through the research process. The core elements should be repeatedly considered and may lead to
further work at the same phase or movement to another phase. Reproduced with permission from Skivington et al.26 This
is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0)
license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the
original work is properly cited. See: https://creativecommons.org/licenses/by/4.0/. The figure includes minor additions
and formatting changes to the original figure.
Definitions of terms used in Figure 3:
l Context: any feature of the circumstances in which an intervention is conceived, developed, evaluated
and implemented.
l Programme theory: how an intervention is expected to lead to its effects and under what conditions.
The programme theory should be tested and refined at all stages and used to guide the identification of
uncertainties and research questions.
l Stakeholders: those who are targeted by the intervention or policy, involved in its development or
delivery, or more broadly those whose personal or professional interests are affected (i.e. who have
a stake in the topic). This includes patients and members of the public, as well as those linked in a
professional capacity.
l Refinement: the process of ‘fine tuning’ or making changes to the intervention once a preliminary
version (prototype) has been developed.
l Uncertainties: identifying the key uncertainties that exist given what is already known and what the
programme theory, research team and stakeholders identify as being most important to find out.
These judgements inform the framing of research questions that, in turn, govern the choice of
research perspective.
l Economic considerations: what are the comparative resource and outcome consequences of the
interventions for those people and organisations affected?
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development work, rather than press ahead with an effectiveness study. In the case of policies or
programmes, for which stopping the intervention is not within the researchers’ control, an evaluability
assessment (see Evaluability assessment) may show that the intervention cannot be usefully evaluated
in its current form and that further development is needed before an informative evaluation can
be undertaken.
Core elements
Parts of this text have been reproduced with permission from Skivington et al.26 This is an Open Access
article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0)
license, which permits others to distribute, remix, adapt and build upon this work, for commercial use,
provided the original work is properly cited. See: https://creativecommons.org/licenses/by/4.0/. The text
below includes minor additions and formatting changes to the original text.
We have identified six core elements that require consideration throughout all of the phases of
complex intervention research. These are (1) context; (2) development and ongoing iteration of
programme theory; (3) involvement of relevant stakeholders; (4) identification of key uncertainties
to define and prioritise research questions; (5) ongoing intervention refinement; and (6) economic
considerations. This section provides an overview of these core elements, with the following sections
linking them to the four research phases (development, feasibility, evaluation and implementation).
Context
Context: . . . any feature of the circumstances in which an intervention is conceived, developed,
implemented and evaluated.
Reproduced with permission from Craig et al.10 Contains information licensed
under the Non-Commercial Government Licence v2.0
Context is dynamic and multidimensional. Key dimensions include physical, spatial, social, cultural,
digital, political or economic features of the circumstances in which interventions are implemented.
Context ‘interacts, influences, modifies and facilitates or constrains the intervention’.64 How an
intervention works may vary across context and what works in one context may not be as effective,
or may even be harmful, in different contexts (see Case study 2). The impact of a new intervention
will depend on what provision already exists. Interventions may need to be explicitly adapted to
fit different contexts (Box 5). As well as being influenced by context, many ‘interventions work to
change the context within which health is produced and become part of the context for future
health behaviours, interventions and outcomes’ (reproduced with permission from Craig et al.10
BOX 5 Risk of underestimating the importance of context: example
Underestimation of the importance of context, or a failure to take account of all of the relevant contextual
dimensions, can lead to difficulties with implementation or a lack of effectiveness.10 The Nurse–Family
Partnership was shown in a number of US trials65,66 and one European trial67 to be effective in improving
a range of pregnancy, parenting, maternal health and social outcomes before it was implemented in the
UK as the Family Nurse Partnership. A large, well-conducted UK effectiveness trial of the Family Nurse
Partnership found that, despite successful implementation, there was no improvement across four primary
outcomes. The trial report concluded that benefits could not be assumed in ‘different health-care settings
and service populations, even when objective programme fidelity from US trials was maintained’.68
Compared with the US settings in which the intervention had first been tested, the UK has well-organised
health visiting services to which the Family Nurse Partnership may not have added a great deal.69
The intervention needed further development to better meet the requirements of a UK context
[see www.dartington.org.uk/fnpadapt (accessed 1 March 2021)].
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Contains information licensed under the Non-Commercial Government Licence v2.0). Theorising
interventions as interruptions in systems highlights the dynamic interdependence of intervention and
context over time. Taking context into account is crucial throughout the research process:
l in theorising how the intervention will generate effects, intended and unintended
l in anticipating and understanding barriers to and facilitators of the implementation, and scaling up
and scaling out of interventions
l in the development phase to make it more likely that the intervention is effective and implementable
among the target population and setting
l at the evaluation phase, to understand how interventions ‘work’ in terms of how they interact with
their context
l in the reporting of research, to help decision-makers understand whether or not the intervention
will work and for whom in the context for which they are responsible.10
Circumstances surrounding the intervention may change after the study has begun, for example
through the introduction of a new policy or service or, in the case of evaluations with long-term
follow-up, more fundamental changes in the social or economic context. The context may also interact
with the intervention and interventions may be designed to be adaptive and responsive to context.
It is important to develop a clear understanding of what aspects of context may be important in a
broader consideration of intervention outcomes and processes, and which of these are particularly
relevant to the research questions to be addressed. Considering these wider contextual factors at the
earliest stage can help to ensure that the research improves understanding of how an intervention
works and how it might operate in or respond to different circumstances. It allows interventions to
be developed, refined and adapted so that they fit with the contexts in which they are implemented.
KEY POINTS 2 Context
l The context (see Context) in which an intervention is being delivered has a role in its success,
or otherwise.
l Theorising an intervention as an event in a system highlights the dynamic interdependence of
intervention and context over time.
l Context is multidimensional and it is important to be clear about which aspects of context are likely to
influence the delivery, effectiveness, reach and sustainability of the intervention.
l An understanding of the interdependence between context, intervention and outcomes should be
developed at the outset and continuously revisited and documented throughout the research process.
l Clear understanding, description and explanation of context enables judgements to be made about
transferability of the intervention and better enables intervention adaptation and implementation.
SIGNPOSTS TO FURTHER READING 2 Context
l Taking Account of Context in Population Health Intervention Research: Guidance for Producers, Users and
Funders of Research.10
l Pfadenhauer et al.’s70 the Context and Implementation of Complex Interventions (CICI) framework.
l A realist conceptualisation of context.71
l Viewing intervention context in a more dynamic way through a systems lens provides many challenges
to complex intervention research.62
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Programme theory
Programme theory describes how an intervention is expected to lead to a set of specified outcomes
and under what conditions. It articulates (1) the key components of the intervention and how they
interact; (2) the mechanisms of the intervention; (3) the features of the context that are expected to
influence those mechanisms; and (4) how those mechanisms may influence the context.72
Case study 3 provides an example of how programme theory has been developed and used. For
interventions designed to be adaptable across contexts, the programme theory should articulate
the key functions that must be consistently delivered and indicate how far interventions can be
responsive to different and changing contexts.40,73 A programme theory may include aspects of
mid-range or grand theories, but its aim is more specific: to articulate how and why an intervention
is expected to work.
Developing programme theory
Programme theory can be used to promote a shared understanding of the intervention and how it
works among diverse stakeholders involved in intervention implementation and evaluation, as well as
among those consuming and using the research. It can also be used to identify key uncertainties and
research questions. Programme theory should be ‘adaptive’, continually updated, developed and refined
as understanding of the intervention and its interaction with the context and system changes over time.
The best practice is to develop programme theory at the beginning of the research project based
on the evidence base and theory from relevant fields with involvement of diverse stakeholders, and to
refine it during successive stages of the research to produce an updated programme theory at project
completion. A refined programme theory is an important evaluation outcome and is the principal aim
for which a theory-based perspective is taken. Improved theory will help inform transferability of
interventions across settings and help produce evidence and understanding that is useful to decision-
makers. It may demonstrate that an intervention is less likely to be effective when transferred to a
given context; this in itself is a useful outcome.
Where researchers are involved in evaluating an intervention (such as a policy) developed by others,
they still need to theorise the intervention before attempting to evaluate it.74 This involves defining the
content and purpose of the policy clearly, and articulating and refining a programme theory. As with
researcher-developed interventions, involvement of stakeholders is critical. Key documents can also
be drawn on (e.g. policy documents or existing funding applications) to refine programme theory.
Developing a programme theory is part of completing an evaluability assessment of an existing or
proposed policy intervention,75 discussed further in Evaluability assessment.
For further guidance, see Signposts to further reading 3: programme theory.
Representing programme theory
Programme theory should always be clearly articulated. It can be helpful to provide a visual representation
of aspects of the programme theory. This is particularly useful for shared understanding among
stakeholders of the intervention and the potentially multiple ways that it may generate outcomes. It is
important to note that any single visual representation will often not be sufficient to fully articulate the
programme theory. There are various ways of depicting a programme theory, for example logic models,
realist matrices and systems maps. Each method shows something slightly different and is, therefore,
useful in different circumstances.
Logic models The terms logic model and programme theory have been used inconsistently in the past,
with logic model often being used interchangeably with programme or intervention theory. Given
that logic models (a method of visually representing some elements of the programme theory) have
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varying levels of detail, typically showing the inputs, outputs and intended outcomes but not always
considering the intervention mechanisms or context dependencies, we distinguish the terms to
highlight the importance of clearly articulating the full programme theory. Nonetheless, logic models
can be very useful alongside programme theory to clarify thinking, to gain a shared definition and
understanding of the intervention among diverse stakeholders, and to guide and communicate with
others about the outcome evaluation. More complex forms of logic model are increasingly used.
They include causal logic models that show mechanisms and pre-conditions (see Case study 4) and
‘dark logic models’ that depict unintended and potentially negative consequences of the intervention
(see Case study 5).76
Realist approaches Programme theory is at the core of realist evaluation. There are a variety of
methods for developing and presenting realist programme theory, such as creating multiple draft
theories for different aspects of the intervention to inform the overall programme theory77 and the
use of realist matrices.72 A realist matrix is a table addressing aspects of the intervention, such as
agency, context, resources, mechanisms and outcomes (see Case study 6). Realist matrices present the
hypothesised causal mechanisms of the intervention and attempt to address the question ‘what works
in which circumstances and for whom?’.
System maps If taking a systems perspective, it may be appropriate to create a system map that
embeds the intervention in the wider dynamic context. Here, the intervention is viewed as an event
within a complex system, in which different components of the system and relationships between them
will react in various ways, with the potential to affect different outcomes and generate system change.
A system map is a conceptual visual map that is created to describe the components of the system
and the relationships between them. Group model building and other soft systems methodologies
can be used to create system maps using inputs from multiple perspectives to gain a holistic and
shared understanding.78–81 An initial system map, created with the input of various stakeholders, may
help to refine the programme theory and to define the scope of the evaluation. A systems perspective
supported by systems mapping will support the inclusion of longer-term, spill-over feedback and
potential emergent effects of interventions that would potentially be missed by other research
perspectives that tend to focus on more proximal, linear effects. For example, an evaluation of the UK
Soft Drinks Industry Levy (SDIL) used system mapping, involving multiple stakeholders, as a starting
point for developing programme theory (see Case study 7). System maps can also be complementary
to the realist approaches described above.82
KEY POINTS 3 Programme theory
l Programme theory describes how an intervention is expected to lead to a set of specified outcomes,
and under what conditions. It should be developed at the outset as a collaborative process involving
researchers and stakeholders.
l The development of programme theory is an iterative process. An updated programme theory should be
produced at the end of each phase of development and evaluation to capture learning and guide next steps.
l Use the programme theory to choose appropriate evaluation outcomes, including measurement and
testing of the theory.
l Visual representation of the programme theory can be useful for summarising programme theory and
communicating with stakeholders. However, a comprehensive programme theory should always be
clearly articulated and not just represented in a logic model(s) or other simplified visual representation.
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Stakeholders
Stakeholder engagement is required throughout the research process to maximise the likelihood that
the research addresses relevant questions and leads to changes in practice or policy:
Stakeholders: Those who are targeted by the intervention or policy, involved in its development or delivery,
or more broadly those whose personal or professional interests are affected i.e. who have a stake in the
topic. This includes patients and members of the public as well as those linked in a professional capacity.
Stakeholders should be involved early in the research process and remain engaged throughout.
Reciprocity is vital, and the goal should be the development of collaborative relationships that
continue throughout the phases of development, evaluation and implementation.
The purpose of stakeholder engagement will differ depending on the context and phase of the
research, but could include drawing on stakeholders’ practical experience; obtaining stakeholders’
perspectives on the problem being addressed by the intervention; gaining stakeholders’ input to and
shared understanding of the programme theory, including understanding of the context and system
properties; identifying potential areas for change; choosing appropriate outcomes; and ensuring that
all ‘voices’ are heard. It can also help with prioritising research questions, choosing the most useful
evaluation perspective, building consensus and fostering relationships to make evaluation more
straightforward, for example by accessing gatekeepers, supporting intervention refinement and
considering issues around transferability and implementation. Where a systems perspective
is taken, stakeholder engagement can help to define the system boundaries and, thus, the scope
of the evaluation.
The risks of not engaging relevant stakeholders in complex intervention research include the
intervention being theorised or considered from a narrow perspective only; the intervention not being
readily implementable or supported by existing system context; the intervention being infeasible or
unacceptable; and the chosen outcomes not being important to the patients, public, policy or practice.
For example, outcomes of surgical interventions for severe and complex obesity depend on patient
engagement with new lifestyle and diet, and work better with multidisciplinary care from psychologists
and dieticians in addition to the traditional surgical teams.88 The development and evaluation of a
surgical intervention like this example, therefore, requires multidisciplinary stakeholder engagement,
not least with the patients who may receive the intervention. Broad thinking is needed to identify a
diverse range of appropriate stakeholders beyond the usual suspects.
SIGNPOSTS TO FURTHER READING 3 Programme theory
l Overview of the various types of theory.83
l The use of programme theory within intervention development.11
l The use of programme theory for evaluating policy-led processes and outcomes.74
l The 6SQuID model for intervention development provides detail on the use of theory.17
l Intervention mapping is a theory-led approach to developing interventions and their evaluation.84
l Extending logic models with a complexity perspective.85
l What theory, for whom and in which context? Reflections on the application of theory in the development and
evaluation of complex population health interventions.86
l Purposeful Program Theory. Effective Use of Theories of Change and Logic Models.72
l Realist reviews to inform programme theories.87
6SQuID, 6 Steps in Quality Intervention Development.
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Stakeholders from professional groups
Engaging stakeholders from professional groups can be difficult for practical reasons: because they
have other priorities or because they have competing or vested interests. For example, social security
policy-makers may attach low priority to the health impact of welfare reform because their chief
concern is the effects on labour market participation; therefore, engaging them in research to
evaluate health outcomes is difficult. There may be drawbacks from aligning research too closely
with stakeholder priorities. It is important to elicit their research priorities, but also to consider why
they are priorities and what decisions they are likely to influence.
These issues may also apply to researchers, particularly those who have been involved in intervention
development and who may have a stake in the success of the intervention.89 Studies have shown that
early positive results are often not replicated in independent evaluation.90 Systematic bias has also
been evidenced in drug trials, whereby the products of the company funding the research are shown
to be favoured over others.91 Thorough consideration of the governance issues, conflicts of interest,
risks and benefits is particularly important for research partnerships with commercial organisations.
Unhealthy commodity industries have been shown to engage in numerous tactics when engaging with
research,92 for example to divert attention away from population-level to individual-level interventions,
despite the former having greater potential to improve population health.93
Researchers need to be aware of these sensitive issues. There should be thorough consideration of the
appropriate involvement of identified stakeholders with integrity and transparency. An element of
critical (and self-critical) distance is needed without losing the benefits of working effectively with
stakeholders (see Signposts to further reading 4: stakeholders).
Co-production of interventions with effective collaboration between a group of stakeholders can
support the move from interventions being driven in a closed manner by researchers, to interventions
being developed in partnership with a range of stakeholders.94 As noted above for stakeholder
engagement, however, partnership and co-production must be conducted openly and in ways that do
not distort research priorities or compromise research integrity.
Patient and public involvement
One group of stakeholders that is particularly important to involve in research is the potential recipients of
an intervention. PPI in research is defined as ‘research being carried out “with” or “by” members of the
public rather than “to”, “about” or “for” them’ (reproduced with permission from INVOLVE).95 As well as
collaboratively developing research questions and interventions that are relevant and appropriate to
participants, and identifying outcomes that are important to them, appropriate PPI is likely to improve the
recruitment and retention in evaluation studies.96 In particular, people with lived experience of the condition
or issue should be seen as having expertise that others cannot bring to the team.97 (Case study 8 illustrates
this ‘patient-as-partner approach’.)
It is critical that PPI is meaningful and robustly conducted, rather than tokenistic.98 The type of
engagement should also be appropriate to the project, for example to the particular condition or issue
of interest, which could be sensitive or stigmatised.99 There are numerous challenges to overcome to
engage patients and the public effectively in research. They include power imbalances between
researchers and patients/public, competing priorities, engagement difficulties and creating effective
partnerships. Researchers should consider following a formal framework for engaging, monitoring and
evaluating stakeholder involvement (see Signposts to further reading 4: stakeholders). To improve PPI,
research should also include some evaluation of the engagement process,100 which should be published
where possible, to enable shared learning.101
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KEY POINTS 4 Stakeholders
l ‘Stakeholder’ is a wide-reaching term for anyone who has a stake in the intervention and/or its
evaluation or implementation; therefore, careful consideration at the outset of the relevant stakeholders
(for different phases of the research) is important.
l It is particularly important to involve patients and the public in research. Consider following a predefined
framework for PPI in your research.
l Stakeholder engagement needs to be genuine rather than to satisfy criteria for funding, publication, etc.
and should include the prioritisation and design of the research rather than merely its delivery.
l Involvement of appropriate stakeholders is crucial to each phase of research, and ultimately to the
prospects of the intervention being effective and the research leading to changes in policy or practice.
At the same time, an element of critical distance between researchers and stakeholders is required,
and researchers need to beware of sensitive issues that involving certain stakeholders may invoke.
The nature of stakeholder involvement should be transparent, with upfront and agreed terms of
references and processes for declaring conflicts of interest.
SIGNPOSTS TO FURTHER READING 4 Stakeholders
l INVOLVE [www.invo.org.uk/resource-centre/resource-for-researchers/ (accessed 1 March 2020)] is a
national advisory group funded by NIHR to support active public and patient involvement in NHS, public
health and social care research. There is an online resource to support researchers to involve the public
in how research is identified, prioritised, designed, conducted and disseminated. INVOLVE’s Values and
Principles Framework102 aims to support the building of collaborative partnerships in research and to
collaboratively produce national standards for public involvement.
l See the National Standards for Public Involvement in Research website for updates.103
l NIHR handbook for researchers on PPI in health and social care research.104
l Different frameworks exist for supporting PPI in research; for a critical overview see Greenhalgh et al.105
l Recommendations for effective engagement with stakeholders for research prioritisation, alongside a
checklist of practices.106
l Reporting of PPI in research: primary research guidelines107 and systematic review guidelines.108
l Guidance on collaboration with industry:
¢ MRC Industry Charter.109
¢ NIHR Model Industry Collaborative Research Agreement (mICRA Guidance)110 and MRC Industry
Collaboration Agreement (MICA).111
¢ MRC UKPRP: Principles for Working with Industry.112
¢ The Lambert Toolkit for universities and companies that wish to undertake collaborative
research projects.113
l Researchers can draw on different tools to engage stakeholders, for example:
¢ For systems methodology – Systems Concepts in Action: A Practitioner’s Toolkit.,114 and Soft Systems
Methodology in Action.115 Examples of soft systems methodology include rich pictures, context diagrams,
multiperspective diagrams, group model building, laddering, concept maps, cognitive maps and causal
loop diagrams.81
¢ The Network for Transdisciplinary Research provides a series of methods and tools for collaboration
between experts and stakeholders (e.g. ideas for clarifying expectations and dealing with power
issues in the multidisciplinary stakeholder group).116,117
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Key uncertainties
A major challenge for complex intervention research is that, at any phase, there are multiple research
questions that could be usefully addressed and alternative research perspectives that may seem equally
plausible. Key to maximising the efficiency and value of research is to focus on addressing the key
uncertainties that exist, taking into account what is already known and what the programme theory,
research team and stakeholders identify as being the most important to find out. These judgements
inform the framing of research questions that, in turn, govern the choice of research perspective. Even if
the fullest possible assessment of an intervention depends on understanding its impact on the system
in which it is embedded, that understanding may need to be developed through a series of studies that
adopt a range of different perspectives, chosen at each phase to be the most relevant to addressing the
key uncertainty at that phase. For example, a common approach that fits well with the linear stages of
research that were proposed in the 2000 complex intervention framework,3 is to focus on establishing
whether or not the intervention ‘works’ by obtaining an unbiased estimate of the average effect. This is
undertaken initially through an efficacy perspective that is applied within tightly controlled conditions,
and then through effectiveness research that is conducted in more realistic conditions. For interventions
where the programme theory suggests that there are homogeneous effects across population subgroups,
with a low degree of system and context dependence, efficacy and effectiveness are likely to be the key
initial uncertainties, with implementation and transferability being the focus of later stages of research.
However, for interventions that are designed to be flexible and adaptable or that interact with contexts
and systems in a dynamic and variable way, the key initial uncertainties may relate less to efficacy and
more to acceptability and compatibility with the wider systems in which they are embedded, with the
assessment of impact on key outcomes taking place at a later evaluation phase.
At any given phase of research there may be more than one key uncertainty, which can be addressed
through separate research questions and parallel paths of inquiry. For example, modelling the
effectiveness and economic implications of scaling up an intervention may be worthwhile alongside a
development or feasibility study, to reduce the risk of developing and testing an intervention that has
little real prospect of being implemented in practice (Box 6).
Prioritising research questions and choosing a research perspective will be influenced both through the
identification of key uncertainties and through the assessment of the likelihood of achieving an unequivocal
answer to that question. There is a risk that research questions, research perspectives and research designs
that are favoured by existing guidance and research funding mechanisms are those that have a greater
BOX 6 When is evidence sufficient?118
Decision analysis can help decision-makers to weigh up the consequences of adopting a new intervention,
taking into account evidence of therapeutic effectiveness for both the new and the existing treatments, but
also wider costs, such as side effects of treatment, the productivity losses of leaving the illness untreated
and the consequences of adopting the intervention if the effectiveness evidence turns out to be false.
Value-of-information analysis can be used to answer the question of whether or not it is worth gathering
extra evidence to reduce uncertainty in the adoption decision. Gathering extra evidence is more likely to
be worthwhile if a new intervention is expected to be much better than the one currently thought of as
optimal, and if the cost of gathering the evidence is small relative to the benefit of making the right
adoption decision.
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probability of finding a certain answer, even though the question may be of less importance. One of the
motivations for updating this framework was to answer calls for a change in research priorities, towards
allocating greater effort and funding to research that can have the greatest impact on health-care and
population health outcomes. This may require a shift away from, for example, efficacy trials of relatively
uncomplicated interventions in tightly controlled conditions, for which research questions are answered
with great certainty but for which the translation of this evidence into diverse, real-world settings is
often highly problematic,119 requiring heroic assumptions about the potential for generalisation and
implementation. In many areas of health intervention research, it may be more useful to give higher
priority to an evaluation that is sensitive to complexity, from which improvements in understanding
and important implications for decision-makers can be identified, albeit with caveats, assumptions and
limitations.7 Thus, theory-based or systems evaluations of complex population-level interventions and
mixed-methods evaluations that emphasise implementation, context and system fit may provide more
useful knowledge to address key uncertainties for decision-makers than evaluations that seek to provide
unequivocal answers to tightly specified questions of less importance. For example, decision-makers may
place greater value on research from a systems perspective that assesses an intervention in terms of its
potential to contribute to long-term impacts on multiple outcomes, through multiple and often indirect
pathways that will vary over place and time, than on research from an effectiveness perspective that
measures short-term effects on a single prespecified outcome.
Identifying key uncertainties, priority research questions and optimal research perspectives will ideally
involve the active participation of a multidisciplinary research team and a diversity of stakeholders, and
ideally with independent oversight, perhaps from a funders’ steering group. Different stakeholders will
have different views on what is the most important to find out. Some may not be in equipoise about
the intervention’s effectiveness because they are satisfied with what is already known and may,
therefore, be more focused on questions of reach, context dependence and issues of implementation;
others may feel that greater certainty of effectiveness is required owing to limitations and potential
bias in the existing knowledge base. Choice of outcome may also vary according to stakeholder
perspective. For example, a local authority evaluating a suite of policies to increase physical activity
may prioritise a natural experiment using routinely collected data on pre- and post-intervention use of
leisure centres and green space in localities with and without the policy. Researchers may place higher
priority on validated measures of physical activity in exposed and unexposed groups to be convinced of
the effect of the intervention. An evaluability assessment would be a useful tool in this case to help
identify the most worthwhile design and focus of evaluation (see Evaluability assessment).
Key uncertainties should be continually revisited as data accumulate and the programme theory
and intervention are updated and refined. Formal methods, such as decision analysis, VOI analysis
(see Box 6) or agent-based modelling (ABM) with uncertainty quantification, may be useful in
prioritising research questions and optimising research design.120–122 However, in many situations this
will be largely a deliberative process underpinned by the purpose of the evaluation and the needs of
research users. Traditionally, research funders and researchers have prioritised research questions and
their associated designs and methods that have a good chance of being answered with a high degree of
certainty and are strongly influenced by hierarchies of evidence. For many complex interventions, the
needs of research users and the complexity of the evaluation may favour decision-making based on a
greater diversity of evidence, thus valuing a wider range of research perspectives and methods, and
on ‘balance of probabilities’ rather than ‘evidence beyond reasonable doubt’. By involving a wider range
of stakeholders in the research team, a consideration of uncertainty in prioritising the next stage of
research may lead to a greater focus on reducing uncertainty around important questions than on
answering less important questions with certainty; the findings may be equivocal but will nevertheless
be of greater value.
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KEY POINTS 5 Uncertainties
l Identify key uncertainties that the research aims to address, given what is already known and the
intervention programme theory. What are the key uncertainties for decision-makers?
l Formulate and prioritise research questions accordingly.
l Uncertainties will change as evidence accumulates, so should be reviewed at each phase of the
research process.
l Engage stakeholders to develop a detailed understanding of where uncertainty lies for those funding,
delivering or receiving the intervention.
l Consider both the importance of the uncertainty and the likelihood of reducing that uncertainty when
prioritising questions and perspectives.
l Identifying which outcomes are important and/or measurable may help prioritise the focus of research.
l In the case of interventions that are occurring anyway outside the control of the research team, such
as changes in policy or health-care delivery, evaluability assessment can support the identification of
key uncertainties.
Intervention refinement
Within each phase of complex intervention research and on transition from one phase to another,
there may be good reason, based on the data collected and/or the development of programme theory,
to refine or optimise the intervention:
Refinement: The process of ‘fine tuning’ or making changes to the intervention once a preliminary version
(prototype) has been developed.
O’Cathain et al.11
Intervention refinement (see Case study 9) in the development, feasibility and implementation phases
can be relatively straightforward, provided that the changes are consistent with the intervention’s
programme theory. Such refinements are covered by the argument that the form of an intervention
can be flexible as long as the key functions specified in the programme theory are delivered.40
However, where the changes are substantial and imply a significant change to the programme theory,
such adaptation may require a more fundamental rethinking of the research process. This more
fundamental kind of adaptation is distinct from refinement, in that it refers to an existing intervention
being adapted to a new population, setting, target outcome or context, and is discussed in Developing
an intervention.
Intervention refinement and flexibility are discouraged in an efficacy evaluation, in which standardisation
and consistency of intervention delivery are prioritised to maximise internal validity. However, from
a systems perspective, adaptability and responsiveness are likely to be desirable features of the
intervention and a key focus of the research. The extent to which variation in programme delivery is
desirable in an effectiveness or theory-based evaluation will depend on the extent to which a flexible
form of delivery is allowed, while preserving the delivery of the intervention’s key functions.40
SIGNPOSTS TO FURTHER READING 5 Uncertainties
l Uncertainty and the evaluation of health and social interventions.118,123
l Decision-theoretic approaches for appraising evidence.124
l Two discussions of the uncertainty of evidence surrounding face masks for the protection of the public
during COVID-19.125,126
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In instances of an ‘identified intervention’ (i.e. one that is driven by policy or practice, rather than
researcher led; see Identifying an intervention), limits on refinement may be set by the policy or
practice context. Refinement of policy- or practice-led interventions will require negotiation with
those co-ordinating the intervention and all other relevant stakeholders, but may be valuably informed
by evaluation results.
Rapid refinement of digital interventions
There are specific challenges that are associated with evaluating digital interventions. These
interventions offer the potential for wide reach and high impact at a relatively low cost. However,
such interventions may require a rapid route to implementation and frequent refinements to avoid
becoming ‘out of date’.127 Considerations specific to evaluating digital interventions have been
summarised by Murray et al.,128 who suggest that traditional evaluation methods, such as RCTs, could
be combined with a more iterative approach to intervention development and refinement. To allow for
multiple versions of web-based or mobile interventions to be deployed simultaneously, Continuous
Evaluation of Evolving Behavioural Intervention Technologies (CEEBIT) trials have been developed.129
Transparent reporting of changes
The level of refinement that is considered acceptable at different points in the research process will
differ depending on the programme theory and research perspective. However, if refinements are
made to an intervention, they should be reported transparently and with justification.
KEY POINTS 6 Intervention refinement
l Refinements to an intervention should retain the key features of the programme theory. Therefore,
acceptable boundaries of refinement should be agreed beforehand.
l It benefits all stakeholders for the optimal version of an intervention to be evaluated and/or implemented.
l Ongoing refinement can improve the potential implementability of the intervention.
Economic considerations
Economic considerations: What are the comparative resource and outcome consequences of the
interventions for those people and organisations affected?
Nearly all complex interventions will be costly to implement and will impose costs on a range of
populations or organisations. Economic evaluation, the comparative analysis of alternative courses of
action in terms of both costs (resource use) and consequences (outcomes and effects), should be a
SIGNPOSTS TO FURTHER READING 6 Intervention refinement
l The INDEX study: guidance on developing complex interventions to improve health and health care.11
l Normalisation process theory: a framework for developing, evaluating and implementing complex interventions
[see also www.normalizationprocess.org/ (accessed on 1 March 2021)].130
l A conceptual framework for adaptive preventive interventions.131
l Developing and evaluating digital interventions to promote behaviour change in health and health care:
recommendations resulting from an international workshop.127
l CEEBIT trials: Continuous evaluation of evolving behavioural intervention technologies.129
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core component of all phases of intervention research. Early identification of the potential costs and
outcomes can help with the setting of research questions and the design of an appropriate economic
evaluation (see Case study 10). Methods for the economic evaluation of health interventions are well
developed.132 Here, we concentrate on aspects that are particularly important for complex interventions.
Early engagement of economic expertise will help identify which perspective to adopt to answer
questions that matter most to decision-makers.133 Recent National Institute for Health and Care
Excellence (NICE) guidance134 recognises that complex interventions are likely to have costs and
outcomes across different sectors, and recommends the adoption of a broad (e.g. societal) rather than
a narrow (e.g. health service) perspective. Use of an impact inventory is a good way of making choices
of perspective and of which costs and outcomes to include, explicit, transparent and comprehensive.135
Another important initial consideration is what economic evaluation framework should be adopted.
Again, the NICE guidance134 advocates broad cost–consequence analysis (CCA) or cost–benefit
analysis (CBA) approaches because narrower approaches, such as cost-effectiveness analysis (CEA)
or cost–utility analysis (CUA), are unlikely to reflect the full range of costs and consequences.
These approaches and the choice between them are discussed more fully in Economic considerations.
Central to all forms of economic evaluation is the identification, measurement and valuation of the
resources and outcomes of both the intervention being evaluated and the appropriate comparators.
What to include may not be obvious to evaluators given the variety of resources required to deliver a
complex intervention and the range of intended and unintended consequences for those directly and
indirectly affected.136 Engaging stakeholders (organisations and individuals involved in commissioning
and delivering the intervention or expected to experience additional costs, savings, benefits or negative
impacts) in the identification process is essential. Economic considerations are often very important to
decision-makers because many of their decisions concern the optimal allocation of scarce resources.
A decision-modelling framework may be useful to guide and synthesise complex intervention research.
This understanding of resources (costs) and outcomes, together with evidence from existing studies,
such as economic evaluations of comparable interventions, should be incorporated in a programme
theory. Programme theories can be used to identify the cost and outcome variables that should be
taken forward into the economic evaluation. Interactions between an intervention and the context in
which the intervention is delivered may lead to variation in costs and outcomes, underlining the
importance of unpicking how causal pathways might work differently for different groups and
incorporating this understanding in an explicit programme theory.137 Use of programme theories in
economic evaluation is considered further in Developing an intervention.
A further consideration in designing economic evaluations of complex interventions is the trade-off
between equity and efficiency; this is important where differential impacts are likely. The costs and
the benefits of complex interventions may vary across groups in the population, such that the most
efficient interventions in terms of population health gain may not be the most equitable in terms of
reducing (or at least not increasing) health inequalities. Considering who the beneficiaries might be and
how costs and impacts might differ between them is a crucial part of planning an economic evaluation
of a complex intervention, and methods have been developed for conducting economic evaluation in
ways that take account of trade-offs between equity and efficiency.138,139
Economic considerations that should be taken into account at particular phases in the process of
developing and evaluating a complex intervention are addressed in the relevant sections below. Ways
in which economic evaluation of a complex intervention might differ from standard approaches are
identified and new methods highlighted.
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KEY POINTS 7 Economic considerations
l Include economists in project teams from the early stages of complex intervention research to ensure
that economic considerations are fully incorporated in all important decisions about intervention and
evaluation design.
l Inclusion of economic considerations in the programme theory will help with understanding of the
problem and shape the design of future feasibility and evaluation studies.
l Depending on the research perspective, it will often be appropriate in complex intervention research
to adopt a broad (e.g. societal) rather than a narrow (e.g. health service) perspective to the scope of
economic considerations included.
l Equity–efficiency trade-offs should be considered when the intervention is likely to have different costs
and benefits for different groups, or where the case for intervention is driven by health equity concerns.
Phases of research
Parts of this text have been reproduced with permission from Skivington et al.26 This is an Open Access
article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0)
license, which permits others to distribute, remix, adapt and build upon this work, for commercial use,
provided the original work is properly cited. See: https://creativecommons.org/licenses/by/4.0/. The text
below includes minor additions and formatting changes to the original text.
The following section outlines four phases of research: (1) developing or identifying the intervention,
(2) feasibility testing, (3) evaluation and (4) implementation. As illustrated in Overview, the phases may
overlap and a research programme may begin at any phase, depending on the key uncertainties about
the intervention in question. Each phase is discussed in detail below. After each phase, we present a
table that addresses the core elements (see Core elements) and relevant issues to consider for that phase,
followed by a ‘key points’ box and a final box that provides signposts to further guidance and resources.
Developing or identifying the intervention
Intervention development: The term ‘development’ is used here for the whole process of designing and
planning an intervention from initial conception through to feasibility, pilot or evaluation study.
This phase of the research process was referred to as intervention development in the previous version
of this framework.1 However, this did not address the evaluation of interventions where researchers are
not involved in their development and do not have experimental control of implementation, which is often
SIGNPOSTS TO FURTHER READING 7 Economic considerations
l Guidance on the development of programme theories and conceptual modelling for economic aspects of
complex intervention development.140
l An introduction to the principles of health economics and economic evaluation relevant to the specific
challenges of public health and its aims of improving population health.141
l Guidance for conducting economic evaluations alongside natural experiments.142
l Textbook on Methods for the Economic Evaluation of Health Care Programmes.132
l NICE methods guidance and reference case for undertaking economic evaluations.134
l Exploring uncertainty in cost-effectiveness analysis.121
l Using Realist Approaches to Explain the Costs and Cost-effectiveness of Programmes.137
l Conceptualizing a model: a report of the ISPOR-SMDM modelling good research practices Task Force-2.140
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the case in policy- or practice-led interventions. Intervention identification and intervention development
represent two distinct pathways of evidence generation to inform policy or practice, characterised by
the two pathways shown in Figure 4.143 In both cases, a key requirement in this phase is to develop a
programme theory for the intervention, identify key uncertainties and formulate research questions
to decide which research phase to move onto next and what further research to prioritise.
Developing an intervention
The MRC-/NIHR-funded INDEX study has developed comprehensive guidance on intervention
development.11 Rather than replicate the INDEX guidance here, we provide an overview of the key
steps and encourage readers to access the main INDEX document (see Signposts to further reading 8:
developing or identifying an intervention).
The INDEX guidance recommends that a robust process of intervention development should involve
the 11 steps outlined in Table 3.
In practice, intervention development approaches will need to be tailored to the capacity of the team,
context and resources. Some of the steps in Table 3 may overlap or need to be repeated. It may not
be possible or necessary to address all of them, but each should be considered for relevance and
importance. Teams involved in developing interventions are encouraged to publish their development
work so that learning can be shared.
Four additional sets of issues that may need to be addressed are (1) the adaptation of existing interventions
to a new context; (2) wider system factors that may need to be taken into account; (3) the consideration
of economic factors; and (4) mathematical modelling or simulation of the intervention.
Adapting an existing intervention
Although the INDEX guidance focuses on the development of de novo interventions, it may often be
the case that the need for a new intervention is responded to through the adaptation of one or more
existing interventions. The term adaptation is distinct from that of refinement, in that it refers to one
or more existing interventions being adapted to a new population, setting or context.144,145 Similarly, an
























Research-driving policy: ‘evidence-based practice’
Policy-driving research: ‘practice-based evidence’
FIGURE 4 Two pathways of evidence generation. Reproduced with permission from Ogilvie et al.143 This is an Open
Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which
permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is
properly cited. See: http://creativecommons.org/licenses/by/4.0/. The figure includes minor additions and formatting
changes to the original figure.
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TABLE 3 Framework of actions for intervention development
Action Consider the relevance and importance of the following:
1. Plan the development
process
l Identify the problem to be targeted and refine the understanding of it
throughout the process
l Assess whether or not the problem is a priority
l Consider which aspects of the problem are amenable to change
l Ask whether or not a new intervention is really needed and if the potential
benefit of the new intervention justifies the cost of development (and consider
the likely short- and long-term cost-effectiveness)
l Determine the time needed to undertake intervention development
l Obtain sufficient resources/funding for the intervention development study
l Draw on one or more of the many published intervention development
approaches, recognising that there is no evidence about which approach is best,
and apply flexibly depending on the problem and context
l Involve stakeholders during the planning process (see next table row)
l Produce a protocol detailing the processes to be undertaken to develop
the intervention
2. Involve stakeholders, including
those who will deliver, use and
benefit from the intervention
l Work closely with relevant stakeholders throughout the development process:
patients, the public, the target population, service providers, those who pay for
health and social services or interventions, policy-makers and intervention
design specialists
l Develop a plan at the start of the process to integrate public and patient
involvement into the intervention development process
l Identify the best ways of working with each type of stakeholder from
consultation to co-production, acknowledging that different ways may be
relevant for different stakeholders at different times
l Use creative activities within team meetings to work with stakeholders to
understand the problem and generate ideas for the intervention
3. Bring together a team and
establish decision-making
processes
l Include within the development team individuals with relevant expertise: in
the problem to be addressed by the intervention include those with personal
experience of the problem, in behaviour change when the intervention aims to
change behaviour, in maximising engagement of stakeholders and with a strong
track record in designing complex interventions
l It may be hard to make final decisions about the content, format and delivery
of the intervention, so only some team members may do this. There is no
consensus about the size or constituency of the team that makes these final
decisions, but it is important early on to agree a process for making decisions
within the team
4. Review published research
evidence
l Review published research evidence before starting to develop the intervention
and throughout the development process (e.g. to identify existing interventions
and to understand the evidence base for each proposed substantive
intervention component)
l Look for, and take into account, evidence that the proposed intervention may
not work in the way intended
5. Draw on existing theories l Identify an existing theory or framework of theories to inform the intervention
at the start of the process (e.g. behaviour change or implementation theory)
l Where relevant, draw on more than one existing theory or framework of
theories (e.g. both psychological and organisational theories)
6. Articulate programme theory l Develop a programme theory. The programme theory may draw on existing
theories. Aspects of the programme theory can be represented by a logic
model or set of models. Programme theory can also help the development
of economic research questions developed in parallel with the intervention
l Test and refine the programme theory throughout the development process
7. Undertake primary data
collection
l Use a wide range of research methods throughout (e.g. qualitative research to
understand the context in which the intervention will operate and quantitative
methods to measure change in intermediate outcomes)
continued
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outcomes, for example the A Stop Smoking in Schools Trial (ASSIST) adolescent smoking prevention
intervention being adapted to tackle substance misuse and sexual health.146–148 A well-developed
programme theory can help identify what features of the antecedent intervention(s) need to be
changed for the intervention to work in its new application.144
Consider the wider system
Acknowledging that an intervention takes place within a wider system guides the intervention
development team to consider the ways in which the intervention and system influence one another,
for example via feedback loops and adaptivity (see Table 2). Mapping the system or parts of the system
can help facilitate this process. See Case study 11 for an example of how system mapping has been
used to support intervention development.
Economic considerations
Consideration of economic aspects at the development phase can help frame the research questions
that will underpin the design of an economic evaluation. The review undertaken to inform intervention
development (see Table 3) should include economic evidence to help decide what economic issues
need to be addressed and how economic ideas, such as insights from behavioural economics,149 can
contribute to the programme theory.
Modelling
The development and justification for an intervention, the potential for an existing intervention to
be adapted to a different context and/or the identification of uncertainties to be addressed in its
TABLE 3 Framework of actions for intervention development (continued )
Action Consider the relevance and importance of the following:
8. Understand context l Understand the context in which the intervention will be implemented. Context
may include population and individuals; physical location or geographical
setting; social, economic, cultural and political influences; and factors affecting
implementation (e.g. organisation, funding and policy)




l From the start, understand facilitators of and barriers to reaching the relevant
population, future use of the intervention, and ‘scale up’ and sustainability in
real-world contexts
10. Design and refine
the intervention
l Generate ideas about content, format and delivery with stakeholders
l Once an early version or prototype of the intervention is available, refine or
optimise it using a series of iterations. Each iteration includes an assessment of
how acceptable, feasible and engaging the intervention is, including potential
harms and unintended consequences, resulting in refinements to the
intervention. Repeat the process until uncertainties are resolved
l Check that the proposed mechanisms of action are supported by early testing
11. End the development phase l There are no established criteria for stopping the intensive development phase
and moving on to the feasibility/pilot or evaluation phases. The concepts of data
saturation and information power may be useful when assessment of later
iterations of the intervention produces few changes
l Describe the intervention to facilitate transferability of an intervention outside
the original team and location in which it was developed
l Write up the intervention development process so that judgements can be
made about the quality of the process, links can be made in the future between
intervention development processes and the subsequent success of interventions,
and others can learn how it can be done
Reproduced with permission from O’Cathain et al.11 This is an open access article distributed in accordance with the
Creative Commons Attribution 4.0 (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and
build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and
indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. The table includes minor
additions and formatting changes to the original table.
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evaluation can often be usefully supported by a mathematical model or simulation of the intervention
in silico. This may be particularly useful for upstream interventions and policies, or where a systems
perspective is being taken to the research. A range of methods can be used (discussed further in Types of
evaluation design and methods), including deterministic models, microsimulation models (e.g. to assess
tobacco control policy150) or agent-based models (e.g. to assess the impact of a potential educational
campaign on fruit and vegetable consumption151). Assessing and/or further refining these models as
data accumulate through all research phases may be an important focus of evaluation activities.
For the economic evaluation, the programme theory needs to be translated into a credible conceptual
and mathematical structure152,153 so that an early-stage decision-analytic model can be formulated
that compares the intervention with one or more relevant comparators. This will help to establish the
potential cost-effectiveness of the planned intervention and highlight areas of uncertainty that should
be explored. VOI analyses can then be undertaken to estimate a monetary value on further research
activities, based on the expected gain from reducing uncertainty surrounding the current cost-
effectiveness decision.154,155 Expected value of perfect parameter information can also be usefully
undertaken to identify parameters that drive the uncertainty in the economic model. The evaluation
can then focus on those parameters with the most uncertainty.
Identifying an intervention
Often, interventions are policy-driven and/or designed in clinical practice. In such cases, researchers
are not usually involved in intervention development, but evidence that they have generated may
have informed this process. In some instances, implementation of policy- or practice-led intervention
may have taken place without a prior evaluation, in which case researchers may need to plan a
retrospective evaluation.
Even if researchers are not involved in the design phase, they should still consider the six core
elements (Table 4). In particular, they should develop a programme theory and use this to identify
key uncertainties. Some policy interventions are based on explicit theory, but many are not. In these
cases, identifying the implicit theoretical basis of an intervention is essential to working out how it
might be evaluated. This is an important step, even if the programme theory is developed after the
intervention has been rolled out. This helps identify mechanisms, important contextual factors and
relevant outcome measures.
TABLE 4 Core elements for developing or identifying the intervention
Core elements Issues to consider Risk of not considering them
Context l What are the immediate contextual influences
on the intervention?
l What is the environment in which the
evaluation will take place?
l Where is the system boundary?
l Lack of understanding of context may
result in an intervention that works in one
setting, but may be ineffective, or even
harmful, when delivered elsewhere
Programme theory l What is the underlying theory or combination
of theories?
l What are the proposed mechanisms of change?
l What are the proposed short-, medium- and
long-term outcomes?
l What are the wider impacts of the
intervention on the system?
l Explore the current evidence base, in particular,
for information to suggest that the proposed
intervention may not work as intended
l Consider context (see row above)
l The programme theory process is an important
step in identifying priority research questions and
helping choose an evaluation perspective
l An intervention that has little chance of
working even in idealised settings
l An intervention that is unlikely to be
sensitive to different contexts ‘in the
real world’
l Failure to measure impacts of the
intervention that might be important
l Unable to advance theory
continued
DOI: 10.3310/hta25570 Health Technology Assessment 2021 Vol. 25 No. 57
Copyright © 2021 Skivington et al. This work was produced by Skivington et al. under the terms of a commissioning contract issued by the Secretary of State for Health and
Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use,
distribution, reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/.
For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.
43
KEY POINTS 8 Developing or identifying an intervention
l Specific considerations for intervention development:
¢ plan the development process
¢ involve stakeholders, including PPI
¢ bring together a team and establish decision-making processes
¢ review published research evidence
¢ draw on existing theories
¢ articulate programme theory
¢ undertake primary data collection
¢ understand context
¢ pay attention to future implementation of the intervention in the real world
¢ design and refine the intervention
¢ consider the wider system within which the intervention operates
¢ consider the future evaluation design (that may affect some of the things that you do in the
intervention development phase).
TABLE 4 Core elements for developing or identifying the intervention (continued )
Core elements Issues to consider Risk of not considering them
Stakeholders l Include relevant stakeholders in the
development process, in particular for
developing theory of the problem; considering
system and context; developing programme
theory; providing feedback to help refine and
improve the intervention; and identifying
potential issues with future implementation
l Choose different approaches to engage
different stakeholders (e.g. evaluability
assessment, interviews/focus groups and soft
system methodologies)
l Resulting intervention that fails to achieve
its proposed effect
l Effective intervention that fails to be
adopted and implemented
l Resulting evaluation that fails to generate
useful data on the processes, mechanisms
and/or outcomes of the intervention
l Reduced chance of impact on policy
and practice
Uncertainty l Where are the key areas of uncertainty to be
addressed in any evaluation of this intervention?
l What are the priority research questions and
optimal research perspective to address them?
l What is the proposed research design to
address these questions and what is the next
stage of research?
l Is the intervention, the programme theory and
the proposed evaluation design sufficiently
developed for the next stage of the research
to be undertaken?
l Failure to agree and optimise the
research perspective and design
l Embark prematurely on underspecified




l What aspects of the intervention could be
improved prior to delivery?
l Delivery of a suboptimal intervention
and/or evaluation
l Failure to effectively gather meaningful
data on potential mechanisms and
outcomes of the intervention
l Waste of resources
Economic
considerations
l What is the existing economic evidence?
l What is the appropriate economic question:
taking account of the system and programme
theory/economic conceptual model developed?
l What perspective(s) is/are appropriate?
l What type of economic evaluation is most
appropriate to address the research question?
l Should spill-over impacts be included?
l Remaining uncertainty not identified and/or
studies duplicate existing evidence
l Inappropriate question with limited focus
l Economic results that underestimate/
overestimate potential cost-effectiveness
l Study does not answer questions
of interest
l Study does not capture the full range of
costs and outcomes
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l Specific considerations for intervention identification, in addition to the relevant key points above:
¢ identify your starting point within the research process most applicable to the current status of the
intervention (i.e. evaluating an existing intervention)
¢ consider which natural experimental methods could be used to evaluate the intervention
¢ develop and refine programme theory if one does not exist.
Feasibility
We follow the Consolidated Standards of Reporting Trials (CONSORT) extension for pilot and
feasibility trials,163 and use the term feasibility to cover both the feasibility of the intervention and
the feasibility of the evaluation design. A feasibility study asks whether or not something can be
undertaken, should we proceed with it and, if so, how:
Feasibility studies: Pieces of research done before a main study in order to answer the question ‘Can this
study be done?’
Eldridge et al.163
Why is a feasibility phase needed?
The feasibility phase explores the feasibility of the intervention and/or the evaluation design to
underpin decisions about whether or not and how to progress to evaluation. Although feasibility
studies are most commonly undertaken prior to effectiveness evaluation, they can also be necessary
prior to an efficacy, a theory-based or a systems perspective evaluation study. This vital preparatory
work is sometimes overlooked or rushed,163 which leads to evaluation studies that are undermined by
problems related to either the intervention or the evaluation design that could have been identified
and overcome through appropriate feasibility research. On the other hand, feasibility studies can
SIGNPOSTS TO FURTHER READING 8 Developing or identifying an intervention
l The INDEX study: guidance on developing complex interventions to improve health and health care156
and the associated reporting guidance GUIDED.157
l Six steps in quality intervention development (6SQuID).17
l Intervention mapping is a theory-led approach to developing interventions and their evaluation.84
l Normalisation process theory: a framework for developing, evaluating and implementing
complex interventions.130
l Evaluating the public health impact of health promotion interventions: the RE-AIM framework.158
l Taking Account of Context in Population Health Intervention Research: Guidance for Producers, Users and
Funders of Research.10
l Natural experiments: an overview of methods, approaches, and contributions to public health
intervention research.159
l Using natural experimental studies to guide public health action.143
l Guidance on conducting economic evaluations alongside natural experiments.142
l Economic evaluation of public health interventions.141
l Reporting of behaviour change techniques.160
l A checklist has been produced for intervention description and replication (TIDieR)161 and has been
extended to population health and policy interventions (TIDieR Population Health and Policy).162
TIDieR, Template for Intervention Description and Replication.
KEY POINTS 8 Developing or identifying an intervention (continued)
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sometimes be overspecified and take more time and resources than are necessary to address the key
uncertainties with the planned intervention or evaluation design.
A feasibility study is designed to explore the uncertainties that have been identified at the
development phase (see Case study 12). The aim is then to address these uncertainties to ascertain
whether or not it is appropriate to move onto the evaluation phase and optimise study design.
Progression criteria
A feasibility study should be designed to assess progression criteria that relate to the feasibility and
acceptability of the intervention and/or the evaluation design. Progression criteria should ideally be
developed with input from an independent steering committee and relevant stakeholders, and be
agreed and signed off prior to the collection of data.
Progression criteria should be used to guide the decision on whether to proceed to the next stage
of evaluation or to undertake further feasibility work, or to return to the development phase
and/or terminate the research. Assessment of progression criteria may require both qualitative and
quantitative data. Examples include (1) qualitative data, such as the acceptability of the intervention
content and mode of delivery for participants and providers, and (2) quantitative data, such as
recruitment and retention rates. See the HelpMeDoIt! study for an example of progression criteria.164
Progression criteria should be worded in a way that provides scope for considered discussion among
the study team and stakeholders, ideally with an independent steering committee making the final
recommendation. The use of a traffic light system for each progression criterion is a useful approach
(green = go, where there are no issues identified; red = stop, where issues identified cannot be
resolved; and amber = amend, where issues identified can potentially be resolved).
In many cases, the key uncertainties to be addressed prior to the evaluation phase relate solely to
aspects of evaluation design. This may be where the development phase has involved substantial
empirical assessment of the intervention, where the intervention is not in the control of the researcher
and so cannot be changed, or where the intervention has already been tested for efficacy. In these
cases, questions of feasibility may relate to evaluation design only, given that there may be no reason
to expect that further changes will need to be made to the intervention to successfully conduct the
evaluation. If this is the case, feasibility work may take the form of a pilot study: a small-scale version
of some or all of the future evaluation study. To expedite the research process, it may be advantageous
to commission a full evaluation in which an initial pilot stage is included, rather than a separate
feasibility phase incorporating a pilot study. All being well, the pilot stage could then be continued
and expanded into a full evaluation, eliminating a substantial delay between the pilot and the
evaluation. If there were problems that needed to be addressed in the pilot, such as problems with
recruitment, retention or measurement of study participants, the pilot would be stopped and the
research design or methods reviewed.
Feasibility of the evaluation design
In terms of evaluation design, a feasibility study should assess key aspects of research design and
conduct, which typically include:
l recruitment – time frame, willingness of participants to be randomised, capacity of those involved
(e.g. clinicians) to recruit participants and effective strategies
l retention – follow-up rates and reasons for attrition
l sample size – capacity to achieve an appropriate sample size
l outcomes – choice of outcome measures, data collection tools and processes (e.g. missing data on
questionnaires or accessibility of routine clinical data), and duration of follow-ups
l analysis – capacity to collect and analyse data within a time frame, and floor or ceiling effects
l unintended outcomes – for example, potential harms or the impact of the intervention on inequalities.
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Feasibility of the intervention design
Feasibility studies provide an important opportunity to implement the intervention on a small scale
and assess any uncertainties regarding the intervention prior to embarking on a full-scale evaluation.
Where prior stages of research have not tested the implementation of the intervention in the same
kind of circumstances that will exist in the evaluation study, the feasibility phase is the first and an
important opportunity to address questions related to optimal intervention content and mode of
delivery; the acceptability of the intervention to participants and providers; adherence; the likelihood
of cost-effectiveness; and the capacity of providers to deliver the intervention and fit within the
setting. Where the intervention programme theory suggests that contextual or implementation factors
may influence the effectiveness of the intervention, these questions should be addressed at the
feasibility phase, even if the intervention has already been tested for efficacy.
Many intervention-related questions that might be assessed in a feasibility study relate to process
evaluation, which aims to understand the functioning of an intervention by examining implementation,
mechanisms of impact and contextual factors.5,165
Depending on the results of the feasibility study, further work may be required to progressively refine
the intervention before embarking on a full-scale evaluation. As discussed in Intervention refinement,
any refinement should have agreed limits and be reported transparently. Ideally, incremental refinements
should each be tested separately; however, in practice refinements can be made simultaneously if
sufficiently rich data are collected to enable judgements about which refinements are helpful and which
are not.
The programme theory should be refined in an ongoing way regularly throughout the feasibility study
and indeed all phases of the research process.
Efficacy signals
To justify the expense of a full-scale evaluation from an effectiveness, theory of change or systems
perspective, as well as evidence of feasibility it is also helpful to have convincing empirical or theoretical
evidence to suggest that the intervention has the potential to be effective. Such evidence may come
from prior research conducted from an efficacy perspective that has demonstrated that the intervention
can work in ideal, controlled conditions. Such ‘efficacy signals’ or evidence of potential effectiveness may
also be drawn from evidence of the effectiveness of similar interventions for which the programme
theory suggests that the effects may be transferable to different populations, settings or outcomes.
Feasibility studies should generally not aim to identify efficacy signals or estimate effect sizes for use in
sample size calculations, given that these will be very imprecise. However, in some cases, a feasibility
study may provide an opportunity to collect data to support the case for potential effectiveness, for
example evidence of short-term impacts on proximal, sensitive and intermediate outcomes.
Economic considerations for the feasibility phase
The aim of an economic evaluation conducted within a feasibility study is to explore the likelihood
that the intervention will be worthwhile, identify key areas of uncertainty and understand whether or
not the data required for a full economic evaluation can be captured. Economic considerations that
should be addressed during the feasibility phase include refinement of the programme theory that will
underpin the full economic evaluation, development and testing of primary data collection tools, and
identification of relevant sources of routinely collected resource use and outcome data. Economic
modelling can be undertaken to assess the likelihood that the expected benefits of the intervention
justify the costs and to help decision-makers decide whether or not it is worthwhile to proceed to a
full-scale evaluation. A VOI study (see Developing an intervention) should be considered if one was not
included in the intervention development phase. If a VOI study was included then it should be updated
at this stage. It should be noted that such analyses may increase rather than reduce uncertainty by
identifying new sources of variation in costs and outcomes. This can be helpful when a policy-maker
believes that an intervention is cost-effective, despite a lack of evidence.
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Case study 10 demonstrates how economic considerations at the design and feasibility phases were
used to build the case for a full-scale trial of a complex intervention.
Evaluability assessment
An alternative or complementary approach to feasibility is evaluability assessment, a systematic,
collaborative approach that is often used with policy-driven or practice-driven (identified) interventions that
can equally be used to plan the development and evaluation of a researcher-developed intervention. It aims
to determine whether or not an intervention can usefully be evaluated and, if so, which methods are the
most appropriate. Its purpose is to ensure that evaluation resources are used efficiently and to minimise
research waste on evaluations of poorly designed and/or implemented interventions, or those for which the
available data or the method of implementation do not permit outcome evaluation. Evaluability assessment
involves collaboration with stakeholders to reach agreement on what are the expected outcomes of the
intervention, what data could be collected to assess processes and outcomes and what are the options for
designing the evaluation.75 The end result is a recommendation on whether or not an evaluation is feasible,
should be undertaken and can be carried out at a reasonable cost, and by which methods this can be
undertaken.166 Five questions to assess evaluability have been suggested by Ogilvie et al.:166
1. Where is a particular intervention situated in the evolutionary flow chart of an overall
intervention programme?
2. How will an evaluative study of this intervention affect policy decisions?
3. What are the plausible sizes and distribution of the intervention’s hypothesised impacts?
4. How will the findings of an evaluative study add value to the existing scientific evidence?
5. Is it practicable to evaluate the intervention in the time available?
Case study 13 provides an example of using evaluability assessment of existing community interventions
to identify practice-based evidence. Table 5 summarises the core elements for the feasibility phase.
TABLE 5 Core elements for the feasibility phase
Core elements Issues to consider Risk of not considering them
Context l Determine the contextual dependencies for the
intervention (e.g. factors affecting delivery and
receipt) and evaluation (e.g. factors affecting
collection of outcome data)
l Consider how these contextual dependencies may
change for a future evaluation or implementation
within different settings
l Incorporate aspects of process evaluation
l An intervention and/or evaluation that
does not demonstrate feasibility and/or
acceptability, with no understanding of why
l An intervention and/or evaluation that fails
to meet progression criteria
Programme
theory
l Begin with a proposed programme theory
l Use programme theory to identify measurable
outcomes
l Refine the programme theory as data are
gathered to inform how the intervention operates
l Incorporate aspects of process evaluation to
explore potential mechanisms of impact
l Produce a revised programme theory by the end
of the phase
l Key contextual dependencies are neglected
resulting in an intervention that fails to
operate as designed
Stakeholders l Input is critical to ensure that relevant data are
collected to inform future delivery, evaluation,
implementation and impact
l Input is critical to programme theory and
key uncertainties
l Lack of useful and convincing data to
inform progression to the next phase of
evaluation and/or implementation
l Planning and progression to the next phase
will not meet stakeholders’ needs or
benefit from their critical insights
l Risk of proceeding with a full-scale
definitive trial for an intervention that
is highly unlikely to be implemented
in practice
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KEY POINTS 9 Feasibility
l Assess the feasibility of the intervention design and/or the evaluation design.
l Use qualitative and quantitative methods to explore and address uncertainties.
l Involve stakeholders to ensure that relevant data are collected for future decision-making.
l If needed, refine the intervention and/or evaluation design (within agreed boundaries) and report
changes transparently.
l Use predefined progression criteria to guide decisions about proceeding to evaluation.
l Identify and measure key resource use and outcomes for the purposes of designing a full
economic evaluation.
l Consider whether or not it is appropriate and relevant to undertake early economic modelling and
VOI analyses.
l Consider conducting an evaluability assessment to determine whether or not and how a full-scale
evaluation should be undertaken.
TABLE 5 Core elements for the feasibility phase (continued )
Core elements Issues to consider Risk of not considering them
Uncertainty l What are the key questions that need to be
addressed to progress to an evaluation study?
l Translate these into progression criteria and
use these progression criteria as the principal
questions to be addressed in the feasibility study
l Prior to evaluation, the feasibility study may assess
the acceptability of intervention and evaluation to
participants, providers and the research setting
l Consider undertaking an evaluability assessment
to determine whether or not and how an
evaluation should be undertaken
l Progression to a large-scale, potentially
expensive evaluation study that then fails
because the evaluation design and methods
and/or the intervention design and
implementation have not been sufficiently
tested for feasibility for acceptability
l Contextual and implementation factors
undermine the intervention in ways that
were not experienced or anticipated in
prior development or efficacy research
Intervention
refinement
l Agree boundaries and limits on how much the
intervention or evaluation design can be refined
l Report all refinement transparently
l Risk of proceeding to the next phase of




l Identify and measure data on resource use across
a range of cost categories consistent with the
perspective of the study
l Identify relevant unit cost sources for the
valuation of resource use
l Consider logistical issues with collecting resource
use data (e.g. practical and logical)
l Develop economic data collection tools and systems.
Test the acceptability of data collection tools
l Consider whether or not qualitative and process
evaluation can feed valuable information into the
economic evaluation alongside the feasibility
study or economic model
l Identify and measure suitable economic outcomes
(preferably preference based)
l Consider which economic evaluation frameworks
are suited to the research question (possibly
consider using more than one framework)
l Consider the use of VOI: potentially useful for
identifying areas of particular uncertainty and
further research, and identifying a monetary value
limit for the costs of any further research activities
l Underestimation of time and resources
required to collect resource use and
outcome data: could ultimately lead
to ‘failure’ of the trial or ‘ineffective
intervention’ owing to poor data collection
l Data collection tools or systems that are
unacceptable to patients/clients or those
delivering the intervention
l Inappropriately designed economic
evaluation for a definitive trial (e.g. full
range of resources and outcomes not
correctly identified and measured)
l Limited economic evaluation
frameworks considered
l Expense of proceeding with a full-scale
definitive trial for an intervention that is
highly unlikely to be cost-effective or
implementable in practice
DOI: 10.3310/hta25570 Health Technology Assessment 2021 Vol. 25 No. 57
Copyright © 2021 Skivington et al. This work was produced by Skivington et al. under the terms of a commissioning contract issued by the Secretary of State for Health and
Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use,
distribution, reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/.
For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.
49
Evaluation
Evaluation: . . . enables judgments to be made about the value of an intervention. It includes whether an
intervention ‘works’ in the sense of achieving its intended outcome identifying what other impacts it has,
theorising how it works, taking account of how it interacts with the context in which it is implemented,
how it contributes to system change, and how the evidence can be used to support real-world
decision-making.
In Purpose of evaluation, we discuss the purpose of evaluation and suggest that the primary focus should
be providing useful evidence rather than minimising bias. Research perspectives and evaluation considers
how research perspectives should inform design choices. The remaining sections consider choice of
outcomes (see Choice of evaluation outcomes), provide information on selection of evaluation designs
(see Types of evaluation design and methods), consider understanding processes (see Understanding processes),
consider economic considerations (see Economic considerations) and consider good practice in reporting
evaluations (see Reporting evaluations).
Purpose of evaluation
A key change in the field of evaluation has been a shift towards assessing the ‘usefulness’ of information
for decision-making, in contrast to focusing exclusively on obtaining unbiased estimates of effectiveness.172
In a trial, randomisation, coupled with other elements of trial design (such as concealment of the allocation
sequence and blinding of participants and researchers), can minimise bias. A statistical model of the
process that determines exposure to the intervention serves the same purpose in a natural experimental
study (see Natural experimental designs); however, this may not be as effective as randomisation at creating
balanced (or ‘exchangeable’) intervention and control groups. However, to maximise the usefulness of the
evidence for decision-making, other elements are required, such as the use of programme theory and
consultation with stakeholders to identify research questions that matter and a process evaluation to
assess elements of implementation, context and mechanisms of impact.5 We emphasise that here we are
advocating for additions to the toolkit of methods, rather than replacements for traditional methods, when
they are appropriate. A more fundamental challenge to the conventional idea that precise and unbiased
estimates of effectiveness are the principal goal of evaluation is the proposal that improving theories about
how to intervene should be the ambition. In this view, effect estimates are inherently context bound, so
that average effects are not a useful guide to decision-makers working in a particular context. More useful
may be contextualised understandings of how an intervention works and details on the most important
enablers and constraints on its delivery across a range of settings.
SIGNPOSTS TO FURTHER READING 9 Feasibility
l More detailed guidance on feasibility studies is in preparation by the MRC/NIHR GUEST
project team.167,168
l Taking Account of Context in Population Health Intervention Research: Guidance for Producers, Users and
Funders of Research.10
l Process Evaluation of Complex Interventions: Medical Research Council Guidance.5
l Applied Methods of Cost–Benefit Analysis in Health Care.169
l Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.170
l Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task
Force report.171
l Evaluability Assessment: A Systematic Approach to Deciding Whether and How to Evaluate Programmes and
Policies. Working Paper.75
l Assessing the evaluability of complex public health interventions: five questions for researchers, funders,
and policymakers.166
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Often, questions about the delivery, reach and maintenance of interventions are assigned to
‘implementation research’ and are explored separately from evaluation questions. Some frameworks,
such as RE-AIM,158 try to pull them together. A key recommendation here is that implementation
questions should be considered alongside evaluation questions from the outset. Moving away from a
narrow ‘effectiveness’ focus should increase the relevance of the evidence produced by evaluation
studies and increase the speed with which interventions that make a useful contribution can be
implemented within policy and practice. This is about explicitly considering from the outset how the
research will make a difference, who will use it and who could benefit from it. For example, who needs
to know the answer to the research questions? One component of a research proposal should be a
‘Pathways to Impact’ statement or an implementation plan; these are often required by funders,173 but
even if not it is a good idea to have given it due consideration.
Research perspectives and evaluation
Table 6 sets out the main research perspectives used in evaluation and relates them to study designs:
(1) efficacy, (2) effectiveness, (3) theory based and (4) systems. Although some designs and perspectives
tend to be closely associated with one another, the mapping is not fixed and designs can be combined to
answer a range of research questions about any given intervention. Efficacy and effectiveness evaluations
do not represent a dichotomy but a continuum,39 and it is ‘likely impossible to perform a pure efficacy
study or pure effectiveness study’.189 An effectiveness evaluation can draw on a theory-based perspective
to help to explore the impact of context and mechanisms on the outcomes being assessed. For example,
a theory-informed process evaluation was conducted alongside an effectiveness trial of the 3D
intervention190 (to improve the management of multimorbidity in primary care, see Case study 14) to
understand how and why the intervention was effective or not, as well as to understand the effect of
context. An effectiveness evaluation can also draw on a systems perspective to help determine which
outcomes should be evaluated. For example, in determining an evaluation strategy to explore the
impacts of the SDIL, researchers drew on a systems perspective and methods (see Case study 7).191
Theory-based and systems perspectives to evaluation can also be used in conjunction; for example,
methods developed using systems thinking could be used to support and focus the involvement of
stakeholders in a realist evaluation.82
TABLE 6 Research perspectives and evaluation
Perspective
What the research perspective means
for evaluation Example of study design used
Efficacy: can this work in
ideal circumstances?
Answers research questions about
whether or not the intervention works
in experimental settings. It aims to
assess whether or not targeting the
hypothesised mechanisms of action of
an intervention produces changes in the
expected outcome, often a mediating
measure (e.g. disease activity), rather
than a health or health-care outcome.
The aim is to obtain a precise, unbiased
estimate of the average effect of the
intervention in a homogeneous context.
In an efficacy study, the experimental
treatment is compared with a placebo or
with no intervention
Case study 15: efficacy RCT for carotid
endarectomy174
continued
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Links to case studies are included in Table 6 to highlight how different study designs may be used to
answer different types of questions. A short description of a selection of these methods is given
in Types of evaluation design and methods; however, before deciding on study design, the range of
outcomes that an evaluation may include should be considered, which is described in the next section.
Choice of evaluation outcomes
A crucial aspect of the design of an evaluation is the choice of outcome measures or evidence
of change. Evaluators need to assess which outcomes are the most important for stakeholders
(e.g. patients, public and decision-makers) and how to deal with multiple outcomes in the analysis.
TABLE 6 Research perspectives and evaluation (continued )
Perspective
What the research perspective means
for evaluation Example of study design used
Effectiveness: what
works in the real world?
Answers research questions about
whether or not the intervention works
in pragmatic real-world settings. The
principal focus is to identify an unbiased
estimate of the average effect of the
intervention, in a heterogeneous context
that is representative of the scenarios in
which the intervention will be applied in
practice. In an effectiveness study, the
comparison is with ‘treatment as usual’
or sometimes with an optimised version
of treatment as usual
Case study 16: individual RCT to evaluate
an intervention for preventing repeat
falls in people with Parkinson’s disease
(PDSAFE)175
Case study 14: cluster RCT, with
embedded process evaluation, to
evaluate an approach to support the
management of multimorbidity176,177
Case study 17: stepped-wedge cluster
RCT to evaluate the World Health
Organization surgical checklist178
Case study 18: synthetic controls to evaluate
pay or performance on hospital mortality179





This perspective emphasises the
importance of understanding how
intervention mechanisms may generate
one or more outcomes that may vary in
different contexts and for different people.
This approach places less value on the
average effect estimate and more value on
understanding the interplay of mechanism
and context, how change is being brought
about and how this may vary across
different contexts and recipients
Case study 20: realist process evaluation
to evaluate robotic-assisted surgery181,182
Case study 21: realist process evaluation
using case study to evaluate an intervention
to support adherence to antiretroviral
treatment and retention in care183
Case study 22: mixed-methods evaluation
of the New Deal for Communities184
Systems: how do the
system and intervention
adapt to one another?
Treats the intervention as a change or
disruption to a complex system and/or
to relationships within the system. For
example, it focuses on the way that a
system’s constituent parts inter-relate
and how systems work over time and
within the context of larger systems.
It recognises the dynamic nature of
systems and specific properties of that
dynamic interdependence, such as
emergence and feedback. Examples
given here include modelling studies,
which are not evaluations in the
traditional sense, but simulations of
what might happen under a given set
of circumstances
Case study 23: social network analysis
(and other systems methods) to evaluate
a developmental asset approach to
adolescent well-being185
Case study 24: process evaluation, taking
a systems perspective, of a local alcohol
availability intervention (Reducing the
Strength)186,187
Case study 25: QCA to evaluate factors
associated with narrowing health
inequalities188
QCA, qualitative comparative analysis.
THE NEW FRAMEWORK
NIHR Journals Library www.journalslibrary.nihr.ac.uk
52
A sharp distinction between a single primary outcome and a number of secondary outcomes is not
necessarily appropriate, particularly where the programme theory identifies impacts across a range of
domains. A good theoretical understanding of the intervention, derived from careful development
work, is key to choosing suitable outcome measures. Rather than always choosing one health outcome
and judging the effectiveness based on that only, effects on intermediate outcomes, such as health
behaviour, health care or a determinant of health or a range of outcomes, should be explored and
theoretically justified. These outcomes should be identified prospectively during the process of developing
the programme theory and be incorporated alongside an a priori analysis plan in a published study
protocol and reported comprehensively in the final evaluation. This approach allows a more broad-based
judgement on effectiveness to be made.
Inconsistencies in measured outcomes makes synthesis of evidence more difficult; therefore, the
use of core outcome sets is recommended where appropriate.192 The Core Outcome Measures in
Effectiveness Trials (COMET) initiative supports the development of core outcome sets, largely for
clinical trials, although includes some resources that may be more widely applicable.193
Outcome measures may capture changes to a system rather than changes in individuals. Examples of
system-level outcomes include changes in relationships within an organisation, the introduction of
policies or new ways of working and changes in social norms or normalisation of practice. They also
include how changing the dynamics of one part of a system alters behaviours in other parts, such as
the displacement of smoking into the home after a public smoking ban. It is possible to use traditional
evaluation designs to answer questions relevant to a systems perspective (see Case study 19). It is
unlikely that all aspects of complexity can be investigated in an evaluation;62 however, a broad
awareness of the system should be considered at the development phase and system boundaries
determined, with consideration of the usefulness of evidence that will be generated.
Pre-identified sources of variation in outcomes are important, and prespecified subgroup analyses
should be carried out and reported. In the case of interventions that are expected to affect inequalities
in health, analyses stratified by socioeconomic position, gender, ethnicity or geography may be
appropriate. Even where such analyses are underpowered they should be included in the protocol and
reported, as they may be useful as input into subsequent meta-analyses or for developing hypotheses
for testing in further research.
A priori sample size calculations are made to ensure that there is enough statistical power to detect a
meaningful target difference in the outcome between the intervention and the comparison groups.
This calculation is often based on a single primary outcome, although different candidate outcomes can
be considered in turn. The final decision for sample size will depend on practicality and usefulness
of evidence, and ideally will be sufficient to detect a meaningful change in all specified candidate
outcomes. The Difference ELicitation in TriAls (DELTA2) guidance194 provides guidance on choosing
target differences in outcomes and on associated sample size calculations.
Another outcome of evaluation is refined or developed theory. Improved theory helps us to understand
the possibility of transferability across settings and to produce evidence and understanding that is
more applicable to informing future decisions by policy-makers. Theory is used to inform evaluations,
but the purpose of evaluation should also be the gradual incremental testing and refinement of theory.
Interventions are likely to require refinement or adaptation to be successful in different contexts,
whereas the theory produced from the study can be generalisable. It is important that results from
experimental trials are not overinterpreted; unbiased estimates may not provide evidence suited to the
application of the intervention in different contexts.172 Decision-makers operating in a context different
from that of the research may be able to learn more from the theory that is developed from the
intervention than from an effect estimate with little information on context or transferability.
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Types of evaluation design and methods
There are many study designs to choose from and different designs are each optimally suited to
different research questions and different circumstances.195 As we have emphasised, there is no one-
to-one mapping of research perspectives to evaluation designs. A purely quantitative approach using
an experimental design with no additional elements, such as a process evaluation, is rarely adequate.
This is particularly true in complexity-informed research using a theory-based or systems perspective;
in such cases, qualitative and mixed-methods designs are essential for evaluation to answer questions
beyond effectiveness.
Studies that use both qualitative and quantitative methods often analyse the data for each method
separately and then consider them together in discussion of the findings. There are techniques for
integrating qualitative and quantitative data and findings;196–198 however, this is not common practice
in the context of RCTs for health interventions, and effort is ongoing to provide future guidance
(see Richards et al.199 for some examples).
A design may rarely be used in a particular field, but that does not mean it cannot be used. You should
make your choice on the basis of the specific needs of your evaluation, in particular the research questions
that you aim to answer. Awareness of the range of experimental and non-experimental approaches should
lead to more appropriate methodological choices. In the following sections we elaborate on some of the
evaluation designs from the case studies referred to in Table 6 and in Case studies. We also include social
network analysis and modelling, which are not designs as such but provide an overview of further methods
that can be used to evaluate complex interventions. We focus on experimental and theory-based designs
that have come to the fore since the previous version of this document1 and the natural experiments
guidance200 were published. The examples that we give of systems methodologies are those most commonly
discussed in relation to systems methods for evaluation of interventions within health research, not
necessarily an exhaustive list of systems methodologies.
Stepped-wedge designs
This is a variant of the cluster RCT design. It can be used to address practical or ethics objections to
experimentally evaluating an intervention for which there is some initial evidence of effectiveness
or that cannot be made available to the whole population at once. It allows a trial to be conducted
without delaying roll-out of the intervention. Eventually, the whole population receives the intervention,
but in a phased implementation. Allocation of the intervention can be undertaken in a randomised
or non-randomised manner.201 This design is increasingly being used and provides an alternative to
regular cluster RCTs, for which there are pragmatic constraints on randomisation or allocation of the
intervention to groups.202 Given that the roll-out of the intervention in a stepped-wedge design has a
temporal element, particular consideration should be given to any changes to the context that occur
concurrently. Stepped-wedge designs should be used with caution given that they introduce many
complexities and there are ethics and resource implications of delivering to all study participants what
the study may find to be an ineffective or even harmful intervention.
Adaptive trial designs
This trial design involves advanced planning of modification to the evaluative design throughout
the study period based on interim data.203 Adaptations to evaluations could include, for example,
the decision to drop inferior trial arms, reassessment of sample size requirements, reassessment of
eligibility criteria or changes to analytical methods. Adaptation of the evaluation is based on careful
planning, simulation of potential scenarios and resulting decision rules. Interim data are evaluated
in accordance with predefined decision criteria and any changes that are made require maintaining
integrity and validity of the study.204 The aims of adaptive evaluations are to address uncertainties
in the planning process and to identify promising interventions by eliminating those with little
likelihood of benefit and reduce the probability of failure early on. One example of an adaptive trial
design is Sequential Multiple Assignment Randomised Trial (SMART),205,206 in which participants are
re-randomised to alternative intervention conditions depending on their responsiveness to the first
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intervention sequence. Typically, unresponsive participants are re-allocated to alternative interventions.
SMART is also being used to refine interventions to optimise the delivery, duration or frequency.205
Natural experimental designs
Natural experimental studies exploit a process or event that occurs independently of the researcher
and divides a population into exposed and unexposed groups, between which outcomes can be compared
to identify the effect of the intervention. There is increasing recognition of the value of using these
designs and considerable methodological development.159,207,208 Sometimes this process is effectively
random, either by design209 or by some imperfection in the way that the intervention is implemented;
usually a statistical model is required to create comparable or ‘conditionally exchangeable’ groups.
Alongside well-established approaches, such as interrupted time series, difference-in-difference and
regression discontinuity studies,210–214 there are some newer methods, such as synthetic controls, for
which experience is accumulating rapidly.215 The synthetic control method involves creating a counterfactual
from a pool of control units such that the pre-intervention trend in the outcome is similar in the exposed
unit (usually a geographical area) and the synthetic control. Mixed-methods evaluations of natural
experiments, as with other effectiveness studies, can provide further insight into intervention mechanisms
and processes.216 Qualitative evaluations of natural experiments can also provide more in-depth
information on the mechanisms by which outcomes are achieved.217 A natural experimental approach
may be appropriate when a RCT is not practical or ethical; where a significant health impact is expected
but there is uncertainty about the nature and size of the effect; or where the intervention has potential
for being replicated and scaled up.159 Other advantages of natural experimental approaches are that
they can be applied retrospectively to interventions that were implemented without any prospective
evaluation using routinely collected data; produce evidence relatively quickly and cheaply; generate
evidence with high external validity while minimising threats to internal validity; and identify effects
on long-term and non-health outcomes.218 Further detail is provided by the MRC’s guidance on
natural experiments200 and in a series of papers on quasi-experimental studies in the Journal of
Clinical Epidiomiology.219
n-of-1 trials
An n-of-1 trial is a randomised controlled crossover trial with a single unit (e.g. person, hospital and
school) that receives different intervention options and, therefore, acts as its own control.220 The unit
of randomisation is not the individual but the intervention order within the cycle allocated to the
individual. This allows the evaluation of how intervention effects vary within individuals, answering
research questions about individual cases.221 A traditional trial would provide the average effect of
an intervention for the group that received it, but would not necessarily provide information on
differences in effect between individuals; n-of-1 trials are particularly useful for testing interventions
and theory at the individual level, potentially providing evidence that allows for personalisation of
interventions. In addition, an aggregated series of n-of-1 trials can be used to determine the effect
of the intervention, including heterogeneity of effects, at the population level. However, challenges
include the difficulty of calculating statistical power and sample size, and the fact that statistical
approaches are as-yet underdeveloped/tested for this type of study design. For examples of n-of-1 trial
designs being used in health behaviour research see McDonald et al.’s221 systematic review, and for
medical intervention see Gabler et al.’s222 systematic review.
Network analysis
Network analysis is an approach that can be applied within the other study designs already mentioned,
rather than being a design in itself. It is a tool to understand the structures of systems by studying
changing relationships within a system, for example of individuals or organisations. It is useful
either where the outcome is connections within a system structure, for example an evaluation of an
intervention to tackle social isolation and improve social networks, or where these connections are
part of the process, for example Rosas and Knight185 show change in actor networks between year 1
and year 2 of a community intervention designed to address adolescent health and well-being
(see Case study 23).185 This method can also provide information on the agents that are central to the
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network or on who may be ‘influencers’ within the network,223 as well as on understanding how the
intervention works.
Modelling
This approach is distinct from traditional evaluation methods in that it is used to predict intervention
effects by simulating outcomes. It can, therefore, be useful in intervention development and
justification, as well as being used in the evaluation phase as data are collected to assess the model
predictions and/or to further improve the model. Microsimulation modelling predicts the effects of
an intervention using known relationships between exposures and outcomes to model the effect of
a change in exposure. Agent-based and system dynamics modelling methods use computational
simulations that draw on objectively measured and experiential data from a range of perspectives.
The starting point for these methods is often other soft systems methodologies. These models can be
used to evaluate different hypothetical scenarios, for example different variants of an intervention, or
to explore spill-over or longer-term effects on health or economic outcomes, which may occur outside
the scope or time frame of an empirical evaluation. For example, in the Evaluation of the health
impacts of the UK Treasury SDIL (see Case study 7) outcomes are measured at 2 years, with additional
modelling to estimate effects for a wider range of health outcomes (e.g. morbidity and mortality, as
well as health service costs) over 5–20 years.224
Models may, thus, be used alone or to complement other designs and can be used throughout
research phases, including development and implementation as well as evaluation. These methods are
just emerging in health-related evaluation research, with few examples as yet. ABM involves virtual
representation of real-world situations that models individuals and their interactions with their
environment, which allows for system properties, such as feedback and emergence.225 See Tracy et al.226
for an overview of ABM in public health, with examples of application and discussion of future
direction (see also Silverman et al.122). System dynamics modelling is an approach that aims to predict
the behaviour of complex systems over time, where the starting point is the structures that trigger the
behaviours of the system itself, rather than the entities within it (as in agent-based models). As yet,
less work has been carried out using system dynamic modelling in evaluative health research.
Other modelling methods also use synthetic populations and simulate individual trajectories under
different scenarios. For example, the effectiveness of the NHS health check programme in Liverpool
was modelled from 2017 to 2040 under five scenarios, including continuation of the implementation
of the programme as it is and targeting implementation to the most deprived areas, with comparison
with no NHS health check.227 The study showed that under current implementation the intervention
was unlikely to be cost-effective or equitable, but that implementation under alternative scenarios
would be more positive. Additional examples that use this (IMPACTNCD model228) and other models
have explored salt policies in England; the potential of trans fats policies to reduce socioeconomic
inequalities in coronary heart disease mortality in England;229 and the impact of pandemic influenza on
the UK.230 The Sheffield Alcohol Policy Model was used to predict the effect of minimum unit pricing
for alcohol in Scotland, including differential impacts on heavy and light drinkers and by socioeconomic
group; this model was key to the development of the policy and in countering legal challenges to its
implementation and will continue to be used in the evaluation of the policy as data accumulate.231
Qualitative comparative analysis
Qualitative comparative analysis (QCA) is a mixed method for establishing causation based on
systematic qualitative and quantitative comparison across a number of cases, for example intervention
sites and exploring how outcomes were achieved.232–234 Qualitative attention to each case is followed
by quantitative exploration of each case by a number of attributes determined to be important.
These attributes are defined through careful review of existing and new data, for which stakeholder
engagement and theoretical arguments are crucial (see Case study 25).188 The QCA approach does
not specify a single causal model but follows the principle of equifinality, which means that the same
outcomes can be achieved by different means, that is there can be more than one causal set.
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Understanding processes
Process evaluation is a critically important component of the evaluation of complex interventions and
is an essential adjunct to the study designs presented so far (see the case study examples set out in
Table 6). Process evaluations can use qualitative and/or quantitative process data to answer questions
around fidelity and quality of implementation (e.g. what is implemented and how?), mechanisms of
change (e.g. how does the delivered intervention produce change?) and context (e.g. how does context
affect implementation and outcomes?).165
Within an efficacy study, a process evaluation would have relatively narrow questions. The key idea of
efficacy studies is that there is a test of causal mechanism, often through mediation analysis. Such analyses
are usually quantitative, but could use qualitative methods to assess how research participants understood
the intervention and made use of intervention components. Because the focus of efficacy studies is to
maximise internal validity, process analyses could usefully examine fidelity to assess whether or not the
intervention was delivered with high fidelity to the theorised mechanism of action. Consideration of
context would not be the focus of a process analysis from an efficacy perspective.
Process evaluations in an effectiveness perspective would be used to inform findings, for example to
provide insight into why an intervention fails unexpectedly or has unanticipated consequences, or why
a successful intervention works and how it can be optimised. This includes exploring the fidelity and
quality of the intervention, clarifying causal mechanisms and identifying contextual factors associated
with variation in outcomes (see Case study 14). Details on the type of measures to consider are
provided in MRC guidance on process evaluation of complex interventions.5
Process evaluations are key components of theory-based and systems evaluations, to the extent that
they seek to answer research questions about how the intervention produces change in a generalisable
way, taking the study further than assessing solely whether or not it works in a specific setting.
An emerging approach is to conduct a realist process evaluation, specifically drawing on realist
evaluation.48 If undertaken alongside an effectiveness evaluation, a realist process evaluation can help
to understand the effects of intervention components rather than only the intervention as a whole;
examine mechanisms of change; explore the effect of intervention context; collect and analyse
qualitative and quantitative data; and aim to build and validate intervention programme theories.235
There are also increasing examples of taking a systems approach to process evaluations, with a
framework developed by McGill et al.236 offering some guidance.
Process evaluations should be conducted to the same high methodological standards and reported
as thoroughly as evaluation of outcomes. The MRC guidance on process evaluation for complex
interventions5 provides further information on how to conduct a process evaluation, including
consideration of relevant theoretical approaches.
Economic considerations
As noted in Economic considerations, there are a range of economic evaluation frameworks (Box 7).
Each framework has different strengths and limitations. CEA measures outcomes in natural units that
relate to, but do not measure directly, the health outcomes of interest; for example, reduced blood
pressure is associated with reduced incidence of stroke, but it does not directly measure the incidence
of stroke or capture the associated range of health improvements. This limits the usefulness of an
incremental cost-effectiveness ratio when evaluating complex interventions with multiple impacts. CUA
uses measures, such as quality-adjusted life-years (QALYs), to compare interventions with a range of
physical and mental health outcomes in terms of their impact on length and quality of life. However,
complex interventions often have outcomes that are difficult to capture fully using QALYs. Ascribing
monetary values to all of the dimensions of benefit in a CBA is methodologically challenging. CCA is
more straightforward and can be used to present evidence on a wide range of costs and outcomes;
however, without valuation of these outcomes (e.g. preference weighting in QALYs or monetary
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valuation in CBA) decision-making requires judgement. Rare but costly outcomes may acquire too
much influence if their frequency is not taken into account. Furthermore, if some outcomes improve
more under some interventions and other outcomes fare better under others, the policy implications of
a CCA may be ambiguous. The importance or ‘weight’ of differing consequences is likely to vary across
stakeholders. A separate exercise, such as a discrete choice experiment (see Case study 26), could add
additional evidence to the value of different consequences to different stakeholders.
Given that complex interventions typically have effects across a wide and diverse range of outcomes,
recent guidance emphasises the use of a broad framework, such as CCA or CBA.134 CCA has the
intuitive appeal of providing data across a range of ‘consequences’ (outcomes) with which decision-
makers are likely to be concerned when making a policy decision. This allows the analyst to adopt a
broad public sector or societal perspective that is appropriate to many complex interventions. It is
important to note, however, that the different frameworks are not mutually exclusive: CBA and CEA
can be carried out and embedded in a wider CCA that provides data on a more comprehensive
inventory of outcomes. The CCA can be useful for identifying the range of impacts likely to be of
interest to researchers and policy-makers prior to deciding which outcomes will be measured and how.
For this reason, it can be a helpful first step towards a CBA.
In addition, there are a number of emerging methodologies that can lend themselves to economic
evaluations of complex interventions. They include Social Return on Investment237 and multi-criteria
decision analysis (MCDA).238 These are not usually considered to be standard tools for economic
evaluation owing to theoretical weaknesses and their handling of outcomes, but they are becoming
more commonly used in the area of complex interventions. MCDA is particularly helpful following a
CCA because it involves a structured, explicit approach to decisions involving multiple criteria.238
Decision analytic modelling120,239 is a useful way of combining data from an economic evaluation with
data from other sources to extrapolate costs and outcomes beyond the study time frame. The use of
advanced modelling techniques, such as microsimulation modelling, network analysis, discrete event
simulation and ABM,153,240,241 is particularly useful for complex and public health interventions, although
simpler model types can also be appropriate.242,243
Reporting evaluations
Evaluations should always be reported in accordance with established guidelines because this will help
to ensure that the key information is available for replication studies, evidence syntheses and guideline
development. The Enhancing the QUAlity and Transparency Of health Research (EQUATOR) Network
maintains a comprehensive database of reporting guidelines [www.equator-network.org/ (accessed
2 March 2021)].
BOX 7 Frameworks for economic evaluation
l CEA: comparison of costs and outcomes measured in ‘natural units’, such as life-years gained, cancers
detected and strokes prevented.
l CUA: comparison of costs and outcomes measured in terms of life expectancy adjusted for ‘utility’, such
as QALYs or disability-adjusted life-years.
l CBA: comparison of costs and health and non-health benefits valued in monetary terms. This can involve
the measurement of non-health benefits across different sectors.
l CCA: comparison of costs and health and non-health benefits across different sectors, measured in units
appropriate to the benefit being considered and reported in disaggregated form.
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Relevant guidelines for reporting are as follows:
l The CONSORT statement is a well-established standard for reporting randomised trials. Relevant
extensions are published for –
¢ social and psychological interventions (CONSORT-SPI 2018)244




¢ cluster stepped-wedge trials248
¢ non-pharmacological interventions249
¢ patient-reported outcomes (CONSORT PRO)250
¢ adaptive designs251
¢ and the SPIRIT-PRO extension for patient-reported outcomes.252
l Reporting of statistical analysis plans.253
l Reporting process.254
l RAMESES II for realist evaluation.255
l SPIRIT 2013 statement provides evidence-based recommendations for the minimum content of a
clinical trial protocol.256
l Standards for reporting qualitative research.257
l STrengthening the Reporting of OBservational studies in Epidemiology (STROBE).258
l Consolidated Health Economic Evaluation Reporting Standards (CHEERS).170
Table 7 provides a summary of the consideration of each of the core elements at the evaluation phase.
TABLE 7 Core elements for the evaluation phase
Core elements Issues to consider Risk of not considering them
Context l Consider the wider contextual factors that
may influence the evaluation in relation to
influences on either the ‘intervention’ or the
‘study processes’




l Has the programme theory changed from
the development and/or feasibility phase?
l What aspects of the wider system have
influenced the desired outcomes?
l Lack of potential learning and understanding
owing to either lack of programme theory or
underdeveloped programme theory
Stakeholders l Gather appropriate input from a range
of relevant stakeholders to ensure that
evaluation methods and outcomes meet
their requirements
l Not collecting the correct data to inform
changes in policy and practice could
negatively impact the utility of the
evaluation and future implementation of
the intervention
Uncertainty l The evaluation should respond to key
uncertainties identified by engaging with
stakeholders, existing evidence and
relevant theory
l Answering research questions that do not
address important areas of uncertainty, so that
the utility of the evaluation will be limited
Intervention
refinement
l Decide beforehand what type of refinement
is appropriate to allow for a robust evaluation
l Not allowing for appropriate changes to the
intervention or study processes may lead to
outcomes that are not useful or meaningful.
Validity of the evaluation may be compromised
by failing to consider what kind of intervention
refinement is acceptable
continued
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KEY POINTS 10 Evaluation
l Where appropriate, involve stakeholders in defining research questions and the choice of evaluation
design and outcomes to ensure that meaningful and useful data are produced for relevant stakeholders.
l Determine the key uncertainties that your evaluation will resolve and frame appropriate research questions.
l Consider a range of ‘useful’ evaluation perspectives and outcomes rather than necessarily focusing
on effectiveness.
l Choose from a range of experimental or non-experimental designs that are focused on answering the
research questions.
l Include methods of evaluation to explore the change process (i.e. mechanisms, process, context and theory).
l Conduct economic evaluation and consider the range of impacts that an intervention may have.
l Clearly report the evaluation, including updated programme theory, following recognised reporting
standards if available.
TABLE 7 Core elements for the evaluation phase (continued )
Core elements Issues to consider Risk of not considering them
Economic
considerations
l Importance of (broad) perspective
l Sensitivity analysis and subgroup analyses
will be crucial
l Identify preferred economic evaluation
framework (other frameworks can
be embedded)
l Consider both a short-term and a long-term
time horizon for economic analyses
l Too narrow a perspective will not reveal the
full economic impact
l Cost-effectiveness of alternative scenarios
will not be identified
l Incorrect frameworks may not identify all
relevant costs and impacts
l Ignoring long-term costs and outcomes may
result in an incorrect cost-effectiveness
conclusion
SIGNPOSTS TO FURTHER READING 10 Evaluation
l For detail on different experimental designs, see the 2006 MRC guidance.1
l PRagmatic Explanatory Continuum Indicator Summary (PRECIS and PRECIS-2) as a tool to help
determine whether or not a trial should be/is on the pragmatic–explanatory continuum.39,259
l For guidance on sample size decisions see the DELTA2 guidance194 and a series of papers in Trials
(2018, issue 19).260
l The COMET database provides a searchable set of developed core outcome sets for various health
areas and target populations.193
l MRC guidance on natural experiments.9
l Synthetic controls.215
l Stepped-wedge cluster randomised trials.202,248
l Commentary and hypothetical example on how theories of change and realistic evaluation differ.44
l Qualitative comparative analysis for evaluation.233
l Discussion and examples of treating qualitative and quantitative data from a RCT interdependently.199
Economic evaluation
l Further reading and advances in the field overall.132,141,242,243,261,262
l NICE guidance.134 The NICE guidance, updated in 2017,134 allows wider perspectives (e.g. NHS and
Personal Social Services, local government and societal where appropriate), inclusion of alternative
non-health outcomes (such as the ICECAP263 measurement of capabilities264 and ‘broader’ approaches
such as CCA and CBA, as appropriate).92
l Alongside observational studies and natural experiments,265,266 economic modelling243 and conceptual
modelling frameworks,140 applied health economic methods, public health practice and research,141 and
reporting guidelines.170
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Implementation
‘Implementation’ is a term used inconsistently within and across disciplines. Here, we use the World
Health Organization (WHO) definition:
Implementation: Deliberate efforts to increase the impact of successfully tested health innovations so as
to benefit more people and to foster policy and programme development on a lasting basis.
Reproduced from WHO267
Successful implementation of interventions, even after they have been shown to be effective, remains
relatively rare.268 There are numerous reasons for this: some relate to how intervention research is
conducted and others focus more on how research findings translate into policy and practice. In this
section, we focus on how the conduct and reporting of intervention research can be undertaken to
maximise its utility and impact. First, we briefly discuss implementation studies that focus specifically
on interventions and strategies to maximise the translation of research into practice or policy.
Implementation science
Within health care, implementation science is an important and developing field of research that
undertakes studies that develop and evaluate strategies for implementing effective interventions that
address local realities, can be implemented at scale and are potentially sustainable.269 Implementation
science has been defined as ‘the scientific study of methods to promote the systematic uptake of
research findings and other evidence-based practices into routine practice, and, hence, to improve the
quality and effectiveness of health services’;270 however, a wider definition would not be restricted to
health care or to the limited range of designs and methods typically used in that context. With this
wider definition, implementation science, therefore, includes interventions and strategies to increase
the uptake and impact of research in policy, including knowledge mobilisation across a range of
potentially relevant organisations, sectors and professions, as exemplified by the range of case studies
of implementation research in a global health context.271
A large part of implementation science research, therefore, involves the development and evaluation
of complex interventions to maximise effective implementation in practice and/or the policy of
interventions that have already demonstrated efficacy or effectiveness. The whole of this framework,
therefore, applies to those implementation studies just as it does to other forms of intervention. The
main specific characteristic of such implementation studies is that the main outcome measures used
will not be health outcomes but measures of implementation effectiveness, such as practitioner or
patient behaviour, uptake of services, reach and policy impact. For example, a cluster randomised trial
of strategies to improve nurses’ hand-washing behaviour used hand-hygiene compliance and adherence
as outcome measures rather than infection rates, with a nested process evaluation identifying which
components of the implementation strategy and context particularly supported compliance.272 The
field of implementation science has many theories and frameworks that can importantly inform the
development of implementation interventions and associated programmes (see Signposts to further
reading 11: implementation). There are also specific standards for reporting implementation studies
and other specific considerations for implementation-focused intervention research that complement
this framework.273
Implementation in all phases
A key motivation for this update was to maximise the usefulness of complex intervention evidence for
decision-makers. For the evidence to be useful, it is important that interventions are developed with
implementation considerations in the foreground at all phases (see Case study 27). A key part of this is
involving stakeholders and being mindful of the realities of the intervention context at all phases/from
the beginning and throughout. Early consideration of implementation increases the potential to
develop an intervention that can be widely adopted and maintained in real-world settings.245 For
example, this may encourage the development of ‘very brief interventions’ that fit with routine practice
and are effective and cost-effective when implemented at scale.274 Such interventions may have more
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impact than very ambitious researcher-led interventions that demonstrate effectiveness and cost-
effectiveness in a research setting, but are not ‘implementable’ for a variety of reasons, such as lack
of fit to health-care practitioners’ usual practice.130 The consequence of neglect is that issues, such as
acceptability to the public or to those who deliver the intervention, may undermine implementation
later on.275 Other benefits of including stakeholders in all phases are to gain better understanding of
the time and resource constraints of real-world evidence users and to engage with, understand and
influence organisational, professional and social systems that may be resistant to change.276–279
As well as anticipating implementation factors in intervention development and design, research
questions in the feasibility and evaluation phases can help to understand and inform implementation.
The intervention programme theory and process and outcome data collected in these phases can help
inform dissemination of the findings and preparation of an implementation manual or plan to maximise
the effective roll-out of the intervention in real-world settings. In addition to the publication of
findings, sufficient details of the intervention and its underlying theory should be reported.273 This
improves the synthesis of evidence that may be more useful to decision-makers (e.g. theoretical
outputs compared with effect sizes) and improves their understanding of the potential transferability
of the intervention to their specific context (see The role of context in implementation).
Details of the intervention and key information related to effective delivery identified in feasibility
and evaluation phases need to be communicated clearly in dissemination via methods that are accessible
and convincing to implementers.280 These may include resource requirements for prerequisites and
delivery (e.g. equipment, staff training, skills and time); barriers to and facilitators of effective
implementation; and potential flexibility in implementation while maintaining programme fidelity.
This includes making recommendations as specific as possible.281
Implementation and evaluation phases combined
In a natural experimental study, evaluation takes place within the implementation of the intervention
in a real-world context. It may be possible to ascertain both the principal health outcomes during
implementation to demonstrate effectiveness and/or the more proximal or process measures available
through readily available data sources collected as part of the implementation. This would allow the
assessment of which implementation or contextual factors support, amplify or undermine the uptake,
(cost-) effectiveness or reach of the intervention.
In the case of highly pragmatic effectiveness trials or specific hybrid effectiveness–implementation
designs, effectiveness and implementation outcomes can be combined in one study, with the aim of
reducing time for translation of research on effectiveness into routine practice. Different hybrid
designs have been proposed based on their focus on effectiveness versus implementation: conducting
an effectiveness study while exploring and gathering data on implementation; dual focus on
effectiveness and implementation; and conducting a study with a primary focus on implementation,
while gathering data on effectiveness.282,283 Green et al.284 describe three studies to show how these
approaches differ in practice.
The role of context in implementation
Understanding interdependence with the context of a given intervention is critical to the success or failure
of implementation. Developing an understanding of context dependence throughout the development,
feasibility and evaluation phases can, therefore, importantly inform what prerequisites need to be in place
for the effects identified in the evaluation phase to be successfully reproduced in implementation.
Understanding context is also central to the transferability of an intervention into different contexts:
an important aspect of long-term implementation. Developing and refining programme theory and
considering wide-ranging contextual factors can help to identify issues related to transferability, for
example that the intervention is unlikely to be effective when transferred to a given context.285 Stakeholder
involvement is then a helpful process to identify potential solutions to overcome identified issues.
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The ‘Context and Implementation in Complex Interventions’ framework that integrates context,
implementation and setting can be used to guide discussions between researchers and stakeholders
on the transferability of interventions.70
Economic considerations of implementation
Economic issues at the implementation phase have not traditionally formed part of the guidance on
economic evaluation, but they can and should be considered (1) at the early stages of intervention and
study development and (2) in the reporting of economic results.
How the results of economic analyses are reported and presented to decision-makers can affect whether
or not and how they act on the results. A key issue is avoiding and anticipating misconceptions in
reporting the results of economic analyses. Interventions described as ‘cost saving’ may well be
potentially cost saving, but savings may be difficult to realise in financial terms during implementation
if there is an element of fixed costs or if the reduced demand for a service withdrawn on economic
grounds is simply replaced with demand for services to meet previously unmet needs. The ‘cost saving’
may refer not to a ‘financial’ saving but to a release of resources for other potential uses, such as a
freeing up of beds or the shifting of resource use from the NHS to another sector, such as social services
(e.g. palliative care).286
Another important issue that is relevant for implementation is how to deal explicitly with multisectoral
issues. The payers of costs and the receivers of benefits of a multisector intervention may not be the
same organisation, which can reduce the incentive to implement an intervention even if it is shown to
be beneficial relative to its cost. Early identification and engagement with appropriate stakeholders and
decision-makers to identify such cross-sectoral impacts will help frame appropriate research questions
and pre-empt any implementation challenges that might arise. Recent work in this area has suggested
methods, such as co-financing between and across sectors,261 to deal with these issues.
Studies to assess the cost of implementation can also be undertaken post evaluation to help aid the
implementation process. This could be particularly important where an intervention is proven to be
effective and cost-effective, yet implementation requires additional investment.
Other considerations specific to the implementation phase
At the implementation phase, observational or experimental studies are often useful even though
there may not be any specific implementation strategies being assessed, as would be the case in
implementation science studies (see Implementation science) or hybrid implementation/effectiveness
designs (see Implementation and evaluation phases combined). Questions that can be assessed at
the implementation stage include assessment of intervention receipt, ‘dose’ received, programme
completion and the characteristics of those receiving the intervention and any inequalities in reach
or completion. Similarly, barriers to and facilitators of effective implementation, including contextual,
system or resource constraints, can be investigated. A key issue in understanding implementation
is the extent to which the intervention has been delivered with fidelity,287 so that problems with
implementation can be distinguished from a lack of effectiveness. Where an intervention is delivered
with low fidelity, it is difficult to determine whether or not a lack of impact in implementation reflects
an intervention that is genuinely ineffective, ineffective in that context or potentially effective but not
observable in this instance owing to low-fidelity implementation. On the other hand, some flexibility
in intervention implementation may support intervention effectiveness across contexts, provided that
the key functions of the programme are maintained.40 Where adaptations have been made to an
intervention in a particular context, it is important to understand exactly what has been adapted.145
Further detail on implementation related to fidelity can be found in the MRC’s guidance on process
evaluation of complex interventions.5
Few evaluation studies are powered to detect rare events, while unanticipated or adverse outcomes
and potentially important longer-term system effects of interventions, such as spill over or diffusion of
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effects through networks, may also not be feasible to measure in an evaluation study within a specific
sample and time frame. These can potentially be measured within the implementation phase, as they
may have differential reach or effectiveness across population subgroups.288 Effects are likely to be
smaller and more variable once the intervention becomes implemented more widely, and unintended
consequences may begin to emerge.76,136 Long-term follow-up may be required to determine whether
or not short-term changes persist, to determine whether or not benefits demonstrated from the
original study do in fact occur and to capture any likely cost impacts (e.g. cost savings). Although
long-term follow-up of complex interventions is uncommon, such studies can be highly informative.
It is worth thinking about how to measure rare or long-term impacts, for example through routine
data sources and record linkage or by recontacting study participants. Plans for the collection of
appropriate outcome data and obtaining appropriate consents should be built into the study design
at the outset. Implementation phase studies may involve randomised or non-randomised control
groups or can be undertaken solely among those who receive the intervention.
Table 8 provides a summary of the considerations of the core elements at the implementation phase.
TABLE 8 Core elements of the implementation phase
Core elements Issues to consider Risk of not considering them
Context l Consider the contextual factors that could
influence the intervention in this and
other settings (e.g. adoption, reach and
maintenance of the intervention)
l What are the key factors that may
determine whether or not evaluation
findings are replicated in implementation?
l Failure to understand how the intervention
interacts and/or interrupts the system in
which it is located
l Interventions implemented in contexts in
which they are unlikely to work
Programme
theory
l What are the key functions and components
of the intervention that need to be
preserved in implementation to maximise
the likelihood of achieving effects found
in evaluation?
l Continue to update programme theory
throughout any implementation phases
l What potential harms, spill-over effects or
longer-term effects can be measured
in implementation?
l Implementation failure
l Failure to learn in the implementation
phase about where fidelity, flexibility and
refinement can be balanced to maintain
intervention effects
l Failure to identify harms, side effects or
potential wider, long-term effects that were
not assessed in the evaluation
Stakeholders l Careful communication of research findings
to stakeholders to support decision-making
as to where and how interventions may be
transferred and key aspects of programme
implementation relevant to their context
l Identifying potential ‘champions’ of the
intervention to support its implementation
l Intervention implemented in contexts in
which the evaluation evidence is unlikely
to generalise
l Implementation failure
Uncertainty l What are the areas of uncertainty in our
implementation plan and theory?
l Are there key barriers to and facilitators of
implementation in real-world contexts that
have not been identified or theorised in
other phases of research?
l What are the critical intervention
components and functions that need to be
maintained in implementation and where can
there be flexibility in intervention form while
preserving key functions?
l Are their effects not anticipated or
measured in the previous stages that can
occur and be assessed in implementation?
l Evidence of effectiveness may not translate
as the intervention is implemented outside
research conditions
l Failure to continue to learn about how the
intervention can best be implemented to
maximise effects
l Failure to optimise implementation
across contexts
l Failure to capture important unanticipated,
rare or long-term system effects that were
not included in the evaluation design
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KEY POINTS 11 Implementation
l Determine key uncertainties about intervention implementation that need to be resolved to ensure
impact, and develop appropriate research questions related to implementation.
l Consider implementation throughout all research phases.
l Involve stakeholders from the early development phase and throughout.
l Incorporate theories, models or frameworks of implementation into intervention design.
l Learn from where others have identified a ‘failure of implementation’.
l Incorporate economic considerations alongside implementation issues from outset. These should be
considered in the programme theory developed at the development phase.
l Publish and actively disseminate full details of the intervention and the updated programme theory,
including a clear indication of the critical functions of the intervention and key context dependencies.
TABLE 8 Core elements of the implementation phase (continued )
Core elements Issues to consider Risk of not considering them
Intervention
refinement
l Refine the intervention, while retaining its
core elements and programme theory,
in response to implementation and
contextual factors
l Intervention failure owing to unnecessarily
rigid adherence to intervention as evaluated
Economic
considerations
l Highlight and work towards multisectoral
evaluation from the outset
l Establish who payers are and who receives
benefits. Co-payment options may be
relevant
l Cost of implementation analyses: overcome
logistical barriers
l Consider requirements for additional
sensitivity analysis to explore applicability
of economic evaluation evidence to the
differing context of large-scale
implementation
l Misconceptions of reported economic results
l Decision-makers misunderstanding economic
results and what that means for their
practice/budgets
l Cost-effective interventions not implemented
in practice
l Cost-effectiveness of large-scale implementation
underestimated or overestimated
SIGNPOSTS TO FURTHER READING 11 Implementation
l Implementation fidelity: the MRC guidance on process evaluation of complex interventions.5
l The Context and Implementation of Complex Interventions (CICI) Framework.70
l Development of a framework and coding system for modifications and adaptations of evidence-
based interventions.145
l Unintended outcomes evaluation approach: a plausible way to evaluate unintended outcomes of social
development programmes.136
l Standards for reporting implementation studies (StaRI) statement.273
l The Implementation Research (‘ImpRes’) tool.289
l An introduction to implementation science.290
l Making sense of implementation theories, models and frameworks.291
l Normalisation process theory: a framework for developing, evaluating and implementing
complex interventions.130
l Implementation research: new imperatives and opportunities in global health.271
l Diffusion of innovations in service organizations: systematic review and recommendations.292
l The quality implementation framework: a synthesis of critical steps in the implementation process.293
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Case studies
This section includes 27 case studies that have been chosen to highlight key points throughout (Table 9).
TABLE 9 Case studies referred to in the report
Case study Description
Core elements
Case study 1 Travel through the main phases of complex intervention research
Case study 2 Considering context
Case study 3 Developing, refining and testing programme theory
Case study 4 Complex logic model
Case study 5 Dark logic model
Case study 6 Realist matrix
Case study 7 System map to develop programme theory
Case study 8 Engaging stakeholders (service users)
Case study 9 Refining the intervention
Case study 10 Economic considerations
Phases of the research process
Case study 11 Intervention development and example systems map
Case study 12 Feasibility trial
Case study 13 Feasibility: evaluability assessment
Case study 14 Evaluation: effectiveness perspective – cluster RCT with theory-informed process evaluation
Case study 15 Evaluation: efficacy perspective
Case study 16 Evaluation: effectiveness perspective with individual RCT
Case study 17 Evaluation: effectiveness perspective with stepped-wedged cluster randomised design
Case study 18 Evaluation: effectiveness perspective with synthetic control design
Case study 19 Development and evaluation: effectiveness perspective drawing on a systems perspective for
intervention development and evaluation
Case study 20 Evaluation: theory-based perspective alongside effectiveness
Case study 21 Evaluation: theory-based perspective with realist approach
Case study 22 Evaluation: theory-based perspective
Case study 23 Evaluation: systems perspective
Case study 24 Evaluation: systems perspective with process evaluation
Case study 25 Evaluation: systems perspective with qualitative comparative analysis
Case study 26 Intervention development and discrete choice experiments
Case study 27 Implementation in all phases
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Case study 1: travel through the main phases of complex intervention research
Study title: Football Fans In Training (FFIT).294–298
Summary: many men lack basic information about how to maintain a healthy weight by eating a balanced
diet and staying physically active. They often feel uncomfortable about joining NHS or commercial weight
management programmes, which they see as being mainly for women. FFIT aimed to help men lose at least
5–10% of their weight and keep it off over the long term. The programme was developed to appeal to
Scottish football fans and to help them improve their eating and activity habits.
A RCT that was undertaken in professional football clubs established the effectiveness and cost-effectiveness
of the FFIT programme; the mean difference between the intervention and the control groups at 12-month
follow-up was 4.94 kg in favour of the intervention group. In addition to weight loss during the 12-week
programme, almost 40% of participants maintained ≥ 5%weight loss at 12-month follow-up.This level of
maintained weight loss is associated with various health benefits, including lower risk of stroke, heart disease,
cancer, diabetes mellitus and other health issues. A CEA demonstrated that FFITwas inexpensive to deliver,
making it appeal to decision-makers for local and national health provision.
The journey of the research project through the phases of complex intervention research is illustrated
in Figure 5.
Key points:
l The study team considered all six core elements during each of the four phases of research.
l Implementation was considered from the outset and the study team engaged with key stakeholders
in the development phase to explore how the intervention could be implemented in practice, if
proven to be effective.
Case study 2: considering context
Study title: Why do interventions work in some places and not others: a breastfeeding support group trial.299
Summary: the Breastfeeding In Groups intervention involved the provision of breastfeeding groups for
pregnant and breastfeeding individuals and aimed to increase breastfeeding and maternal satisfaction.
Findings from the effectiveness study (pragmatic cluster RCT) showed that breastfeeding rates increased
in three intervention localities, declined in three and remained unchanged in one.300 This could not be
explained by the quantity of the intervention delivered (number of group meetings or attendances).
Qualitative and quantitative data were collected to develop seven case studies to explore differences in
context in the different areas. The study found that the history and context of the locality, including
structural and organisational factors, professional relationships, leadership, multidisciplinary partnership
working and readiness to change, all influenced successful policy implementation.
Key points:
l This study was informed by a realist approach and offered insights into the influence of context on
the impact of the intervention.
l The study chose methods in a pragmatic way and used ethnographic in-depth interviews, focus
groups, observations and survey data to build case studies.
l Data collection and analysis were conducted before the findings of the outcome evaluation were
known to minimise bias in interpretation. Retroductive logic was then applied to explain the
outcomes from the effectiveness trial.
l Systems thinking was used to inform the analysis; for example, the localities were interpreted as
systems composed of numerous interacting elements.
l Overall, the explanatory model that was constructed provided insights into the necessary attributes
for successful policy initiation and sustainability. As well as providing a plausible explanation for the
trial results, the model may be useful for other trials of complex interventions.
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Ref ine the intervention
Economic considerations
Identify key uncertainties
Develop and ref ine
programme theory
Evaluation
A full-scale RCT was undertaken in 13 SPL clubs,
including a full cost-effectiveness evaluation. All six
core elements were addressed during the evaluation
phase. Findings demonstrated that FFIT could help a
large proportion of men to lose a clinically signif icant
amount of weight293,294
Implementation
Implementation was considered throughout the entire process of FFIT. The programme was intended to be delivered
long term and not run as a research project. Successful implementation was inf luenced by engaging closely with 
the SPFL, Scottish Government and University of Glasgow. All six core elements were addressed throughout 
the implementation phase295
Feasibility
The feasibility of delivering FFIT was tested by every football club in the SPFL (with exception of one). This included
a formal ‘pilot trial’ in two clubs. Intervention sessions were observed at all clubs, to enable learning on what
happened in different contexts, (e.g. ‘big’ clubs vs. ‘small’ clubs). There was signif icant engagement with clubs 
and the Scottish Government. All six core elements were addressed during the feasibility phase292
Develop/identify the
intervention
FFIT was not developed 
from scratch. It built on 
(1) a programme already 
being run by the SPFL; 
(2) other identif ied weight
management programmes;
and (3) existing theory on
behaviour change and gender
sensitisation. Since FFIT
needed a feasible budget and
benef its for clubs involved the
SPFL was signif icantly
engaged as a stakeholder
throughout the process. In
particular, football clubs were
consulted on the practicalities
of how the programme could










































Case study 3: developing, refining and testing programme theory
Study title: Improving care at scale: process evaluation of a multi-component quality improvement
intervention to reduce mortality after emergency abdominal surgery (EPOCH trial).301
Summary: this stepped-wedge cluster randomised trial tested a large-scale quality improvement
programme that aimed to improve 90-day survival rates for patients undergoing emergency
abdominal surgery.302 The programme theory was developed prior to evaluating the quality
improvement programme. Current evidence and learning from other quality improvement
programmes were used to justify inclusion of elements of the programme theory. Contextual
factors were considered so that delivery of the programme theory could be tailored to local
contexts; those leading the implementation in each hospital were supported to focus on the
aspects of the intervention that would work in their local context, for example one consideration
of context was the available human and financial resources. Desired outcomes were identified,
along with the strategies, individual activities and resources intended to achieve those outcomes.
Importantly, data collection was then aligned with elements of the programme theory to ensure
that the mixed-methods process evaluation gathered relevant data to allow interpretation of
the programme theory. Findings from the process evaluation, therefore, informed reflections on
the programme theory. The overall findings suggested that some, but not all, aspects of the EPOCH
programme theory were implementable in the context of hospital resources. The programme
theory potentially underestimated the influence of social influences (e.g. the time-consuming
and challenging nature of building and maintaining social relationships) and system influences
(e.g. a major system reorganisation in the NHS) on the quality improvement programme. This
helped to identify barriers to improvement, and feeds into the development of future quality
improvement programmes.
Key points:
l The programme theory was well articulated throughout the paper.
l Contextual factors were considered allowing tailored programmes to be delivered in
different hospitals.
l Data collection methods were aligned with elements of the programme theory to support
interpretation of the findings.
l Overall, the development, implementation and post-study reflection of the programme theory
resulted in suggested improvements for future implementation of the quality
improvement programme.
Case study 4: example of a complex logic model
Study title: How to and how not to develop a theory of change to evaluate a complex intervention: reflections
on an experience in the Democratic Republic of Congo.303
Summary: the Democratic Republic of Congo faces many health system challenges, one of which is the
flawed wage system for health workers. This has a number of impacts, including reduced motivation
and inadequate delivery of health care. The authors outline the process of developing a theory of
change to inform the development and evaluation of an intervention that sought to improve
government payments to health workers. They developed a logic model in collaboration with key
stakeholders that was reviewed before the intervention was implemented and again afterwards. The
logic model (Figure 6) attempts to demonstrate the complexity of the intervention. Key findings from
this work include the importance of ensuring that all relevant stakeholders are included, the challenge
of managing power dynamics among stakeholders and the importance of exploring the impact of the
intervention on the wider system.
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Resources Activities Long-term outcomes Impacts
Experts on WISN Agreement to use WISN
methodology by government
Software and equipment
available in all zones
(i)
Health off icials at all
levels able to use iHRIS
Legitimate health workers are





iHRIS used to record
information on HRH (iii)
Government agree to use
iHRIS data to update
payroll
Commitment of





























































KEY Assumptions Interventions Indicators  (i) Rationale
   1.
   2.
   3.
   4.
   5.
   6.
   7.
   8.




iHRIS software deployed into central, peripheral and zonal
levels
Health off icials trained in use of iHRIS
Data on HR for AASP zones entered onto iHRIS
Recruitment and training of data operators for
identif ication exercise
Biometric identif ication of health workers carried out
Communities, government and partners actively
approached and involved in biometric identif ication
Data from biometric identif ication recorder in iHRIS
Data analysed together to produce situational report on HR
and data shared with government
Advocacy to use WISN with the government
Application of WISN methodolgy to assess staff ing needs
using HR data
Advocacy work between government and DFID/IMA to
commit f inances to HRH










80% of all zones in Kasaï-Occidental have iHRIS
National document on staff ing norms
produced by MoH
80% of zones have HRH information recorded
on iHRIS
80% of target zones have completed the
identif ication exercise
X% of zones have shown a change in HRH
staff ing according to SNIS indicators?
X% increase in number of health workers paid
by government according to midline survey
X% increase in motivation of health workers
according to midline survey
Budget expresses commitment to payment of
health workers to be mechanised according to
the identif ication exercise
X% improvement in performance





HR information systems improve
decision-making on workforce
planning (Spero et al., 2011 Hum
Res Health 9:6)
Financial incentives affect
motivation (Agyepong et al., 2004;
Ferrinho et al., 2004; McCoy et al.,
2008)
Motivation is a critical inf luence of
performance (Franco et al., 2002
Soc Sci Med, 54: pp. 1255–66)
Improving performance of HRH
and ratio of health workers leads
to improved health systems (WHO















Access to zones possible
Health workers are engaged with the programme, are willing and have the 
time to undertake training. Health workers have adequate technical ability, 
and all inputs required for iHRIS to be operational are available,  
(e.g. electricity, internet, etc.) 
Advocacy successful with government to use personalised form  of iHRIS
Health workers are available and present during the census and illegitimate
workers are not registered through discouraging practices of corruption 
Political traction with government to address HR issues and implication of 
relevant ministries 
Political will by government to adopt norms and national capacity and 
systems to enforce norms and rationalisation of staff
Budget process occurs transparently 
Leakages don’t occur between execution of budget and payment of workers 
Health workers reduce user fees if paid adequately 
Health workers are also well trained and other non-f inancial incentives 
affecting motivation are addressed by ASSP
FIGURE 6 Logic model of a complex intervention to improve payment of salaries to health workers. Reproduced with permission from Maini et al.303 This is an Open Access article
distributed in accordance with the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work
non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/
licenses/by-nc/4.0/. The figure includes minor additions and formatting changes to the original figure. ASSP, Accès Aux Soins de Santé Primaires; CODESA, community health committee;
DFID, Department for International Development; FP, family planning; HR, human resources; HRH, human resources for health; iHRIS, IntraHealth International (Chapel Hill, NC, USA);







































l The logic model shows the resources and activities as well as the outcomes and impacts that you
might expect to see in a more traditional logic model; however, it also includes assumptions,
interventions, indicators and rationale.
l Importantly, the hypothesised mechanisms of change, including the pathways of each element,
are considered.
l Contextual factors and their influence on the intervention processes are also included.
Case study 5: example of a dark logic model
Study title: Communities in charge of alcohol (CICA): a protocol for a stepped-wedge randomised controlled
trial of an alcohol health champions programme.307
Summary: this study evaluated an asset-based community development approach to reducing alcohol
harm. Volunteers were trained to become ‘Alcohol Health Champions’, to provide advice to individuals
and to mobilise community-level activity focused on alcohol availability. As part of the development
work for the evaluation, the authors considered the possible unintended harms of the intervention
(dark logic). They developed a ‘dark’ logic model that demonstrates how potential negative
consequences could result from the intervention (Figure 7).
Key points:
l The development of a dark logic model in advance of the evaluation helps evaluators to include
appropriate methods to measure possible negative consequences.
l The dark logic model could inform changes to the intervention and reduce the risk of future harm.
Case study 6: example of a realist matrix-presenting programme theory
Study title: Dealing with context in logic model development: reflections from a realist evaluation of a
community health worker programme in Nigeria.308
Summary: in this paper, the authors describe the development of a logic model within the context of
an ‘ongoing realist evaluation which assesses the extent to which and under what circumstances a
community health workers programme promotes access to maternity services in Nigeria’.308 The
development of a logic model is seen as key to identifying relevant hypotheses regarding context,
mechanisms and outcomes, and how interventions lead to change. As part of the process of developing
the logic model and to help elucidate the contextual factors influencing the community health workers
programme, the authors ran stakeholder workshops and developed matrices of candidate theories as in
Table 10, which outlines the tentative ‘context, mechanism and outcomes’ for the supply component of
the community health worker programme. This paper helpfully outlines eight lessons learned by the
authors of this realist evaluation.
Key points:
l The realist matrix enabled blending of context into the initial working programme theory, which in
turn helped to map the relations between programme elements and identify evaluation measures
to understand how, why, for whom and under what circumstances the intervention achieved
its outcomes.
l Creating a programme theory is not the end – it is important to view programme theory as a
flexible and iterative process to understand an intervention.
l Stakeholder engagement is crucial to ensure the development of a ‘shared language’ that is
meaningful to a wider audience, not only researchers.
DOI: 10.3310/hta25570 Health Technology Assessment 2021 Vol. 25 No. 57
Copyright © 2021 Skivington et al. This work was produced by Skivington et al. under the terms of a commissioning contract issued by the Secretary of State for Health and
Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use,
distribution, reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/.




































    f ind it hard to





















    delays for ‘at
    risk or in-need’
    populations
• Increased risk
    of relapse for
    those recruited
    from recovery




    of ‘do gooders’
• Marginalisation
    of individuals
    with literacy
    diff iculties,
    offending
    histories,
    and/or those at
    risk of benef it
































Use conf idence 






– How to give 
brief alcohol 
advice





































































of lifestyle advice in
communities
FIGURE 7 Dark logic model for Communities in Charge of Alcohol. Light blue arrows, potential links between harms; orange
arrows, links between logic model inputs and outputs; black arrows, dark logic model mechanism; dark blue arrows, main logic
model mechanism. AHC, Alcohol Health Champion. Reproduced with permission from Cook et al.307 This article is distributed
under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/),
which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the
original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to
the data made available in this article, unless otherwise stated. The figure includes minor additions and formatting changes
to the original figure.
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Case study 7: system map to develop programme theory
Study title: Evaluation of the Health Impacts of the UK Treasury Soft Drinks Industry Levy (SDIL).
Project Protocol.224
Summary: White et al.224 took a systems approach to evaluate the UK’s SDIL: a graduated levy on the
producers of sugar-sweetened drinks. The levy is intended to encourage the reformulation of drinks,
with the aim of reducing sugar consumption and its associated health consequences. The researchers
theorised the levy as an ‘event in a complex system’224 that might precipitate reactions among a wide
array of stakeholders and affect a range of dietary and health outcomes. Anticipating direct and
indirect effects across a range of interacting food and health systems, the researchers developed
a bounded conceptual system map to articulate their understanding of how the intervention was
expected to work, guide evaluation design and help identify data sources to support evaluation
(Figure 8). The evaluation design includes multiple methods, for example qualitative process evaluation,
natural experiment study, economic evaluation and simulation modelling of long-term (5–20 years)
health and economic outcomes, with synthesis and triangulation of findings across methods planned.
TABLE 10 Matrix of context, mechanism and outcomes for the supply component of the community health worker programme
Levels of context Levels of mechanisms Levels of outcomes
Individual context:
C1 – Non-experienced staff
experience
C2 – Demoralised staff
C3 – Status and skill mix of
MCH staff (CHWs, CHEWs
and midwives)
Individual mechanism:
M1 – Availability of health workers
and skill mix of MCH staff ensured
Individual outcome:
O1 – Altruism and increased social responsibility
O2 – Increased staff motivation
O3 – Increased satisfaction
O4 – Improved staff performance
Institutional context:
C3 – Irregular salaries
C4 – Poorly functioning
facilities
C5 – Strained working
relationships between CHEWs
and nurses following policy
change in PHC facility
management
Institutional mechanism:
M2 – Continuous training of staff
M3 – Supportive supervision of staff
M4 – Collegial working environment
M5 – Regular payments are instituted
M6 – Availability of equipment
supplies and infrastructure
Institutional outcome:
O5 – Increased staff retention
O6 – Improved quality of care delivered by facility
O7 – Increased utilisation of ANC by women
O8 – Increased skilled birth attendance
Macro context:
C6 – New government policy
on social protection of
vulnerable populations
implemented as a pilot
Macro mechanism:
M7 – Availability of SURE-P
regulatory oversight
Macro outcome:
O9 – Reduced maternal mortality rate
O10 – Reduced infant mortality rate
ANC, antenatal care/clinic; CHEW, community health extension worker; CHW, community health worker; MCH, maternal
and child health; PHC, public health care; SURE-P, Subsidy Reinvention and Empowerment Programme.
Notes
From the above, we can start formulating hypotheses such as C1 +M1, M2, M4, M5 = O5, O6.
Candidate theory 1: if different incentives (e.g. regular payments, training and improved working environment) are
available in a timely manner, this will lead to improved and sustained health worker motivation, job satisfaction,
performance and improved retention of staff in the context of Anambra State that is characterised by irregular salaries
and poorly functioning facilities.
Reproduced with permission from Ebenso et al.308 This is an Open Access article distributed in accordance with the terms of
the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this
work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.
The table includes minor additions and formatting changes to the original table.
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FIGURE 8 Conceptual system map for the UK SDIL. Context: modifying factors (e.g. age, gender, socioeconomic position and household composition) and macro-level factors (e.g. Brexit,







































l A review of published evidence enabled the development of a preliminary conceptual map of the
system and a theory for the SDIL.
l An interactive expert workshop refined the system map and verified hypothesised entities and their
relationships, as well as the underlying programme theory.
l An online Delphi study built consensus among a wide range of stakeholders from all sectors and
groups identified on the map, and enabled refinement of the map and programme theory.
l The final map allowed the generation of specific hypotheses concerning causal pathways central to
the programme theory, the identification of potential data sources to measure outcomes associated
with each key pathway and the design of a range of qualitative and quantitative studies to assess
change in relation to these pathways.
l Synthesis of the findings from these studies will be used to revisit and refine the system map and
programme theory, and derive generalisable causal inference.
Case study 8: engaging stakeholders (service users)
Study title: Reducing relapse and suicide in bipolar disorder: practical clinical approaches to identifying risk,
reducing harm and engaging service users in planning and delivery of care – the PARADES (Psychoeducation,
Anxiety, Relapse, Advance Directive Evaluation and Suicidality) programme.309
Summary: this study evaluated approaches to reduce harm and improve outcomes for people with
bipolar disorder. Stakeholder engagement, mainly in the form of service user involvement, was central
throughout the duration of the Psychoeducation, Anxiety, Relapse, Advance Directive Evaluation and
Suicidality (PARADES) programme, from the initial grant application to study close and dissemination.
Service users were individuals with lived experience of bipolar disorder. ‘Involvement principles’ were
agreed between service users and researchers at the outset of the programme and guided stakeholder
engagement. Service users contributed to the PARADES programme in numerous ways, including
delivering the intervention; offering insights on the duration and frequency of intervention sessions;
practical issues, such as venue choices and accessibility; translating materials into culturally sensitive
resources for participants; and helping to develop recruitment strategies. They also contributed to the
interpretation and writing up of findings and the dissemination strategy. At the end of the study, they
developed a user-friendly guide to the Mental Capacity Act310 for people with bipolar disorder.
Key points:
l PPI activities in this study were wide-ranging and central throughout the project.
l Involving service users with lived experiences of bipolar disorder had many benefits for the
research. It enhanced the intervention but also improved the evaluation and dissemination methods.
l The benefits were two-way because there were positive outcomes for service users involved in the
study, including more settled employment, progression to postgraduate study, fellowship funding
and co-authorship of several papers.
Case study 9: refining the intervention
Study title: The person-based approach to enhancing the acceptability and feasibility of interventions.311
Summary: this paper describes using mixed-methods approaches to develop an in-depth understanding
of the needs and views of people who will use the intervention. This understanding ‘enables intervention
developers to design or modify the intervention to make it more relevant, persuasive, accessible and
engaging’.311 Three illustrative examples are used to demonstrate the iterative process:
l Illustrative example 1 involved developing guiding principles that informed the design of a digital
intervention for asthma self-management. Guiding principles were developed based on existing
evidence and relevant issues that the intervention would need to address. The process involved
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developing key intervention design objectives to address identified issues, and intervention features
were developed to address these design objectives.
l Illustrative example 2 used think-aloud interviews, alongside PPI input, to improve the intervention
booklet. This involved changing the images and wording of the booklet several times, leading to
a more acceptable resource for participants. This refinement process is likely to lead to higher
engagement with the booklet.
l Illustrative example 3 also used think-aloud interviews to improve the usability of a physical activity
planner for people with diabetes mellitus. In this example, a physical activity planner was found to
be difficult to use, resulting in participants overestimating their level of physical activity. Several
iterations of the planner were developed based on interviews and observations and this iterative
process led to the planner being much more feasible and accurate.
Key points:
l The feasibility and acceptability of these interventions was improved by involving potential users to
inform intervention refinements.
l This process of iterative intervention refinement increases the chances that the interventions will
be acceptable to participants and feasible to deliver.
l It is also likely that this refinement process will increase the chances of the interventions being
found to be effective in a future evaluation.
Case study 10: economic considerations
Study title: Adaptation of the New Orleans Intervention Model (NIM) for infants entering foster care –
the Best Services Trial (BeST?) in Scotland, UK.265,312–318
Summary: the New Orleans Intervention Model (NIM) for infants entering foster care seeks to improve
the quality of placement decisions while also improving the mental health outcomes for these infants.
The intervention is set within a complex context, spanning social care and the NHS, in which the
comparator (service as usual) varies in service delivery across the UK. The development and testing of
the intervention within a UK context has been conducted in an iterative manner,312 with the inclusion
of economic considerations from the outset.313
An early-stage exploratory economic model was developed comparing the proposed NIM intervention
with the existing local foster care service. A full economic evaluation was deemed inappropriate at
this stage, as the existing foster care service was not clearly defined and there was no direct clinical
evidence on health outcomes in this or the proposed new system. Instead, a CCA framework was used
to map and measure existing local services and compare them with a hypothetical model of the NIM
intervention. This allowed decision-makers to compare the potential costs and consequences of these
two approaches and form their own view of the importance of the different outcomes.141
Evidence from the early-stage model helped to build a case for a Phase II exploratory trial in
Glasgow,314–317 including development and feasibility testing of economic resource use data systems.
The feasibility study led to a definitive Phase III trial318 that included short- and long-term economic
analysis from multiple perspectives;265 included NHS and Personal Social Services, public sector and
wider societal perspectives; and used a range of frameworks, including CUA and CCA to capture
changes in the intersectoral costs and outcomes associated with child maltreatment.
Key points:
l An iterative approach was taken for the design and conduct of the economic evaluation.
l The evaluation took into account outcomes spanning a range of sectors; short-term, intermediate
and long-term time horizons; and evidence from a range of sources.
l The use of multiple economic evaluation frameworks will provide decision-makers with a
comprehensive, multiperspective guide to the cost-effectiveness of the NIM.
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Case study 11: intervention development: example systems map
Study title: Tackling ‘wicked’ health promotion problems: a New Zealand case study.319
Summary: this study describes a complex environmental approach to addressing ‘wicked’ health
promotion problems. The starting point for this research was the problem – obesity, poor nutrition and
inadequate levels of physical activity among Māori, Pacific and low-income people in New Zealand –
rather than a particular intervention. The project involved literature reviews, focus groups, stakeholder
workshops and key informant interviews to identify important areas for intervention and provide
recommendations for action. The system was mapped (Figure 9) and analysed, identifying ‘control
parameters’, ‘elements of a system that have a controlling influence on other system elements, acting
to set the boundaries within which the system can operate’,319–322 that are open to manipulation.
Stakeholder workshops explored the options for interventions to affect change on the control
parameters, and intervention areas were then prioritised.
Key points:
l The research took a systems perspective that aimed to inform system-level change.
l Mapping of the relevant systems facilitated the identification of a suite of interventions that were
likely to be effective, taking into account feasibility, acceptability, sustainability, equity, side effects
and costs.
l A collaborative strategy for intervention development was used, with effort taken to include
relevant multidisciplinary stakeholders, including community members and policy-makers.
l A mixed-methods approach was taken utilising data from multiple sources.
l Cost–benefit in terms of intervention options was considered from the outset to ensure value
for money.
Case study 12: feasibility trial
Study title: Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with
ledipasvir-sofosbuvir among people who inject drugs.323
Summary: this study explored the feasibility of an intervention to reduce secondary transmission of
the hepatitis C virus in people who inject drugs. The uncertainties identified at the start of the study
included the feasibility of treating people at high risk for secondary transmission and the optimal
approach for delivering treatment. The study also explored the feasibility of recruitment, adherence
to the intervention, retention in the study and potential harms. The findings demonstrated that both
modes of delivery were feasible and acceptable to participants. It was also feasible to recruit people
who inject drugs for this type of treatment, retain them over a 12-week follow-up period and achieve
positive viral responses to treatment.
Key points:
l Uncertainties were identified before the study commenced, which guided the choice of intervention
and evaluation methods.
l The feasibility and acceptability of the intervention and evaluation methods were tested.
l Useful data were gathered to optimise the design of a future evaluation.
l The findings addressed the initial uncertainties, thereby strengthening the support for future
funding and/or evaluation.
Case study 13: feasibility, evaluability assessment
Study title: Practice to evidence: using evaluability assessment to generate practice-based evidence in rural
South Georgia.324
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FIGURE 9 Physical activity system map with interventions. Reproduced from Signal LN, Walton MD, Mhurchu CN, et al. Tackling ‘wicked’ health promotion problems: a New Zealand






































Summary: the Emory Prevention Research Centre used evaluability assessment methods as part of
an initiative to gather practice-based evidence on cancer prevention from community interventions
in south-west Georgia, USA. Of nine interventions that were identified and screened for eligibility,
two were selected for a full evaluability assessment. Each evaluability assessment comprised a review
of documents related to the intervention, site visits, meetings with stakeholders and reviews of
published literature. The aim was to assess the feasibility and usefulness of an evaluation based on the
programme theory underpinning the intervention, the availability of data, stakeholder interest and its
potential contribution to the evidence base. From the two evaluability assessments, one intervention
was identified as eligible for a quasi-experimental outcome evaluation. Data limitations precluded an
outcome evaluation of the second intervention and a recommendation was made instead for either a
process evaluation of one component of the programme or a descriptive case study.
Key points:
l In the context of scarce evaluation resources, partnerships between research and practice can
helpfully identify interventions that can generate useful findings and inform future implementation.
l Interventions were screened from current practice and evaluability assessments used to assess
those with the potential for formal evaluation and to recommend an evaluation method.
l Findings from the initiative described were included in national resources for practitioners looking
at evidence-based practices and helped the community organisations expand and strengthen
their programmes.
Case study 14: evaluation (effectiveness perspective: cluster randomised controlled trial
with theory-informed process evaluation)
Study title: Management of multimorbidity using a patient-centred care model: a pragmatic cluster-
randomised trial of the 3D approach.177
Summary: this pragmatic cluster RCT is an effectiveness study of the 3D intervention, a primary care
approach for patients with multimorbidity, which focuses on quality of life and self-management to
achieve goals agreed between the patient and the health-care provider. The intervention aimed to
improve health-related quality of life. Process and cost-effectiveness evaluations were also completed.
There was no difference in quality of life between intervention and control groups.
Key points:
l Cluster RCTs are useful when an intervention is aimed at communities rather than individuals, and
also where there is potential for treatment contamination, for example where control participants
may gain access to intervention materials. However, they are more complex to design and analyse
and increase the sample size requirements.
l The trial process evaluation sought to understand how and why the intervention was effective
(or not) and to identify strategies for implementation that considered the influence of context,
as well as practical issues related to adoption, delivery maintenance and reach. Examples of
research questions were ‘to what extent was the intended intervention delivered to patients?’177
and ‘how did patients perceive the intervention and its delivery?’.177
l The interpretation of findings was enhanced by the nested qualitative process evaluation that
followed a prespecified protocol.190,325
l An external pilot of the study was conducted before proceeding to this trial.
l A study protocol was written, published and followed.326 This included a prespecified analysis plan
for primary and secondary outcomes.
l Economic evaluation of cost consequences and cost-effectiveness was conducted alongside
the trial.327
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Case study 15: evaluation (efficacy)
Study title: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.174
Summary: this RCT in 50 centres tested, among 659 patients with a high risk of stroke (70–99% stenosis
of a carotid artery), whether or not the addition of carotid endarterectomy to optimal medical therapy
(compared with optimal medical therapy alone) reduces the risk of stroke. The trial results indicated that
carotid endarterectomy was beneficial.
Key points
This efficacy trial can be differentiated from an effectiveness trial based on the following characteristics259 –
l The inclusion criteria for the trial were narrow. The main group of interest were those who were at
high risk of stroke and those who were most likely to respond to the intervention. The exclusion criteria
were wide-ranging; therefore, the intervention was tested on a very narrow group of patients.
l The intervention delivery was tightly constrained with little flexibility, and those delivering the
intervention were highly trained. The surgeons taking part had to be approved by an expert panel
and had to have completed at least 50 carotid endarterectomies in the last 24 months.
l The control intervention was not treatment as usual but included antiplatelet therapy and the same
co-interventions applied to the intervention arm were also given to control patients.
l Follow-up was very intensive at multiple time points.
l Practitioner adherence to the study protocol was monitored.
l In real-world practice, much of the above would not happen; therefore, the impact of the
intervention is likely to be different in a more pragmatic setting.
Case study 16: evaluation (effectiveness perspective: individual randomised controlled trial)
Study title: Exercise- and strategy-based physiotherapy-delivered intervention for preventing repeat falls in
people with Parkinson’s: the PDSAFE RCT.175
Summary: people with Parkinson’s disease are at an increased risk of falls. Although there is some
evidence that exercise might reduce fall risk, the findings are mixed. This study examined the clinical
effectiveness and cost-effectiveness of PDSAFE, an exercise- and strategy-based intervention for fall
reduction for people with Parkinson’s disease. The study was a multicentre, individual RCT with an
embedded economic evaluation and qualitative process evaluation. A published protocol included
prespecified subgroup analyses. This was useful because, although the intervention was not effective
overall in terms of reducing fall risk, these analyses indicated that it may be of benefit for those with
‘moderate’ Parkinson’s disease, but it may increase falls in those with more severe Parkinson’s disease.
The authors concluded, therefore, that a different treatment strategy could be used for those with
more severe Parkinson’s disease and that the benefits indicated for those with ‘moderate’ Parkinson’s
disease would need to be further studied in an effectiveness trial for this group before implementation.
Key points:
l This trial tested the intervention in those patients who are representative of those likely to receive
the intervention in routine practice.
l The qualitative process evaluation provided information on barriers to and potential facilitators of
participation (e.g. existing social support). These aspects could be incorporated to further enhance
this intervention for more targeted groups, for whom the intervention is more likely to be effective.
l An economic evaluation was conducted as part of the trial and included subgroup analyses.
l Engagement with stakeholders, including professionals and patients, supported the development of
some of the study materials.
l In line with good reporting practice, CONSORT and Template for Intervention Description and
Replication (TIDIER) descriptions were provided.
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Case study 17: evaluation (effectiveness perspective: stepped-wedged cluster randomised design)
Study title: Effect of the World Health Organization (WHO) Checklist on Patient Outcomes: a stepped wedge
cluster randomized controlled trial.178
Summary: this stepped-wedge cluster RCT examined the effects of implementing WHO’s surgical
safety checklist on in-hospital complications, length of stay and mortality. The stepped-wedge design
was used because the surgical safety checklist intervention was thought more likely to do good than
harm; therefore, it would be unethical to not deliver or to withdraw the intervention. The surgical
safety checklist was randomly rolled out in sequence until five clusters had received the intervention.
The different clusters (surgical specialties) switched treatment from control (no checklist) to
intervention (surgical safety checklist) at different time points. The clusters crossed over in one
direction, that is the checklist was introduced and not withdrawn after implementation. The surgical
specialty cohorts acted as their own controls providing data before and after the checklist intervention.
The analyses compared all data in the steps before (controls) with the steps after (intervention) the
intervention. The results indicated that use of the surgical safety checklist led to important reductions
in morbidity and length of hospital stay.
Key points:
l The stepped-wedge cluster randomised design is especially useful where (1) it would be unethical
to not deliver or to withdraw the intervention; (2) randomising individuals or procedures would not
be possible; (3) contamination is likely to be a major problem; (4) there are practical or financial
constraints that make it impossible to deliver the intervention to all participants at the same time.
l Issues with the stepped-wedge design are that it can require a large number of data. In this
example, routinely collected data were used to address this issue. It can also be difficult to
implement the interventions within the planned time frame because of the practicalities of working
within complex health-care organisations.
Case study 18: evaluation (effectiveness perspective: synthetic control)
Study title: Examination of the synthetic control method for evaluating health policies with multiple
treated units.179
Summary: The Advancing Quality scheme (a hospital pay-for-performance scheme) was re-evaluated using
the synthetic control method and the findings were contrasted to the original differences-in-differences
analysis (in which the main assumption is parallel trends). The original differences-in-differences study
compared intervention hospitals with hospitals that did not introduce the Advanced Quality scheme, and
found that risk-adjusted hospital mortality was reduced for the three incentivised conditions.328 Concerns
were raised about whether or not the parallel-trends assumption was upheld given an inspection of
risk-adjusted mortality in the periods before the introduction of the Advanced Quality scheme. The data
were, therefore, re-evaluated using the synthetic control method, which allows for estimation of intervention
effects by constructing a weighted combination of control units. This represents an estimate of what the
intervention group would have experienced in the absence of the intervention; see the full paper for
the methods.179 Results did not align with those from the original differences-in-differences analysis, but
rather found that the scheme did not reduce mortality for incentivised conditions and that mortality was
significantly increased in non-incentivised conditions. Sensitivity analysis upheld findings from the synthetic
control method.
Key points:
l Many public health interventions cannot be evaluated using RCTs and rely on the assessment of
observational data.215 Building synthetic controls, using a weighted combination of potential control
units, is one way of overcoming any difficulties in selecting available, suitable controls.
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l Where the validity of the parallel-trends assumption is doubtful, the synthetic control method
may be useful. This method allows for the effects of unobserved confounders to change over time
by weighting the control group so that it has similar pre-intervention characteristics to the
intervention group.329
l This study adds to concerns that the parallel-trends assumption underlying the differences-in-differences
approach may not be plausible in settings where the differences between the comparison groups
in pre-intervention outcomes are relatively large, showing the appropriate use of a synthetic
control approach.
Case study 19: development and evaluation – effectiveness perspective (drawing on a
systems perspective for intervention development and evaluation)
Study title: Whole of Systems Trial of Prevention Strategies for childhood obesity: WHO STOPS
childhood obesity.180
Summary: this paper presents the protocol for a stepped-wedge cluster RCT evaluating WHO STOPS, a
complex intervention targeting childhood obesity that was developed using a systems perspective. The
intervention engages and facilitates community members to agree a system map of causes of childhood
obesity for the community; ‘identifies intervention opportunities through leveraging the dynamic
aspects of the system’;180 and uses these to co-produce systems-oriented action plans that are
implemented in a way that allows flexible and iterative development of the intervention over time.
Pilot work undertaken with communities using group model building to build causal loop diagrams
indicated that participants were able ‘to identify multiple systems that impact childhood obesity’180
and ‘design interventions that considered non-linearity, feedback, and complexity for intervention
development’;180 see Allender et al.330 for a worked example of a causal loop diagram. The evaluation
will test the impact of the intervention on childhood obesity prevalence. Ten communities will be
randomised: five to receive the intervention at year 1 and five to receive the intervention at year 3.
The evaluation also draws on a systems perspective and includes numerous systems methods to
explore the impact of the intervention at a systems level.
Key points:
l The study involves stakeholder engagement and considers implementation and context from
the outset.
l Systems boundaries will be predefined and agreed by a range of community stakeholders.
l Systems change will be assessed alongside the primary outcome (childhood obesity) using a variety
of methods, for example using social network analysis.
l A dynamic logic model will be created and updated throughout.
l Economic evaluation is included in the trial, using approaches that are suitable to capture systems
change as well as equity impacts.
l Qualitative methods, largely drawing on soft systems methodology (e.g. group model-building
workshops),331 and quantitative methods will be employed throughout, and the process evaluation
will assess the response of the community to the systems intervention.
Case study 20: evaluation (theory-based perspective, alongside effectiveness)
Study title: A realist process evaluation of robot-assisted surgery: integration into routine practice and
impacts on communication, collaboration and decision-making.182
Summary: robot-assisted surgery has been shown to have potential benefits for patients; however,
despite the technology being available, this has not yet fully been implemented into routine practice in
the NHS. This realist evaluation aimed to explore ‘how and under what circumstances robot-assisted
surgery is effectively introduced into routine practice, and how and under what circumstances robot-
assisted surgery impacts communication, teamwork and decision-making’.182 This was done alongside
an effectiveness trial of robot-assisted surgery.332,333
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Phase 1 comprised a literature review that explored stakeholder theories of how robot-assisted
surgery can become embedded into routine practice, and particularly how it affects communication,
decision-making and teamwork. The theories were further developed using data from stakeholder
interviews. In phase 2, four theories were selected from the initial theories developed in phase 1 for
testing in a multisite case study across four NHS trusts. This involved multiple methods, such as video
recordings of operations, ethnographic observation, post-operation interviews and a questionnaire.
In phase 3, interviews with surgical staff from other specialties were completed to explore whether or
not the results of phase 2 were generalisable and to refine the theories to include the experience of a
wider group of surgical specialties.
Key points:
l A theory-based evaluation can usefully be carried out alongside an effectiveness trial to understand
the variations in implementation of the intervention and the influence of context on outcomes.
l Multiple methods can be used to investigate how and under what circumstances an intervention
affects processes related to the implementation of an intervention.
l Data collection and analysis took an iterative approach meaning that refinement of theories was
ongoing, and further data could be gathered as necessary.
l Theory-based evaluation can provide standalone findings, as well as complement an
effectiveness evaluation.
l The study resulted in several practical recommendations to support the implementation of robot-
assisted surgery into routine surgical practice. For example, engaging staff at different levels,
including surgeons who will not be using robot-assisted surgery, whole-team training and a suitably
sized operating theatre.
Case study 21: evaluation (theory-based perspective with realist approach)
Study title: ‘Patients are not following the [adherence] club rules anymore’: a realist case study of the
antiretroviral treatment adherence club, South Africa.183
Summary: effectiveness studies have shown positive results of the adherence club intervention model,
an antiretroviral treatment delivery model, in terms of improved retention in care and adherence
to antiretroviral treatment for people living with human immunodeficiency virus (HIV). However,
understanding how, why and under what health system contexts the intervention could be most
effective were not clear. The aim of this realist evaluation was to test the initial programme theory
and to ‘determine how, why, for whom, and under what health system context the adherence club
intervention works (or not) in real-life implementation’.183 The study identified certain mitigating
circumstances that could inform implementation of the intervention.
Key points:
l The evaluation was transparent, in that a prespecified plan for the research was set out in a
published protocol paper.334
l Mixed methods were used within a case study approach. Qualitative methods were used ‘to explore
implementation features related to the context and mechanisms, and quantitative methods to
describe and classify the outcomes’.183
l Data from various participants (health-care providers and patients) were triangulated to verify what
was obtained.
l An explanatory tool [Intervention-Context-Actor-Mechanism-Outcome (ICAMO; intervention–
context–actor–mechanism–outcome)] was used to construct theories, building on realist context –
mechanism – outcome configurations, to explore how the ‘outcome (O) is generated by a mechanism
(M), being triggered in context (C), through an actor (A), when the intervention is implemented (I)’.183
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l Links between each element of ICAMO were conceptualised and then compared and contrasted
with the initial programme theory. A transparent and systematic process was followed.
l The initial programme theory was modified to reflect findings, providing an updated explanation of
how, why, for whom and under what health system conditions the adherence club intervention
works (or not).
l Guidelines for reporting realist evaluation studies were followed.255
Case study 22: evaluation (theory-based approach)
Study title: The impact on health inequalities of approaches to community engagement in the New Deal for
Communities regeneration initiative: a mixed-methods evaluation.184
Summary: this study drew on a theory of change approach to evaluate the New Deal for Communities,
thus exploring how and why the intervention ‘works’. It explored the social and health impacts of
different community engagement approaches that were undertaken as part of the New Deal for
Communities regeneration initiative in England. There were 39 local New Deal for Communities
programmes that were each given a budget to engage residents in planning and implementing
initiatives to reduce crime and worklessness, and improve community cohesion, housing, the physical
environment, education and health. The study used primary and secondary data, underpinned by
theories of engagement and empowerment, to categorise the community engagement approach of
each programme into four types and explore community empowerment as a mechanism of change
within these approaches. Analysis explored how the four community engagement types related to
different health and social outcomes, ultimately looking at whether or not the different community
engagement approaches explained any of the differential outcomes of the New Deal for Communities
programmes (that were previously identified). Economic analysis was also undertaken to explore the
cost-effectiveness of different community engagement approaches. Statistical results were mixed and
most were not statistically significant, and evidence of effectiveness was inconclusive because of
limited accurate cost data. However, patterns of change were consistent with theories about the
relationship between empowerment and health and social outcomes. The theoretical interpretation
highlighted which of the different community engagement approaches could be problematic and may
lead to unintended negative health and social outcomes, and which could more plausibly have positive
impacts and, thus, how community engagement approaches could be made to work better. The findings
highlight the need for prudent application of theory to make sense of effectiveness studies, in this case
where results are inconclusive.
Key points:
l The typology of community engagement had strong theoretical underpinnings and was sense
checked with the New Deal for Communities residents and practitioners, who were also advisors in
the study.
l Theory of change was explored by testing plausible programme theories in practice.
l The value of this study lies in providing an understanding of the mechanisms of change and
relationship with context, rather than the effect estimate.
Case study 23: evaluation (systems perspective)
Study title: Evaluating a complex health promotion intervention: case application of three systems methods.185
Summary: the Delaware Young Health Program IM40 was an initiative to address the health and
well-being of young people in Delaware through a developmental assets approach. It was funded by
AstraZeneca plc (Cambridge, UK), a pharmaceutical company. By drawing on systems thinking and
complexity science, the study aimed to identify and examine underlying patterns and structures in the
network of individuals and their relationships that influenced system-wide behaviours, for example a
culture shift in communities to better value young people. IM40 was a complex intervention in the sense
that it sought to influence several levels simultaneously (individual, professional, procedural and policy)
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and it was flexible and adaptive. Participating local communities were expected to follow a set of
principles rather than adopt particular strategies. Each community had a different starting point in
terms of relationships between organisations and existing strategies. Three systems science methods
were used: group model building and viable systems model assessment to identify underlying patterns
and structures, and social network analysis to evaluate change in relationships over time.
Key points:
l IM40 was expected to change underlying system dynamics, structures and conditions; therefore,
the evaluation identified systems-oriented research questions and methods.
l The systems-oriented research questions were checked with stakeholders to ensure that they were
relevant and useful. The study used mixed methods to gather data.
l A developmental evaluation focus was taken, which was appropriate to the complexity involved and
the early stage of the work.
l Group model building was used to collaboratively create a causal model of the intervention with
key stakeholders. The viable systems model method was used to model and assess the emergent
organisational structure of the intervention. Social network analysis was conducted to explore shifts
in the relationships between actors in the system. Strengths and limitations of each method used
are reported in the paper.
Case study 24: evaluation (systems perspective with process evaluation)
Study title: Consequences of removing cheap, super-strength beer and cider: a qualitative study of a UK local
alcohol availability intervention.186,187
Summary: ‘Reducing the Strength’ is an intervention in which local authorities ask retailers to stop
selling ‘super-strength’ beer and cider. Street and homeless drinkers are the target population for
the intervention. The mixed-methods process evaluation took a systems perspective to explore the
pathways through which the intervention may lead to intended and unintended consequences.
The authors interviewed relevant stakeholders including compliers and non-compliers (shop keepers),
the target public (homeless people) and stakeholders from a wider array of relevant services (homeless
service providers relevant to alcohol and accommodation provision, and community safety officers).
This was carried out to determine whether or not the intervention was developed to fit coherently
within the wider system and to look at the consequences of different forms of adaptation and
feedback, for example finding that homeless people adapt by changing their method of intoxication
or by switching to shops that do not comply with the intervention. The authors conclude that
owing to the above issues and the small-scale implementation and limited range of products
included in Reducing the Strength, the intervention can make only a modest impact on alcohol
harms. However, the intervention may lead to wider system changes as it impacts on services
not just individual drinkers.
Key points:
l Reducing the Strength was conceptualised as an event in a complex system, and the way in which
multiple people or agents within the system responded to it was explored.
l Multiple perspectives were sought.
l The study drew on complexity theory and developed multilevel theories of change to explain the
impacts of the intervention.
l The qualitative work identified how the Reducing the Strength intervention affected components of
the system and teased out the mechanisms by which the intervention triggered system changes.
l Qualitative methods may help address barriers to evaluating local health policy innovation, ‘which
can include small delivery scales, rapid delivery timescales, and a demand from local decision makers
for evidence that is sufficiently contextually rich to be recognisable to them as local’.186
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Case study 25: evaluation (systems perspective with qualitative comparative analysis)
Study title: A qualitative comparative analysis of factors associated with trends in narrowing health
inequalities in England.188
Summary: targets for reducing health inequalities in England were adopted by the UK Government
in 2001. Seventy ‘spearhead’ local authority areas were identified (those in the bottom fifth for five
factors related to mortality, morbidity and the Index of Multiple Deprivation: 28% of the population
in England). An example target was that the difference in life expectancy between the English and
the spearhead areas average should reduce by 10%. The study aimed to explore variation between
areas on their progress in achieving the targets, particularly looking at cardiovascular disease and
cancer outcomes. QCA was used to explain why particular ‘cases’ have particular outcomes. Each
spearhead area was a case in the analysis and each case was thought of as a local system, with
different organisational attributes and contextual features. Data were gathered about the local
conditions of each case (at present time and 3 years previous) using questionnaires completed by
relevant professionals in each area. Secondary data were also used, for example hospital admissions
and crime rates. The fsQCA software (version 3.0; Ragin and Davey, Irvine, CA, USA) was used to
explore the effects of the attributes on the outcome indicators in combination with each other rather
than individually. This showed the different configurations of attributes, for example the combination
of ‘individual commitment and champions’ and ‘higher spend per head on cancer programmes’, that
were associated with narrowing/widening inequalities between spearhead areas and English averages.
Necessary and sufficient conditions were then identified for each morbidity and mortality outcome;
for example, for narrowing the cancer gap, ‘championing’ was present in all configurations and was
absent where the cancer gap was not narrowing. Results of the study were presented at a series
of local stakeholder workshops, and to understand more about the sufficient conditions identified,
such as individual commitment and championing, the authors planned to have discussions with
local stakeholders.
Key points:
l QCA focuses on inter-relations between the system’s constituent parts rather than on the
individual components.
l Substantive and theoretical reasoning, rather than experimental design, is used to justify
causal pathways.
l Anomalous cases are used as triggers for further investigation.
l Stakeholder involvement is key to the QCA process, both for defining and measuring important
attributes and for interpreting the results.
Case study 26: intervention development – discrete choice experiments
Study title: Using discrete choice experiments to inform the design of complex interventions.262
Summary: discrete choice experiments can be used to quantify user preferences for different aspects
of an intervention and to explore heterogeneity in preferences among users. This study used a discrete
choice experiment in combination with a qualitative study to develop a voluntary medical male
circumcision intervention for HIV infection prevention in the United Republic of Tanzania. Qualitative
data from interviews and participatory group discussions with women, young men (< 20 years) and
older men (≥ 20 years) were used to identify barriers to and facilitators of voluntary medical male
circumcision, such as the role of female partners, service providers’ attitudes and social stigma.
A discrete choice experiment (n = 325) was used to measure men’s preferences for or against
characteristics of voluntary medical male circumcision services, such as availability of partner
counselling, age-separated waiting areas and female health-care staff. The findings were used to
develop an intervention that included community information booths, separate waiting areas and
training for providers on client friendliness.
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Key points:
l Qualitative and quantitative data were combined to develop an intervention to inform the
development of a complex intervention.
l Participant preferences are an important determinant of uptake and adherence to an intervention,
such as voluntary medical male circumcision, given the stigma associated with HIV.
l The use of a discrete choice experiment, informed by qualitative information about barriers to and
facilitators of, enabled the researchers to design an intervention aligned with user preferences.
Case study 27: implementation in all phases
Study title: An informal school-based peer-led intervention for smoking prevention in adolescence (ASSIST):
a cluster randomised trial.146
Summary: the ASSIST programme identified the most influential students in schools from the 12- to
13-year age group, who were then trained to act as peer supporters during informal interactions
outside the classroom to encourage their peers not to smoke. The intervention was based on diffusion of
innovation theory and adapted an effective adult-focused sexual health programme. It was developed in
collaboration with health and education professionals, and the intervention and evaluation methods were
assessed in a feasibility study. A cluster randomised effectiveness trial in 59 schools with nested process
and economic evaluations found the intervention to be cost-effective. Key contextual factors, intervention
mechanisms and variations in implementation were identified.335–337
Key points:
l The intervention was designed to have minimal dependence on school resources, and to avoid poor
implementation, often identified as a key problem of smoking education in real-world classrooms.
l A feasibility study identified a number of changes to the prototype programme to improve its
acceptability to students and schools and to improve the reach of the programme to male students.
l In the evaluation phase cluster randomised trial, the intervention was delivered as closely as possible
to a real-world implementation. Process evaluation data and the programme theory were used to
identify the critical components of the intervention and key barriers to and facilitators of delivery.
l Programme implementation involved an intervention manual that identified both critical components
and adaptable components, allowing for flexible implementation while retaining the key mechanisms
of change. A training manual for the trainers and ongoing quality assurance were built into longer-
term roll-out, based on the programme theory and process evaluation findings.
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Appendix 1 Oversight of the project
Who Role
Project team To undertake all aspects of the project including leading the data gathering, data analysis
and writing the framework document
SAG (see Appendix 3
for members)
To act as the oversight body for the work, specifically to:
l provide expert advice to the project team
l monitor progression of the project in relation to overall timelines
l approve the proposed methodology
l approve the membership of the writing group
l approve/comment on the publication policy
l approve/comment on the main project outputs
l contribute to the promotion and dissemination of the updated framework
l follow the terms of reference as agreed
Writing group (authors) To be part of the author group for the work, adhering to specified authorship criteria.
This included:
l providing written and critical commentary related to area of expertise
l delivering a significant contribution to the main project outputs
MRC PHSG and MRP
Boards
Reviewed and approved the framework
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Appendix 2 Updating the Medical Research
Council guidance on complex interventions:
an outline proposal for developing an
integrated body of guidance
1.
  
 Background: the need for updang and integrang the MRC guidance 
The MRC guidance on evaluang complex intervenons (CIs) was first published in 2000, and 
updated in 2008. Over this period, interest in complex intervenons has grown rapidly, and more 
specialised guidance has been published or is being developed in several related areas, including 
intervenon development, intervenon descripon, process evaluaon, natural experimental 
approaches, dealing with intervenon context, group-delivered intervenons, realist trials, surgical 
trials, exploratory trials, trial management, disability research and knowledge translaon [see 
References for examples]. A number of other areas that were idenfied as gaps in the 2008 
guidance, such as research priority-seng and the applicaon of complex systems science to health 
intervenons, have also aracted interest, but are not yet covered by accessible guidance for 
producers or users of evidence. Both the 2000 and 2008 core guidance documents connue to be 
highly cited (figure), but given the pace and extent of methodological development, there is a strong 
case for updang the core guidance, linking it with related developments, and also addressing some 
of the remaining weaknesses and gaps in the exisng guidance. 
Aim & objecve: To idenfy and summarise aspects of the 2006 MRC complex intervenon 
guidance that require updang, with the aim of using this gap analysis as a starng point for 
discussion (through workshops and authorship group) to achieve consensus on focus points and 
resulng updates for the new guidance.  
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Source: Web of Science. The ‘2000 Guidance’ refers to Campbell et al. (2000) and the ‘2008 Guidance’ 
    refers to Craig et al. (2008). 
2. Proposed outputs 
The 2000 and 2008 guidance each comprised a long version, published online by the MRC, and a 
short version published by the BMJ. The MRC’s process evaluaon and natural experiments guidance 
followed a similar model. Citaons of the short versions greatly outnumber citaons of the long 
versions, although the longer versions have important addional detail and have a very high number 
of downloads. For the updated guidance we recommend two products to disseminate the updated 
core guidance: 
a) A downloadable pdf version of the core guidance. 
b) A journal arcle (ideally published simultaneously in a number of journals, as the CONSORT 
statements are) which would describe the importance and need for the guidance as well as 
outlining its content, also referring potenal users to the detailed online pdf version and 
signposng resource. 
In addion, we will connue discussions about creang an online resource comprising the updated 
core guidance with links to signpost other related source documents (e.g. the MRC’s process or 
natural experiments guidance) or to brief summary statements prepared specifically, with links to 
other useful published resources already available online. 
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 Gap analysis: based on scoping reviews to find publicaons that idenfy gaps and 
weaknesses in the exisng guidance, or that provide more detailed guidance on specific 
topics. This will take the form of horizon scanning and further literature review: a brief 
scoping review will be followed by discussion at the Scienfic Advisory Group (SAG) meeting 
(24/11/17). Our inial search (google scholar, forward/backward citaons) will focus on: 
(a) New approaches/progress since previous guidance; (b) Cricisms of exisng guidance;
(c) Other gaps. Prior to the SAG meeng we will develop a brief list of topics to address in 
the updated guidance. We will present these topics to the SAG (by sending a summary in 
advance and by presentaon of an overview at the meeng). Following discussion at the 
SAG meeting we will finalise a list of topics that we will explore in more depth. 
 Expert workshop: The findings from the gap analysis will inform the agenda for an expert 
workshop to be held in early 2018. Each of the ‘topics/themes’ idenfied for update should 
be represented (by an expert) at the workshop i.e. we will invite experts based on these 
themes. The aim of the expert workshop is to achieve consensus on topics that should be 
newly covered or updated by the new guidance and as a basis for the project team, along 
with the rest of the authorship group, to produce the updates and addions. Follow-up 
consultaon (email and a consensus meeting) will be used to achieve consensus on the 
details of the updated guidance. 
 Idenfy relevant case studies: Worked examples of the development, implementaon, or 
evaluaon of a complex intervenon. This will be started at the workshop and finalised 
through consultaon afterwards.  
 Convening a steering group to oversee the work, review and approve drafts, and ensure 
stakeholder commitment; and a wring group to draft the update and linked summaries 
 Drafng the update and summaries 
 Drafng the journal arcle and managing the publicaon process 
 
4. Representaon 
(a) Steering group: The steering group will meet on an infrequent basis (e.g. two or three mes 
over meline of acvity). The steering group members are: (chair) Martin White (NIHR 
Public Health Research Programme), David French (MRC–NIHR Methodology Research 
Programme), Jo Rycroft-Malone (NIHR Health Services Delivery Research Programme),
Mark
 
Pecrew (Co-author of previous guidance), Marn Ashton-Key (NIHR HTA Programme
& Consultant Adviser, NETSCC), Janis Baird (Co-author of previous process evaluaon 
guidance), Jane Blazeby (MRC Hubs for Trial Methodology Research), Samuel Rowley 
(Observer), Gavin Malloch (Observer). All will be offered authorship (alongside formal 
authorship criteria).  
(b) Wring group: The wring group will meet on a more regular basis (tbc), be engaged in the 
progress of the guidance and contribute to the wring process. Members of the wring 
group will be acknowledged as authors on the final guidance. The project team will be 
members of the wring group, with addional authors idenfied as appropriate, e.g. to fill 
gaps in expertise.   
 
(c) Project team: Employed researchers Kathryn Skivington & Lynsay Mahews; senior staff 
from the host instuon Sharon Simpson, Peter Craig, Laurence Moore. 
3. Proposed stages of development 
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Appendix 3 Advisors/consultees
Members of the Scientific Advisory Group
Martin White (chairperson), Martin Ashton-Key, Janis Baird, Jane M Blazeby, David P French,
Mark Petticrew and Jo Rycroft-Malone.
Participants of the expert workshop
Jean Adams, Rob Anderson, Till Baernighausen, Janis Baird, Jane Blazeby, Chris Bonell, Kathleen Boyd,
Rona Campbell, Neil Craig, Steven Cummins, Frank DeVocht, Matt Egan, Matt Field, David P French,
Michael Grayling, Judith Green, Marie Johnston, Frank Kee, Mike Kelly, Natasha Kriznik, James Lewsey,
Alastair Leyland, Ronan Lyons, Petra Meier, Susan Michie, Graham Moore, Jane Noyes, Chris Owen,
Mark Petticrew, Harry Rutter, Jo Rycroft-Malone, Falko Sniehotta, David Taylor-Robinson,
Rebecca Walwyn, Katrina Wyatt and Lucy Yardley.
In addition, input was received from (although invited, could not attend the workshop) Marion Campbell,
Ruth Dundas, Pat Hoddinot, Russ Jago, Alicia O’Cathain and Eva Annette Rehfuess.
Systems meeting
Steve Cummins, Matt Egan, Vanessa Er, Mike Kelly, Karen Lock and Harry Rutter (follow-up meeting only).
Intervention development meeting
Graham Moore, Alicia O’Cathain, Lucy Yardley and Ed Duncan.
Provided final feedback
Matt Egan, Matti Heino, Graham Moore, Dave Richards, Mark Robinson, Mike Robling and
Jeremy Segrott.
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Appendix 4 Online consultation questionnaire
Q1. Please indicate which stakeholder category you belong to






Service user (Patient or Public)
Other (please specify)






Patient or public involvement
Other (please specify)
Q3. Figure 2: This diagram presents the key elements for developing and evaluating complex interventions. Is this
diagram a useful way of capturing the research process (please elaborate)? [TEXT BOX HERE]
Q4. Definition of complexity and research perspectives: The updated framework presents a new definition of
complexity, and suggests different perspectives of the research process. How useful is it to have the framework for
addressing complexity presented in this way? [TEXT BOX HERE]
Q5. Figure 3. This figure relates to the concept of using different research perspectives (as noted in Q3). Does Figure 3
make sense (please elaborate)? [TEXT BOX HERE]
Q6. Missing elements: If you think there are key elements missing from the guidance, can you briefly outline what they
are? [TEXT BOX HERE]
Q7. Signposting to other guidance: We are keen to signpost to further guidance where appropriate. If we have missed
any specific guidance that may be helpful to readers can you please note it here, thank you. [TEXT BOX HERE]
Q8. Clarity: Was anything in the guidance particularly unclear (please elaborate)? [TEXT BOX HERE]
Q9. Case studies: We are collating case studies to include in the guidance. We would welcome suggestions in the
following areas:
l Modifying interventions to improve their intervention design and/or evaluation design
l The use of programme theory throughout the research process
l Involvement of stakeholders throughout the research process
l Economic considerations throughout the research process
l The exploration and use of context throughout the research process
l Addressing uncertainties throughout the research process
l Complexity informed approaches to intervention research
Q10. Other feedback: If you have other comments that may be useful as we finalise the guidance, please provide brief
details [TEXT BOX HERE]
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Appendix 5 Approaching complexity in
evidence synthesis
The synthesis of complex intervention studies can be particularly challenging and there are numerousimportant considerations applicable to conducting evidence synthesis of complex interventions, including
(but certainly not limited to: see Signposts to further reading 12 for detailed discussion and guidance):
l Context – a similar intervention could be implemented in different contexts with very different
results; therefore, in synthesising these results it may be important to consider the context in
which they were achieved. There are different ways of taking account of context within evidence
syntheses: see Signposts to further reading 12 for further reading. In terms of developing the protocol
for a complex intervention evidence synthesis, it may be necessary to adapt traditional frameworks,
for example to extract data to consider contextual complexity, such as on timing and setting,
dependent on each review’s aims.338
l Uncertainty – similar to undertaking primary intervention research, whether or not it makes sense
to take a systems perspective is dependent on what the users of the review actually want to know,
that is where their uncertainty lies and their related priorities.89,339–341
l Stakeholder engagement – taking account of multiple perspectives is key to understanding
complexity; stakeholders can be involved in each stage, for example determining the scope of the
review, framing and defining the review questions, understanding context and interpreting results.
It is also important to ensure that the review is relevant and useful to the needs of those with an
interest in using the findings, preventing research waste.341,342
l Theory-based review – a different approach to the standard evidence synthesis is a ‘theory-led’
approach, for example a realist review.343 Realist synthesis takes a different approach to systematic
review in that the focus is on coming to an understanding about the theory behind the interventions,
exploring the circumstances in which interventions work or do not work, and for whom. The Cochrane
Handbook also provides guidance to support the synthesis of studies aiming to increase understanding
of intervention complexity, for example through synthesis of qualitative evidence.344
Useful discussions and guides about approaching complexity in evidence syntheses have been
published; see the box below for further details.
SIGNPOSTS TO FURTHER READING 12 Complexity in systematic reviews
l A special issue in BMJ Global Health on concepts and methods for evidence-informed health
decisions,345 including:
¢ Determining whether or not a complex systems perspective would be useful for your evidence
synthesis: consider the questions laid out by Petticrew et al.89 in box 2 of their paper.
¢ Considering complexity within qualitative evidence synthesis346,347 and in mixed-methods research.348
¢ Tools and frameworks for considering context within evidence synthesis.349
¢ WHO-INTEGRATE: a new evidence-to-decision framework tool, particularly developed to be used
with complex interventions, to support the transparent consideration of all decision criteria.350
¢ Special issues of the Journal of Epidemiology and Community Health: one largely devoted to considering
complexity in systematic reviews of interventions351 and one to complex interventions in systematic
reviews developed by the Agency for Healthcare Research and Quality.352
¢ A tool for assessing the complexity of interventions within systematic reviews: intervention
complexity assessment tool for systematic reviews.353
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¢ Version 6.1 of the Cochrane Handbook includes new chapters on intervention complexity, qualitative
evidence, network meta-analysis and synthesising findings using alternative methods to meta-analysis.344
¢ PRISMA-CI is an extension of PRISMA, the accepted standard for encouraging consistency and
transparency in systematic reviews.354 PRISMA-CI incorporates issues specific to complex
interventions, alongside an ‘explanation and elaboration’ guideline to support its use.355,356
¢ Meta-ethnography can inform the development, evaluation and implementation of complex
interventions. The eMERGe reporting guidance aims to improve the reporting of meta-ethnography.357
¢ GRADE is being adapted to address non-randomised studies of complex interventions, alongside
guidance on how sources of complexity can be considered when using GRADE to rate certainty
of evidence.358
GRADE, Grading of Recommendations Assessment, Development and Evaluation; PRISMA, Grading of
Recommendations Assessment, Development and Evaluation; PRISMA-CI, Grading of Recommendations
Assessment, Development and Evaluation – Complex Interventions.
SIGNPOSTS TO FURTHER READING 12 Complexity in systematic reviews (continued)
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Appendix 6 Checklist for developing and
evaluating complex interventions
This checklist is intended as a tool to help researchers prepare funding applications, researchprotocols and journal publications. It may also help reviewers to assess whether or not the
recommendations have been followed.
Item
If NO, please justify.
If YES, briefly describe




1. Have you determined the aim(s)/purpose(s) of the intervention?
2. Have you identified the key uncertainties given existing
evidence about the intervention and the context in which it will
be tested or implemented?
3. Do the research questions and methods address the
key uncertainties?
4. Does the choice of research perspective (efficacy, effectiveness,
theory-based, systems) reflect the key uncertainties that have
been identified?
Engaging stakeholders
1. Have you engaged stakeholders in the design/identification of
the intervention and the development of the research protocol?
2. Have you engaged stakeholders in the conduct of the research
and the dissemination of findings?
3. Have all stakeholders declared any potential conflicts
of interest?
Considering context
1. Have you identified all the dimensions of context that may
influence how the intervention achieves its effects?
2. Have you considered how context may affect the scaling up or
scaling out of the intervention?
Developing and refining programme theory
1. Have you developed a programme theory for your intervention
that describes the key components and mechanisms of the
intervention and how it interacts with the context in which it
will be implemented?
2. Have you updated the programme theory to incorporate the
new evidence gathered by the study?
Refining the intervention
1. Have you refined the intervention so that it is optimised for the
context in which it will be implemented?
2. Have you specified how far and in what ways the intervention
can be refined during implementation without undermining the
programme theory?
Economic considerations
1. Have you considered whether or not the value of the evidence,
in terms of informing future decision-making, justifies the cost
of the research?
2. Have you identified an economic evaluation framework that is
appropriate to the expected outcomes of the intervention?
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Item
If NO, please justify.
If YES, briefly describe




Developing interventions – have you used a formal framework
(such as INDEX) to guide development of the intervention?
Identifying interventions – for policy and practice interventions,
have you performed an evaluability assessment to determine
whether or not and how an evaluation should be undertaken?
Feasibility – have you defined and used clear progression criteria
to guide decisions about whether to proceed to an evaluation
study?
Evaluation – have you chosen an appropriate study design to
answer the research questions and provide robust evidence to
inform decision-making about further intervention refinement,
evaluation or implementation?
Implementation – have constraints and enablers of implementation
been considered at all phases, from intervention development,
through feasibility and effectiveness testing, to large-scale roll-out?
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